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English abstract 
With the onset of lactation, dairy cows have to mobilize body reserves, mainly body fat, to 
cover the output of energy via milk. The homeorhetic metabolic adaptation to the needs of 
milk production is accomplished through the orchestrated action of hormones. In contrast to 
the “classical hormones” that knowingly control parturition, lactation and metabolism, the 
role and importance of messenger molecules originating from body fat (adipokines), of their 
receptors and also of nuclear receptors as key regulators of gene expression was only scarcely 
investigated in dairy cows. In particular, data on body fat were largely limited to 
subcutaneous (s.c.) fat from one location easily accessible via biopsy, whereas potentially 
heterogeneous reactions between different s.c. depots and also in different visceral (v.c.) fat 
were not yet comprehensively addressed. The aim of this dissertation was to characterize the 
mRNA expression of several adipokines and related factors that are involved in insulin 
sensitivity (IS) and in inflammation during the transition from pregnancy to lactation and 
during the subsequent lactation. In addition, dietary supplementation with either CLA vs. a 
control fat (supplementation period day 1 to day 105 or 182 of lactation) was tested for 
potential effects on the target mRNAs. The tissue in focus was adipose tissue (AT) with its 
different locations. Initially, suitable reference genes were identified as a methodological 
prerequisite for the studies. Using tissue samples obtained from both primiparous and 
pluriparous cows from animal experiments within a project cooperation, the time course of 
the mRNA abundance of 12 different target genes and 7 reference genes was characterized in 
s.c. fat and in liver from pluriparous cows and in three different s.c. and in three v.c. fat 
depots, in liver, skeletal muscle, and in mammary gland from primiparous cows. Two acute 
phase proteins, i.e. haptoglobin (Hp) and serum amyloid A3 (SAA3), were newly established 
as adipokines in cattle; both mRNAs yielded similar time course patterns with a peripartal 
peak. Treatment with CLA was mostly not affecting Hp and SAA3 mRNA expression; the 
decrease observed for Hp and SAA3 mRNA in 2 out of 6 fat depots tested indicates local anti-
inflammatory effects of CLA. No CLA effect was observed for the Hp serum concentrations 
and for hepatic Hp mRNA. Indeed, we confirmed liver as the main site of Hp production. For 
the prioritization of nutrient uptake towards the mammary gland, IS in other peripheral organs 
is knowingly reduced. The mRNA expression of the target genes related with IS, i.e. 
adiponectin (ADIPOQ), leptin (LEP), their receptors (LEPR, LEPRB, ADIPOR1, ADIPOR2), 
of two nuclear receptor isoforms (PPARγ, PPARγ2) and of two pro-inflammatory cytokines 
(TNF-α, IL-6) in s.c.AT and in liver from pluriparous cows was mostly decreased from day 
21 prepartum to day 21 postpartum in s.c.AT except TNF-α; in liver increases were observed 
for LEPRB and ADIPOR2, and decreasing abundance for all other hepatic target mRNAs 
except TNF-α and ADIPOR1 which remained constant in this time. In later lactation, 
prepartum values were reached again and were largely maintained until wk 36. The groups 
treated with CLA or control fat differed detachedly in mRNA abundance of PPARγ, LEPRB 
and TNF-α in liver and of PPARγ2 in s.c.AT; cows of the CLA group had also higher insulin 
concentrations and reduced systemic IS persisting after the end of CLA supplementation. In 
primiparous cows, changes with the duration of lactation were observed for most of the target 
mRNAs (except LEP) but not in all tissues investigated; time course and direction of change 
were partly divergent between the different tissues. CLA treatment for 105 days decreased the 
mRNA abundance of ADIPOQ, ADIPOR2, PPARγ2 and TNF-α in v.c.AT and in the 
mammary gland. The results of these studies provide a longitudinal characterization of the 
expression of genes that are particularly related to AT as a heterogeneous functional regulator 
in lactating dairy cows. The known effect of CLA inhibiting milk fat synthesis might at least 
be partly explained by the down-regulation of PPARγ2 in the mammary gland observed 
herein. The importance of the CLA induced effects on IS for animal health can presently not 
be finally assessed due to lack of validated reference values for IS in high yielding dairy 
cows. 
  
  
German abstract 
Zur Kompensation des Energieverlustes über die Milch zu Beginn der Laktation müssen 
Körperreserven, vor allem Fett, mobilisiert werden. Diese metabolische Anpassung wird durch 
verschiedene Hormone reguliert. Im Gegensatz zu den „klassischen Hormonen“ die Geburt, 
Laktation und Stoffwechsel kontrollieren, ist die Bedeutung spezieller Signalmoleküle des 
Fettgewebes, den sogenannten Adipokinen, sowie deren Rezeptoren und verschiedener 
Kernrezeptoren bei Milchkühen bisher kaum untersucht. Insbesondere Daten zum Fettgewebe 
waren bislang primär auf das für Biopsien leicht zugängliche subkutane Fettgewebe limitiert, 
wobei die Lokalisation am Schwanzansatz im Fokus stand. Mögliche Unterschiede zwischen 
verschiedenen subkutanen Depots sowie zu den einzelnen viszeralen Depots waren dagegen nicht 
herausgearbeitet worden. Ziel der vorliegenden Dissertation war daher die Charakterisierung der 
mRNA-Expression verschiedener Adipokine sowie verwandter Faktoren, welche einen Einfluss 
auf Insulinsensitivität (IS) und Entzündungsprozesse im Übergang von der späten Gravidität zur 
Laktation und danach während der Laktation haben. Zusätzlich sollte der mögliche Einfluss 
konjugierter Linolsäuren (CLA) oder eines Kontrollfettes (Supplementation von Tag 1 bis 105 
bzw. 185 der Laktation) auf die Zielgene ermittelt werden. Das Hauptaugenmerk lag hierbei auf 
dem Fettgewebe (AT) unterschiedlicher Lokalisationen. Als Voraussetzung für die 
unternommenen Studien erfolgte zu Beginn die Etablierung geeigneter Referenzgene. Bei primi- 
und pluriparen Kühen wurde der zeitliche Verlauf der mRNA-Expression von zwölf Ziel- und 
sieben Referenzgenen charakterisiert. Bei pluriparen Tieren erfolgte die mRNA-Quantifizierung 
im subkutanen Fettdepot am Schwanzansatz sowie in der Leber; bei primiparen Kühen zusätzlich 
in zwei weiteren subkutanen sowie drei viszeralen Fettdepots, in der Skelettmuskulatur sowie in 
der Milchdrüse. Zwei Akute Phase Proteine (APP), Haptoglobin (Hp) und Serum Amyloid A3 
(SAA3), wurden als neue Adipokine des Rindes identifiziert. Die mRNAs beider APP wiesen den 
gleichen Zeitverlauf mit einem Peak um den Geburtszeitraum auf; CLA beeinflusste weder die 
Hp- noch die SAA3 mRNA-Expression. Die sinkende Expression in zwei der sechs untersuchten 
Fettdepots deutet auf lokale anti-inflammatorische CLA-Effekte. CLA beeinflusste dabei weder 
die Hp-Serumkonzentrationen noch die mRNA-Expression in der Leber. Die vorliegenden 
Ergebnisse bestätigten zudem die Leber als den Hauptort der Hp-Synthese. Um die 
Nährstoffaufnahme der Milchdrüse zu priorisieren, sinkt die IS der übrigen peripheren Organe. 
Die mRNA-Expression von mit IS in Bezug stehenden Zielgenen Adiponektin (ADIPOQ), Leptin 
(LEP), deren Rezeptoren (LEPR, LEPRB, ADIPOR1, ADIPOR2), zweier Kernrezeptorisoformen 
(PPARγ, PPARγ2), sowie zweier pro-inflammatorischer Zytokine (TNF-α, IL-6) zeigte mit 
Ausnahme von TNF-α im s.c.AT bei pluriparen Kühen eine Verringerung zwischen Tag 21 vor 
der Geburt des Kalbes und Tag 21 danach. In der Leber waren LEPRB und ADIPOR1 erhöht, 
während die übrigen Zielgene, ausgenommen TNF-α und ADIPOR1, welche konstant exprimiert 
waren, an Tag 21 postpartum im Vergleich zu Tag 21 antepartum eine verringerte mRNA-
Expression aufwiesen. In der späten Laktation erreichten die Werte wieder das vorgeburtliche 
Niveau und blieben konstant bis Woche 36. Für die mRNA-Expressionen von PPARγ, LEPRB 
und TNF-α in der Leber und PPARγ im s.c.AT zeigten sich fütterungsbedingte Unterschiede. Die 
Versuchstiere der CLA-Gruppe wiesen zudem höhere Insulinkonzentrationen sowie eine 
reduzierte systemische IS auf, die über das Ende der CLA-Supplementation Bestand hatten. Bei 
primiparen Kühen zeigten sich für die meisten Zielgene (ausgenommen LEP) laktationsbedingte 
Veränderungen. Diese konnten jedoch nicht in allen Geweben nachgewiesen werden. Der 
zeitliche Verlauf sowie die Änderungsrichtung wiesen leichte Unterschiede zwischen den 
Geweben auf. Die CLA-Supplementation über 105 Tage verringerte die mRNA-Expression von 
ADIPOQ, ADIPOR2, PPARγ und TNF-α in v.c.AT sowie in der Milchdrüse. Die Ergebnisse der 
vorliegenden Arbeit stellen eine longitudinale Charakterisierung der Expression von Genen zur 
Verfügung, die bei Milchkühen in Zusammenhang mit AT als funktionellem Regulationsorgan 
stehen. Der hemmende CLA-Effekt auf die Milchfettsynthese kann zumindest teilweise durch die 
hier ermittelte Down-Regulation von PPARγ in der Milchdrüse erklärt werden. Die Bedeutung der 
hier beobachteten, CLA-induzierten Effekte auf die IS in Hinblick auf die Tiergesundheit kann 
derzeit aufgrund fehlender Referenzwerte für die IS bei hochleistenden Milchkühen noch nicht 
endgültig bewertet werden.  
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Introduction 
1. Introduction 
With livestock animals as matter of research, physiology needs to consider a complex 
system with numerous interactions and feedback mechanisms. This system does not only 
comprise the biological organism of the animal itself, but also the herd with the 
interactions between animals, and the underlying technical and human subsystems 
involving the natural environment and also socio-economic factors. In view of the 
worldwide declining arable land and increasing population, the use of land for “food, feed 
or fuel” needs to be balanced. The ability of livestock, in particular ruminants, to make 
use of grasslands otherwise not accessible for food production, as well as the option of 
using human food “waste” for feed provides an opportunity to feed more people and also 
presents other advantages. 
With this background, animals that are able to efficiently convert nutrients into milk or 
meat are required. Genetic selection for increased productivity can have negative side 
effects on animal health and welfare. For example, in dairy cows increasing milk yield is 
commonly related to metabolic disorders, to reduced fertility, lameness and compromised 
immune function and thus increased susceptibility towards infectious disease e.g. 
mastitis. In consequence, the turnover rates within a herd increase resulting in a shorter 
productive life of the animals. To reduce these negative effects different managerial, 
nutritional, and genetic approaches are used. Nowadays, different feed supplements are 
introduced aiming to improve health of farm animals and thus counteracting the short 
productive life. 
 
1.1. Negative energy balance and insulin sensitivity during early lactation 
During early lactation, dairy cows undergo a state of negative energy balance (NEB) and 
cows have to mobilize body resources, mainly body fat, to cover the output of energy via 
milk. Voluntary feed intake does not increase as fast as milk production increases in early 
lactation; in adaptation to this, homeorhetic changes of hormonal regulation and, in 
consequence, metabolism occur, leading to a repartitioning of nutrients mainly from fat 
reserves to the mammary gland (Bell and Bauman, 1997).  
Glucose is a primary fuel for fetal life. The placenta translocates glucose from maternal 
blood circulation in an insulin-independent manner (Bell and Bauman, 1997). This 
process is facilitated by the development of insulin resistance in peripheral tissues. In 
2 
 
early lactation, the peripheral insulin sensitivity is further reduced, e.g. in muscle and 
adipose tissue (AT) allowing to direct glucose towards the mammary gland (Bell, 1995). 
Similar to placenta, glucose uptake is an insulin-independent process in the mammary 
gland tissue as well. The endocrine mechanisms affecting insulin sensitivity are well-
documented but the role of AT derived messenger molecules, i.e. of adipokines and also 
of their receptors in these adaptive processes are only at the outset of being known and 
understood.  
 
1.1.1. Homeorhetic adaptations around parturition 
The importance of a successful transition from pregnancy to early lactation is well 
accepted and determines the profitability of dairy cows. Health problems, nutrient 
deficiency, or poor management may impede the ability of cows to reach maximal 
(production) efficiency (Drackley, 1999). The most critical time for dairy cows is early 
lactation during which the energy requirements increase up to 4 fold in a short time from 
pregnancy and dry period to lactation (Carriquiry et al., 2009). In compensation of the 
new requirements, cows start to mobilize body fat and muscle tissue. Increasing growth 
hormone serum concentrations directly after parturition (Gross et al., 2011; Doepel et al., 
2002) force liver to increase gluconeogenesis and AT to reduce lipogenesis (Renaville et 
al., 2002). Growth hormone increases the utilization of nonesterified fatty acids (NEFA) 
indirectly via IGF-1 in muscle and in mammary gland by increased blood flow as 
reviewed by Renaville et al. (2002). Most of the energy requirement during lactation is 
needed for milk production i.e. in 4 days after parturition, 97% of net energy and 83% of 
metabolizable energy based on energy and protein intake is used for milk production 
(Drackley, 1999). The nutrient uptake of the mammary gland is insulin independent 
therefore other insulin dependent tissues start to increase fatty acid oxidation and to 
decrease glucose uptake and utilization because of the low plasma insulin concentrations 
and the decrease in insulin sensitivity in early lactation (Butler et al., 2003). Liefers et al. 
(2003) showed that the leptin (LEP) concentration is high in the dry period and declines 
to a nadir at parturition thus they suggest that, at least in short term, LEP reflects energy 
balance consequently it is low during early lactation. Recent studies on obesity 
summarized by Ahima and Osei (2008) identified many new molecules related to insulin 
sensitivity i.e. adiponectin (ADIPOQ) and its receptors (ADIPOR1 and ADIPOR2), LEP 
and its receptors [e.g. LEP receptor isoform b (LEPRB)], interleukin-6 (IL-6), tumor 
necrosis factor-α (TNF-α), peroxisome proliferator-activated receptor-γ (PPARγ), 
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PPARγ2, etc. Many of these molecules are AT derived and are named adipokines. 
Although different aspects of these molecules are well established in monogastrics, there 
is less information available in ruminants. 
 
1.1.2. Lipid metabolism during the transition period 
As already mentioned in previous sections, early lactation is accompanied with NEB and 
reduced insulin sensitivity. In normal conditions when tissues are insulin responsive, AT 
deposits fatty acids in the form of triglycerides. Under reduced insulin sensitivity 
conditions or low insulin concentrations in serum, a situation typical for early lactation, 
AT starts lipolysis and thus serum NEFA concentrations increase. Extreme rates of 
lipolysis in AT increase the uptake of NEFA by liver and the liver triglyceride content 
(Figure 1). In early lactation, cows have a high total lipid and triacylglycerol content in 
liver whereas glycogen content decreases (Drackley et al., 2005). In severe cases hepatic 
lipidosis or fatty liver may happen. Otherwise, NEFA is metabolized to ketone bodies or 
 
 
Figure 1: Schematic of metabolic relationships between AT, liver, and mammary gland 
during the transition period; NE = norepinephrine, Epi = epinephrine, CPT-1 = carnitine 
palmitoyltransferase-1, GPAT = glycerol-3-phosphate acyltransferase, TG = triglyceride, 
CoA = coenzyme A, VLDL = very low density lipoprotein (adapted from Drackley et al., 
2006). 
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is released from liver in the form of very low density lipoproteins (VLDL). Both NEFA 
and VLDL are also used in milk fat production as well (Drackley, 1999; Drackley et al., 
2006). 
 
1.2. Regulators of insulin sensitivity 
1.2.1. ADIPOQ system 
ADIPOQ was identified in 2001 in bovine fetal serum as a glycoprotein. ADIPOQ shows 
92 and 82% identity with murine and human ADIPOQ, respectively (Sato et al., 2001). 
ADIPOQ is secreted mainly from AT and exerts insulin sensitizing effects via adiponectin 
receptor 1 and 2 (ADIPOR1/2; Figure 2) in humans (Kadowaki and Yamauchi, 2005). 
The ADIPOR1 is ubiquitously expressed, including abundant expression in skeletal 
muscle. The ADIPOR2 is most abundantly expressed in liver (Kadowaki et al., 2006). 
ADIPOQ reduces the tissue triglyceride content in muscle and liver thus increasing 
insulin sensitivity via increasing the expression of PPARα. ADIPOQ also activates AMP 
activated protein kinase thereby stimulating ß-oxidation and thus decreasing the 
triglyceride content in liver and in muscle tissue (Kadowaki and Yamauchi, 2005). 
 
 
Figure 2: Adiponectin action and its receptors and their functions in different tissues 
(revised after Kadowaki and Yamauchi, 2005 using Wu et al., 2003 and Puigserver et al., 
2001).  
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In dairy cattle, the mRNA abundance of ADIPOQ in subcutaneous (s.c.) AT has been 
reported to be constant (Lemor et al., 2009) or to decrease (Koltes and Spurlock, 2012) 
during the transition from pregnancy to lactation. In intestinal AT, a down-regulation of 
ADIPOQ mRNA from the dry period to peak and late lactation was demonstrated 
(Komatsu et al., 2007). For ADIPOR1 and ADIPOR2 in s.c.AT, constant (Sadri et al., 
2010b) or decreasing values were reported (Lemor et al., 2009). Reduced abundance of 
ADIPOQ and its receptors in AT point to reduced insulin sensitivity during early 
lactation. ADIPOQ is negatively correlated with fat mass and adipocyte size, respectively 
(Cnop et al., 2003; Skurk et al., 2007).  
Studying mammary tissue samples, Ohtani et al. (2011) showed a stable expression of 
ADIPOR1 and ADIPOR2 in peak [60 day postpartum (p.p.)] and late (240 day p.p.) 
lactation. Indeed, ADIPOR2 had the same level of expression in the dry period in 
comparison to the lactation period whereas ADIPOR1 was down-regulated.  
 
1.2.2. LEP system 
LEP was first identified in mice (Zhang et al., 1994) and subsequently in sheep (Dyer et 
al., 1997) and cattle (Ji et al., 1998). LEP is highly conserved across all species, with 
human LEP showing 84 and 83% homology with mouse and rat LEP (Zhang et al., 1994). 
The word LEP comes from the Greek word Leptos which means thin. LEP regulates feed 
intake via its effects on the central nervous system. Increasing LEP suppresses feed intake 
and increases energy expenditure (Ricci and Bevilacqua, 2012).  
LEP is the first adipokine identified and is secreted mainly but not exclusively from AT 
and its expression is proportional to fat mass and adipocyte size (Delavaud et al., 2002). 
LEP affects energy homeostasis and improves insulin sensitivity (Houseknecht and 
Portocarrero, 1998). Serum LEP is reduced p.p. vs. antepartum (a.p.), but at the level of 
the mRNA in s.c.AT from tail head of multiparous cows no changes were observed 
(Lemor et al., 2009; Sadri et al., 2010b). A down-regulation of AT LEP mRNA was 
reported comparing 3 to 10 weeks dry cows with cows in peak lactation, thus AT LEP 
mRNA is higher in dry cows (Komatsu et al., 2007; Thorn et al., 2008).  
LEP exerts its effects via its receptors. LEPR was first identified in mice (Tartaglia et al., 
1995). Multiple splice variants of the LEPR gene encode at least 6 different isoforms of 
LEPR in rodents (Ahima and Flier, 2000; Ingvartsen and Boisclair, 2001). They share a 
common extracellular ligand binding domain but differ in size of the intracellular domain 
(Figure 3). The long form of LEPR - LEPRB - has the primary biological role (Bartha et 
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al., 2005). The LEPRB contains intracellular motifs required for activation of the JAK 
(janus kinase)-STAT (signal transducers and activators of transcription) signal 
transduction pathways being the signal transduction pathways attributed to LEP (Bjørbæk 
et al., 1997; Vaisse et al., 1996). The LEPRB is mainly expressed in different brain 
regions, in particular the paraventricular, ventromedial, and arcuate nuclei of the 
hypothalamus (Williams et al., 1999). LEPRB is also expressed in peripheral tissues 
(Chelikani et al., 2003). In dairy cows’ AT, Lemor et al. (2009) reported an increase in 
mRNA abundance of LEPRB comparing days p.p. vs. a.p. consistent with the 
observations of Thorn et al. (2008) reporting a 10 fold increase in LEPR mRNA 
abundance in AT and a 2 fold increase for the same receptor in liver tissue from late 
pregnancy to early lactation. Hypoinsulinemia associated to NEB in early lactation might 
be responsible for the mentioned induction of LEPRB in liver and AT (Lemor et al., 2009; 
Thorn et al., 2008). 
 
 
Figure 3: The leptin receptor has six isoforms obtained by alternative splicing, which are 
designated ObRa, ObRb, ObRc, ObRd, ObRe, and ObRf (also named LEPRA, B, C, D, E, 
and F respectively). The number below each LEPR form indicates the number of amino 
acids characteristic of each isoform. The box 1 motif is required for JAK interaction and 
activation. However, only the long form (ObRb) contains motifs for the complete 
activation of the JAK/STAT pathway. Three tyrosine residues, whose phosphorylation is 
important for leptin signaling, are indicated in LEPRB: Y985 interacts with the SH2-
containing protein tyrosine phosphatase 2, Y1077 with STAT5, and Y1138 with STAT3 
(adapted from Marroquí et al., 2012). 
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1.2.3. PPARγ and PPARγ2 
Peroxisomes are subcellular organelles found in most plant and animal cells that perform 
diverse metabolic functions including β-oxidation of fatty acids, and cholesterol 
metabolism. The PPAR were identified in 1990 and belong to a nuclear hormone receptor 
superfamily (Tyagi et al., 2011). Nuclear hormone receptor proteins form a class of ligand 
activated proteins that, when bound to specific sequences of DNA, serve as on-off 
switches for transcription within the cell nucleus (Abbott, 2009). The PPAR regulate gene 
expression via binding to specific DNA sequences, peroxisome proliferator response 
elements (PPRE), in the promoter regions of target genes (Figure 4). Prior to DNA 
binding, PPAR forms a heterodimer with the retinoid X receptor (RXR), another member 
of the nuclear receptor super family (Abbott, 2009). 
 
 
Figure 4: Signal transduction of genes regulated by peroxisome proliferator-activated 
receptor γ (revised after Houseknecht et al., 2002 using Rosen and MacDougald, 2006 
and Herrmann et al., 2009). 
 
The family of PPAR includes three members (Figure 5): PPARα, PPARδ, and PPARγ. 
They play an essential role in energy metabolism; however, they differ in the spectrum of 
their activity. PPARγ regulates energy storage in AT, whereas PPARα is expressed 
predominantly in the liver, and to a lesser extent, in muscle, in the heart, and in bone. 
PPARδ, ubiquitously expressed in the whole body, regulates energy expenditure. PPARγ 
is further subdivided in four isoforms (Evans et al., 2004): 
 γ1 - expressed in virtually all tissues, including heart, muscle, colon, kidney, pancreas, 
and spleen. 
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 γ2 - expressed mainly in AT. 
 γ3 - expressed in macrophages, large intestine, and AT. 
 γ4 - expressed in endothelial cells. 
 
Figure 5: Metabolic integration of PPAR regulating energy homeostasis in liver, muscle, 
and adipose tissue (adapted from Evans et al., 2004). TZD: Thiazolidinediones, PPAR: 
peroxisome proliferator-activated receptor. 
 
PPARγ2 is a nuclear receptor highly expressed in AT (Herrmann et al., 2009). It is 
important for adipocyte differentiation and regulates insulin sensitivity by 
transcriptionally activating adipocyte-specific genes involved in insulin signaling, glucose 
and fatty acid uptake, and lipid-storage (Herrmann et al., 2009). There are different 
agonists for PPARγ. Linoleic and arachidonic acid are two natural agonists. 
Thiazolidinediones (TZD) e.g. Ciglitazone, Pioglitazone, and Rosiglitazone are synthetic 
agonists (Nosjean and Boutin, 2002). PPARγ2 agonists increase plasma ADIPOQ 
concentrations and thus improve whole body insulin sensitivity in monogastrics (Combs 
et al., 2004).  
 
1.2.3.1. PPARγ2 in AT 
The peripartal plasticity of AT in response to changes in hormones and specific nutrients 
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is well documented and is under control of regulators of transcription like PPARγ (Loor, 
2010). PPARγ is a key regulator of insulin sensitivity in non-ruminants (Rosen and 
MacDougald, 2006). Therefore, nutritional regulation of PPARγ around parturition might 
support insulin responsiveness in bovine AT. The PPARγ mRNA is stably expressed after 
parturition up to 3 weeks p.p. in AT of dairy cows without differences between cows with 
high or low lipolytic activity as indicated by plasma NEFA concentrations (van Dorland 
et al., 2011). In addition, no difference between PPARγ mRNA expression in AT of cows 
in peak and late lactation was observed as well (Komatsu et al., 2007). PPARγ mRNA 
abundance in AT increases in cows fed with a high energy diet in comparison to low 
energy diet. In the same experiment, they found no effect of TZD administration to diet 
on AT PPARγ mRNA (Schoenberg and Overton, 2011). For the first time in dairy cattle, 
Schoenberg et al. (2011b) reported that TZD up-regulate expression of PPARγ mRNA in 
s.c. tail head fat as well as LEP mRNA similar to monogastrics. Therefore, PPARγ has an 
important regulatory effect in bovine AT similar to monogastrics. 
 
1.2.3.2. PPARγ2 in the mammary gland 
In bovine mammary tissue, PPARγ2 is probably localized in epithelial cells (Bionaz and 
Loor, 2008). Bionaz and Loor (2008) supported this hypothesis by the low expression of 
adipocyte specific genes indicating a low number of adipocytes in lactating mammary 
parenchyma. PPARγ2 is up-regulated up to 3 fold at the onset and throughout 240 days in 
lactation in comparison to 15 d a.p. Previously, similar data was reported for PPARγ. 
Although lactating cows were compared to cows dried-off for 3 to 10 weeks a.p., PPARγ 
was stably expressed during the dry period and peak and late lactation (Komatsu et al., 
2007). PPARγ2 agonists i.e. rosiglitazone and long chain fatty acids were not directly 
influencing mammary PPARγ2 mRNA expression. However, PPARγ2 putative target 
genes (mostly genes related to lipid synthesis) were up-regulated by treatment with 
PPARγ2 agonists (Kadegowda et al., 2009).  
 
1.2.3.3. PPARγ2 in liver 
Liver has a major role in energy metabolism during the transition period. Studies in 
monogastrics associated liver PPARγ with triglyceride homeostasis (Gavrilova et al., 
2003) as reviewed by Rogue et al. (2010). Deletion of PPARγ in liver causes impairment 
in insulin sensitivity (Gavrilova et al., 2003; Matsusue et al., 2003). A decrease in the 
triglyceride content of the liver, a reduction in mRNA abundance of genes dealing with 
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lipid metabolism, and an increase in triglycerides and free fatty acids content occurs in 
plasma of mice with PPARγ gene deficiency. In addition, PPARγ2 but not PPARγ1 in 
murine liver was up-regulated in response to a high butter fat diet (Yamazaki et al., 2011) 
Thus, high fat diets will induce fatty liver in a PPARγ2 dependent manner.  
In dairy cows, feeding a mixture of 50% each of the cis-9, trans-11 and the trans-10, cis-
12 isomer of conjugated linoleic acid (CLA) to dairy cows during late pregnancy and 
early lactation had no effect on PPARγ expression in liver tissue biopsies (Sigl et al., 
2010). This observation regarding to changes in PPARγ mRNA a.p. and p.p. based on the 
real-time PCR quantification cycle values revealed no changes in this time period. In an 
experiment where cows were grouped based on plasma beta-hydroxybutyrate (BHB) 
concentrations (van Dorland et al., 2009), no difference in liver PPARγ mRNA was found 
by BHB grouping or by days around parturition (day 70 a.p. to 98 p.p.). In another 
experiment, hepatic gene expression profiling between cows in mild NEB and severe 
NEB revealed no shift in PPARγ mRNA abundance (McCarthy et al., 2010).  
 
1.2.3.4. PPARγ2 in muscle and pancreas 
In a murine muscle cell line, PPARγ2 follows the same regulatory pathways as in 
adipocytes, i.e. PPARγ2 is reduced in inflammation (TNF-α treatment) and the omega-3 
polyunsaturated fatty acid eicosapentaenoic acid attenuates this effect (Magee et al., 
2012). Indeed, muscle PPARγ mRNA abundance increased more than 10 fold in growing 
steers from 10 to 22 months of age when the size of intramuscular adipocytes was 
increasing independently of breed (Albrecht et al., 2011). A very low abundance of 
PPARγ2 in muscle tissue in comparison to AT was demonstrated as well (Huff et al., 
2004). 
The PPARγ is expressed in pancreatic ß-cells and it could be related to lipotoxic effects of 
fatty acids in these cells (Kawai et al., 2002). Overexpression of PPARγ suppresses 
insulin secretory capacity of pancreatic islets (Ito et al., 2004). Moreover, PPARγ inhibits 
glucagon gene transcription in islets of pancreatic tissues (Krätzner et al., 2008). 
Nevertheless, it remains controversial whether PPARγ contributes to the function of ß-
cells (Welters et al., 2004). 
 
1.2.3.5. Conflicting information available about PPARγ isoforms 
Two isoforms are defined for PPARγ gene in cattle i.e. PPARγ1 (NIH gene back 
accession number: Y12419) and PPARγ2 (accession number: Y12420) (Sundvold et al., 
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1997). The two isoforms show 90% homology. At the mRNA level, the isoforms can be 
differentiated only if at least one of the primer pairs is located at the first 259 bp of 
PPARγ2 or at the first 155 bp of PPARγ1 (Figure 6). 
 
 
 
Figure 6. Alignment of bovine peroxisome proliferator-activated receptor γ 1 (PPARγ1, 
NIH gene bank accession number: Y12419) and PPARγ2 (accession number: Y12420) 
sequences. Horizontal lines indicate missing base pairs. Vertical lines define homologue 
sequences. Dots are used for differences between the two sequences. Digits define the 
number of nucleotides. 
 
Otherwise the primer will not be specific to the isoform. There is another sequence 
submitted in NCBI database under the name of PPARγ (accession number: NM_181024) 
while is actually 100% identical to PPARγ2 (accession number: Y12420) and in many 
cases it is misleading; for example, Kadegowda et al. (2009), Bionaz and Loor, (2008), 
Schmitt et al. (2011), and Ji et al. (2012) reported a PPARγ primer which is actually 
specific to the PPARγ2 isoform based on alignment analysis. My survey of the published 
data (Harvatine et al., 2009; Huff et al., 2004; Komatsu et al., 2007; MacLaren et al., 
2006; Mani et al., 2009; McCarthy et al., 2010; Schoenberg and Overton, 2011; 
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Schoenberg et al., 2011a, b; Sigl et al., 2010; Soliman et al., 2007; van Dorland et al., 
2009; van Dorland et al., 2011) revealed that actually many of the published data 
regarding to PPARγ or PPARγ2 are presenting both isoforms. 
 
1.2.4. TNF-α and IL-6 
TNF-α is a proinflammatory cytokine produced by different cells, mainly by stimulated 
monocytes. TNF-α is involved in inflammation, cell apoptosis, and insulin sensitivity 
(Antuna-Puente et al., 2008; Galic et al., 2010; Gnacińska et al., 2009; Kershaw and Flier, 
2004). High concentrations of TNF-α lead to reduced insulin sensitivity (Hotamisligil, 
2000) and attenuated secretion of ADIPOQ from adipocytes (Maeda et al., 2002). In 
humans, TNF-α is not or only marginally secreted from AT in lean and healthy 
individuals (Mohamed-Ali et al., 1997). However, TNF-α is related to lipid metabolism in 
AT: the net action of TNF-α is to decrease free fatty acid uptake and lipogenesis while 
increasing lipolysis (Sethi and Hotamisligil, 1999). Indeed, TNF-α will increase 
production of free fatty acids and triglycerides in liver as discussed earlier (Popa et al., 
2007). 
In dairy cows, a reduction in plasma TNF-α is reported after parturition (Schoenberg et 
al., 2011b; Winkelman et al., 2008). Indeed, recombinant TNF-α induced insulin 
resistance in steers (Kushibiki et al., 2001) and this was also demonstrated in cows with 
fatty liver (Ohtsuka et al., 2001) indicating negative correlation of serum TNF-α with 
insulin sensitivity. 
IL-6, another proinflammatory cytokine, is expressed in different cells i.e. immune cells, 
endothelial cells, and myocytes. Recently, it was shown that IL-6 is also expressed in and 
released from adipocytes. In non-inflammatory conditions, nearby 25% of IL-6 
circulating in blood are estimated to origin from AT in humans (Mohamed-Ali et al., 
1997). IL-6 is closely linked to lipid metabolism (Garcia-Escobar et al., 2010) and insulin 
resistance (Rotter et al., 2003) beside its role in inflammation. Increased abundance of 
plasma IL-6 is linked to greater lipolysis (Morisset et al., 2008). In addition, lipolytic 
effects of IL-6 in a porcine adipocyte cell culture system are reported (Yang et al., 2008) 
similar to human AT (van Hall et al., 2003). Data are still controversial about IL-6. In 
cases of obesity and type 2 diabetes, IL-6 increases. In contrast, there are studies 
suggesting beneficial effects of IL-6 on the disease causing lipolysis without negative 
effect on insulin-mediated glucose transport (Ji et al., 2011).  
13 
 
Introduction 
 
1.2.4.1. IL-6 and TNF-α in bovine AT 
Both IL-6 and TNF-α are proinflammatory cytokines and initiate an acute phase response 
(APR) in cows (Kushibiki et al., 2003, Nakagawa-Tosa et al., 1995, Yoshioka et al., 
2002). However, limited data is available on IL-6 and TNF-α expression in AT of cattle. 
In dairy cows, AT TNF-α mRNA expression is increased from 8 weeks a.p. to the day of 
parturition and then remains stable for the following 5 weeks p.p. (Sadri et al., 2010a). 
This links TNF-α to the process of body fat mobilization in early lactating cows and 
initiates a similar role for TNF-α in increasing lipolysis in AT as shown for monogastrics 
(Sethi and Hotamisligil, 1999). In AT culture samples obtained from dairy cows, IL-6 and 
TNF-α were increased in response to lipopolysacharide (LPS) treatment (Mukesh et al., 
2010). Thus, adipose depots of dairy cows seems immune responsive and capable of 
synthesizing proinflammatory cytokines in response to inflammation (Mukesh et al., 
2010).  
 
1.2.4.2. IL-6 and TNF-α in bovine liver 
In an experiment to test effects of repeated liver biopsies, IL-6 and TNF-α mRNA were 
detectable in bovine liver biopsies with or without LPS stimulation. The TNF-α mRNA 
abundance was higher than the one of IL-6 (Vels et al., 2009). Both cytokines were up-
regulated after LPS vs. NaCl treatment. In liver of dairy cows, TNF-α mRNA exhibited a 
peak at the day of parturition and another peak at day 49 p.p. (Loor et al., 2005). In 
addition, restricted energy intake resulted in a more pronounced up-regulation of TNF-α 
(Loor et al., 2006). In consistence with data from monogastrics, treatment of cows with 
TNF-α to introduce chronic inflammation caused an increase in liver triglyceride content 
thus relating inflammatory pathways to the introduction of fatty liver (Bradford et al., 
2009). 
IL-6 up-regulates acute phase protein (APP) production in hepatocytes isolated from 
slaughtered cattle if it is added to the cell culture medium in combination with TNF-α. 
However, the presence of only one of these cytokines stimulates concentration of serum 
amyloid A (SAA), but not haptoglobin (Alsemgeest et al., 1996). IL-6 is expressed in 
bovine liver Kupffer cells obtained from slaughtered calves and is up-regulated by LPS 
stimulation (Yoshioka et al., 1998). In microarray and qPCR data of cows with ketosis 
(Loor et al., 2007), IL-6 mRNA was 3 fold up-regulated as compared to healthy cows. 
Network analysis revealed that IL-6 is related to many liver specific pathways e.g. 
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lipoprotein metabolism and fatty acid oxidation (Loor et al., 2007). The alteration of 
pathways affected by IL-6 might lead to liver lipidosis, ketosis, and insulin resistance 
(Loor et al., 2007). IL-6 is thus an important molecule especially regarding the huge 
amount of NEFA which should be processed in the liver of dairy cows in early lactation. 
 
1.3. Acute phase proteins  
Acute phase proteins comprise more than 200 proteins that undergo marked changes in 
their serum concentration after infection, injury, trauma, or surgery depending on the 
protein. The APP include negative or positive proteins, i.e. showing a decrease or an 
increase in their serum concentration in response to stimuli. Albumin and transferrin are 
examples of negative APP. Haptoglobin, C-reactive protein, SAA, ceruloplasmin, 
fibrinogen, and alpha-1-acid glycoprotein (AGP) are examples of positive APP which are 
mainly produced by hepatocytes although extrahepatic expression was also shown 
(Murata et al., 2004). 
The acute phase response is closely related to the immune response as an early defense 
mechanism in the body. Production of cytokines and chemokines by immune cells 
(monocytes, lymphocytes, etc.) is the first step after sensing of antigens or remaining of 
dead cells by these immune cells. The main proinflammatory cytokines are IL-6 and  
TNF-α. They have numerous functions as described in the previous chapter including 
induction of the APR. Production of these cytokines by immune cells causes hepatocytes 
to produce APP (Cray et al., 2009). The APP have vast biological functions depending on 
the protein. Herein, the focus will be on haptoglobin and SAA. 
 
1.3.1. Haptoglobin  
Haptoglobin (Hp) is a plasma protein that binds free hemoglobin thereby inhibiting 
hemoglobin induced oxidative damage (Ceciliani et al., 2012). Haptoglobin comes from 
the Greek word haptein (to bind) and (hemo)globin, and was first discovered in human 
plasma in the late 1930s. Haptoglobin has different functions as reviewed by Ceciliani et 
al. (2012) i.e. limitation of iron availability for bacteria, binding hemoglobin and thus 
prevention of oxidative stress, anti-inflammatory, angiogenesis stimulation, and 
chaperone-like activity. Haptoglobin in AT might act as a monocyte chemoattractant 
factor (Maffei et al., 2009). 
The Hp and SAA are the two main APP in farm animals i.e. cattle, sheep, and goat (Cray 
et al., 2009). In dairy cows, Hp is the most prominent APP. Although SAA response is 
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quicker than Hp (Heegaard et al., 2000), the Hp concentrations in plasma increase more 
in comparison to SAA in dairy cows (Stenfeldt et al., 2011). Measurement of APP in 
blood is used as diagnostic marker for diseases as summarized elsewhere (Ceciliani et al., 
2012; Cray et al., 2009). 
Haptoglobin was shown to be expressed in different cells i.e. leukocytes and milk somatic 
cells (Thielen et al., 2005) and tissues i.e. liver (Yoshioka et al., 2002), reproductive 
system (Lavery et al., 2004), digestive tract (Dilda et al., 2012), and mammary gland (Lai 
et al., 2009; Thielen et al., 2007). Liver is the main source of Hp (Lecchi et al., 2009). 
However, Hp expression in bovine AT has not been shown until now. 
The Hp concentration in blood from healthy dairy cattle is low (< 20 μg/mL). In 
inflammatory situations, the Hp concentration in blood increases. For example, during an 
experimental model of dairy cow mastitis (Eckersall et al., 2006), serum Hp concentration 
increased 5 fold in comparison to a saline control. Injection of 2.5 μg/kg body weight per 
day recombinant TNF-α to lactating dairy cows (Kushibiki et al., 2003) increased serum 
concentrations of Hp more than 1000 fold in comparison to a saline control. Indeed, APP 
are related to the mild inflammatory conditions related to obesity and the consequent 
insulin resistance in humans (Festa et al., 2002). In dairy cows, the association between 
Hp concentrations in serum and in milk and the metabolic status of dairy cows peripartal 
was demonstrated (Hiss et al., 2009) i.e. cows having higher NEFA and BHB exhibiting 
higher Hp in serum. 
 
1.3.2. Serum amyloid A 
SAA is an APP belonging to a family of apolipoproteins. In cattle, pigs, horses, dogs, and 
cats, SAA is a major APP (Eckersal and Bell, 2010). In 1988, the SAA protein was 
characterized in dairy cows (Husebekk et al., 1988). Expression of SAA increases up to 
1000 fold in response to various injuries, infection, etc. From an evolutionary point of 
view, SAA is a highly conserved protein detectable in different vertebrates. Four different 
SAA isoforms have been detected in humans and in mice. Two acute phase SAA (A-SAA) 
i.e. SAA1 and SAA2 are mainly expressed in liver (Uhlar and Whitehead, 1999). Other 
isoforms are SAA3 and SAA4. SAA3 is mainly expressed extrahepatically in rat and mice 
(Chiba et al., 2009; McDonald et al., 2001). Previously, SAA3 was known as a 
pseudogene in human. In 2003, McDonald’s group characterized a mammary SAA3 (M-
SAA3) in humans that was slightly different in size in comparison to other mammals 
(Larson et al., 2003). SAA3 was shown to be secreted from mammary epithelial cells into 
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colostrum and milk (Molenaar et al., 2009; Eckersall et al., 2006). SAA3 is the 
predominant SAA isoform in AT (Scheja et al., 2008). SAA4 is a constitutively expressed 
SAA isoform (C-SAA4) which is moderately expressed in response to inflammatory 
stimuli (de Beer et al., 1996). 
The biological functions of SAA are poorly understood. However, SAA binds to 
cholesterol, modulates the innate immune system, and opsonizes gram positive and 
negative bacteria (Ceciliani et al., 2012). SAA similar to the other APP is a biomarker of 
diseases (Eckersall and Bell, 2010). M-SAA3 increases in cases of mastitis (Eckersall et 
al., 2006). In addition to inflammation and infection, M-SAA3 increases in mid to late 
involution (Molenaar et al., 2009). Indeed, M-SAA3 has antibacterial activity against E. 
coli, Streptococcus uberis, and Pseudomonas aeruginosa. Therefore, M-SAA3 may have a 
role in protecting the mammary gland during mammary remodeling and infection and in 
neonatal calves’ gastrointestinal tract as an antimicrobial against infection (Molenaar et 
al., 2009). SAA3 is not only an APP but also is shown to be related to obesity and the 
respective insulin resistance (Lin et al., 2001); it also acts as chemoattractant in AT in 
which an increase in SAA3 is linked to recruitment of monocyte-macrophages in AT (Han 
et al., 2007).  
 
1.4. Conjugated linoleic acids 
Conjugated linoleic acids are octadecadienoic acids (C18) containing two conjugated 
double bonds, separated by a single bond (Figure 7). Different CLA isomers exist; the 
main CLA isomers are the cis-9, trans-11 and the trans-10, cis-12 CLA isomer (Pariza et 
al., 2001). 
 
1.4.1. Use of supplements containing conjugated linoleic acids  
Nutritional quality is an important issue making food choice. In addition, consumers are 
increasingly aware of the links between diet, health, and disease prevention. Moreover, 
the importance of bioactive food components to enhance human health is increasingly 
discussed. CLA is one of the bioactive molecules present in animal derived foods. 
Ruminant products i.e. milk and meat contain CLA isomers. To increase the CLA 
concentration in these products, CLA is supplemented to the animal’s diet. In addition, 
CLA reduces milk fat production in dairy cattle. Particularly, the trans-10, cis-12 CLA 
isomer is known for its milk fat reducing effect (Bauman et al., 2011). 
 
17 
 
Introduction 
 
Figure 7. Isomers of conjugated linoleic acids (Adapted from James Cook lab web page 
http://www.cook.wisc.edu/). 
 
Studies on CLA in dairy cows are divided to diet supplementation, abomasal infusion, 
and intravenous infusion of individual CLA isomers, mixtures of CLA isomers, or oils 
rich in linoleic acid (i.e. sunflower or safflower oils). CLA infusion in comparison to 
dietary supplementation of CLA causes a more severe milk fat depression (MFD). There 
is a curvilinear relationship between abomasal infusion of CLA and MFD. A maximum 
response of 50% reduction in milk fat yield via infusion of 7.5 g/d trans-10, cis-12 CLA 
isomer was achieved. One-half of the maximal effect was achieved by 3.5 g/d infusion of 
the trans-10, cis-12 CLA. Infusion of higher amounts of CLA into the abomasum caused 
a weak additional MFD response (de Veth et al., 2004). Lactating cows use the majority 
of energy intake for milk production. The energy required for milk fat synthesis is one-
half of the energy required for milk production. Therefore, the CLA induced MFD effect 
could be used effectively to reduce the energy requirements for milk production (de Veth 
et al., 2004). A meta-analysis was conducted on a data set which was compiled from 14 
experiments involving abomasal infusion of CLA isomers for more than 4 days and 
indeed having a MFD higher than 25%. The results showed that dry matter intake 
decreases by 1.5 kg/d during CLA induced MFD. The dry matter intake reduction 
accounts for a part of the energy spared from reduced milk fat synthesis (Harvatine et al., 
 
 
trans-10, cis-12 CLA 
 
 
cis-9, trans-11 CLA 
 
 
linoleic acid (cis-9, cis-12) 
18 
 
2009). In early lactation, the energy spared by MFD can be used for higher yield of milk 
and/or protein (Bauman et al, 2008). In dairy cows, MFD is considered as a specific effect 
of CLA at the mammary gland; both short and long term application of CLA to induce 
MFD had no effect on plasma concentrations of glucose, NEFA, BHB, insulin, IGF-1, 
growth hormone, and LEP in the majority of cases (Baumgard et al., 2002; Baumgard et 
al., 2000; Castaneda-Gutierrez et al., 2005; de Veth et al., 2006; Perfield II et al., 2002). 
In conclusion, homeostatic responses seem unaltered. In monogastric animals, CLA are 
also known for reducing body fat. Plourde et al. (2008) summarized the results of 
different studies about CLA induced body fat changes in humans and in mice and stressed 
the discrepancies related to substantially different experimental designs used in humans 
as compared to animal studies: the adiposity reducing effect of CLA is consistent in mice 
studies. In dairy cows receiving CLA supplements, body fat seems largely unaffected as 
evident from various indicators for body fat content and lipolysis at least during short 
term treatment (Baumgard et al., 2002) or treatment including a 4 week a.p. and a 5 week 
p.p. interval (Kay et al., 2006). However, when comparing fat cell size in different s.c. 
and visceral (v.c.) fat depots from CLA treated cows vs. a control group, we recently 
observed a decrease of adipocyte size with CLA treatment in 5 out of 6 different depots 
(Akter et al., 2011) whereas fat depot mass was decreased by CLA only in the 
retroperitoneal fat depot at 105 DIM (von Soosten et al., 2011; Akter et al., 2011). 
However, reduced mammary lipid synthesis during CLA treatment is consistent with the 
decreased lipid synthesis and body fat effects in other models, but the cellular responses 
and mechanisms are quite different, as reviewed by Bauman et al. (2008). The CLA doses 
used to elicit reductions in body fat are much greater than the doses used to reduce milk 
fat synthesis in the dairy cow (about 0.5 vs. 0.05% of the diet), and the dose used to 
induce MFD in the cow is expected to be much lower than the effective dose required to 
elicit direct AT responses in monogastrics. 
 
1.4.2. CLA supplementation and alteration of gene expression 
Genes related to CLA induced MFD in the mammary gland are well documented 
(Bernard et al., 2008). CLA (trans-10, cis-12) induced MFD was accompanied by a 
dramatic reduction (> 35%) of the mRNA abundance of enzymes involved in mammary 
uptake and intracellular trafficking of fatty acids [lipoprotein lipase (LPL) and fatty acid 
binding protein (FABP)], de novo FA synthesis [acetyl-CoA carboxylase (ACC) and fatty 
acid synthase (FAS)], desaturation [stearoyl-CoA desaturase (SCD)], and esterification 
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[glycerol-3 phosphate acyl transfrase (GPAT) and acyl glycerol phosphate acyl transfrase 
(AGPAT)]. Similarly, intravenous administration of trans-10, cis-12 CLA, either from 2 
to up to 6 g/day (Viswanadha et al., 2003) or 10 g/day (Harvatine & Bauman, 2006), 
depressed milk fat yield. In the latter study (Harvatine & Bauman, 2006), a joint decrease 
observed in the expression of genes involved in mammary uptake of fatty acids (LPL), de 
novo fatty acid synthesis (FASN), and the regulation of lipid metabolism e.g. sterol 
regulatory element binding transcription factor 1 (SREBP1), thyroid hormone responsive 
spot 14 (THRSP or S14), insulin induced gene 1 (INSIG1). 
In s.c. fat depot of dairy cows, effects of CLA on gene expression showed that expression 
of genes related to lipid synthesis i.e. enzymes like LPL, SCD, FAS, and FABP4 increased 
4 days after abomasal infusion of 7.5 g/d trans-10, cis-12 CLA. An important nuclear 
receptor and regulator of lipid synthesis, PPARγ, was also increased due to abomasal 
CLA infusion (Harvatine et al., 2009).  
In monogastrics, CLA are known as ligands for PPARs (Bensinger and Tontonoz, 2008). 
Supplementation with the trans-10, cis-12 CLA isomer induced severe hepatic steatosis in 
mice with less effect in rats and hamsters. Regardless of species, lower body adiposity is 
observed when hepatic steatosis happens suggesting that the liver is not able to oxidize 
fatty acids mobilized from AT (Vyas et al., 2012). CLA (trans-10, cis-12) reduced the 
cellular and secreted ADIPOQ protein in the murine adipocyte 3T3-L1 cell line (Miller et 
al., 2008) and decreased LEP mRNA abundance in AT from rats (Gudbrandsen et al., 
2009). Analogous findings for circulating LEP could not be established in dairy cattle 
(Baumgard et al., 2002; Block et al., 2003). Dietary supplementation of an equal mixture 
of cis-9, trans-11 and trans-10, cis-12 CLA isomers fed to pigs had no effect on LEPRB 
immunofluorescence intensity in AT (Di Giancamillo et al., 2009) although LEP 
expression measured using Western blotting and by immunofluorescence intensity was 
lowered. To our knowledge, there is no information available on CLA effects on LEPRB 
expression in cattle.  
 
1.4.3. CLA supplementation and insulin sensitivity 
Using an RQUICKI index which is calculated from blood metabolites (glucose and 
NEFA) and insulin concentrations, insulin sensitivity in cows can be estimated (Holtenius 
and Holtenius, 2007). The majority of studies about CLA supplementation to cows’ diets 
reported that the blood concentrations of insulin (Baumgard et al., 2002, Baumgard et al., 
2000, Castaneda-Gutierrez et al., 2005, de Veth et al., 2006), glucose, BHB, and NEFA 
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are not affected (Bauman et al., 2011) . Exceptionally, Baumgard et al. (2000) and 
Selberg et al. (2004) reported that NEFA and IGF-1 concentrations increased in serum of 
cows infused abomasally with the trans-10, cis-12 CLA isomer. Long term administration 
of a mixture of CLA isomers (2 weeks a.p. through 20 weeks p.p.) is only reported once 
(Bernal-Santos et al., 2003). Unfortunately, insulin was not measured in their study. In a 
mouse model, an increase in insulin release capacity of islets of Langerhans in CLA 
(trans-10, cis-12) fed mice was reported (Poirier et al., 2005) and was explained by an 
increase in ß-cell mass and number. Similarly, obese men treated with trans-10, cis-12 
CLA showed hyperproinsulinemia (Risérus et al., 2004). Indeed, supplying a 50:50 
mixture of cis-9, trans-11 and trans-10, cis-12 CLA isomers increased serum insulin 
concentrations in women (Raff et al., 2009).  
 
1.4.4. CLA supplementation and APP 
Conjugated linoleic acids and their relation to inflammatory cell signaling were recently 
reviewed by Reynolds and Roche (2010) addressing isomer specific effects of CLA on 
different ILs, TNFs, interferon gamma. Less is known about the contribution of CLA to 
APP in particular Hp and SAA. Obese rats treated with a mixture of CLA isomers had 
reduced Hp serum concentrations but Hp mRNA in liver was unchanged (Noto et al., 
2007). It was suggested that the anti-inflammatory effect of CLA occurs at the level of 
AT although the technique used by Noto et al. (2007) for mRNA quantification was not 
sensitive enough to detect Hp mRNA in AT. A reducing CLA effect on TNF-α mRNA 
and protein in AT was also observed (Noto et al., 2007). In another study (Silvestre et al., 
2011), higher concentrations of Hp and fibrinogen (one of the APP) were observed in 
plasma of cows fed with safflower oil (rich in linoleic acid) vs. palm oil (mainly 
containing saturated fatty acids). In growing heifers, Hp was decreased by addition of a 
rumen protected poly unsaturated fatty acid when compared with a non-supplemented 
diet (Araujo et al., 2010). Other inflammatory proteins e.g. alpha-1-acid glycoprotein 
were not affected by CLA supplementation in piglets, although serum lysozyme and total 
serum immunoglobulin G were higher (Corino et al., 2002). SAA and pro-inflammatory 
cytokines i.e. TNF-α, COX-2, and IL-1ß were down-regulated by cis-9, trans-11 CLA vs. 
butter fat in hamsters (Valeille et al., 2005).  
In contrast to the studies in monogastrics, majority of the factors we already discussed are 
scarcely investigated in dairy cattle and in some cases no information is available. In early 
lactation, dairy cows experience different levels of NEB and reduced insulin sensitivity. 
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The cases of reduced insulin sensitivity addressed in monogastrics are in animal models 
of obesity, type 2 diabetes, or high fat diets which cannot be conveyed to dairy cattle. 
Therefore, understanding the pattern of the aforementioned factors related to insulin 
sensitivity and inflammatory system of dairy cattle and defining the contribution of 
dietary supplementation with CLA to the pathophysiological status of dairy cattle is 
highly relevant. To be able to address these aspects, we defined our objectives in next 
section. 
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2. Objectives 
Herein, the expression of selected adipokines, one classical (LEP mRNA and protein) and 
one yet scarcely characterized in cattle (ADIPOQ mRNA) together with their respective 
receptors (LEPRB, ADIPOR1, and ADIPOR2 mRNA) was recorded. The mRNA 
abundance of nuclear receptors PPARγ and PPARγ2 as regulators of gene expression, of 
the proinflammatory cytokines IL-6 and TNF-α, as well as of the APP Hp and SAA3 was 
quantified. The serum concentrations of Hp, insulin, NEFA, and glucose were determined 
and an index estimating insulin sensitivity (RQUICKI) was calculated from the latter 3 
variables. In two trials, we studied cows in 1
st
 lactation from day 1 to 105 p.p. or cows in 
higher lactation number from 21 days a.p. until day 252 p.p. The aforementioned cows 
received a commercially available 1:1 mixture of cis-9, trans-11 and trans-10, cis-12 
CLA isomers during a period of 105 (primiparous cows) or 182 (pluriparous cows) days 
in milk, respectively. We hypothesized that based on the extent of NEB, cows in 1
st
 vs. 
higher lactation number might divergently respond to CLA with regard to the target 
genes. CLA might affect insulin sensitivity in different tissues of dairy cows. Indeed, the 
serum factors related to insulin sensitivity in dairy cows might be affected similar to 
monogastrics. With regard to the aforementioned factors, the objectives of this study 
were:  
1) to characterize physiological changes of either mRNA expression or protein 
concentration of the aforementioned factors in a whole lactation cycle of dairy cows, 
2) to investigate effects of a dietary supplementation of CLA during the first 105 or 182 
days in milk, 
3) to record potential post-treatment effects of CLA supplementation, 
4) to compare the mRNA expression of the target genes between 3 different v.c. and 3 
s.c. adipose depots, and in liver, skeletal muscle, and mammary gland, and 
5) to discover possible differences between cows in 1st vs. higher parities. 
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ABSTRACT 
 
Selection of stable reference genes (REF) is important in real-time PCR data 
normalization. Bovine tissues such as the mammary gland, liver, muscle, and s.c. fat from 
the tail head have been thoroughly explored for stable REF, whereas fewer reports exist 
for other fat depots. Therefore, a suitable combination of REF was tested for different 
tissues of dairy cattle. Holstein dairy heifers (n = 25) were supplemented (100 g/d) with a 
control fat (n = 15) without conjugated linoleic acids or with rumen-protected conjugated 
linoleic acids (n = 10) from the day of calving until slaughter at 1, 42, or 105 d 
postpartum (n = 5, 10, and 10, respectively). Samples from 6 fat depots (omental, 
mesenterial, retroperitoneal, s.c. tail head, s.c. withers, and s.c. sternum), liver, 
semitendinosus muscle, and mammary gland were collected. The REF mRNA were 
quantified and their stability was analyzed using geNorm
plus
. The 3 most stable REF in 
individual fat tissues and muscle were EMD (emerin), POLR2A (RNA polymerase II), 
and LRP10 (lipoprotein receptor-related protein 10); in mammary gland were 
MARVELD1 (marvel domain containing 1), EMD, and LRP10; and in liver were HPCAL1 
(hippocalcin-like 1), LRP10, and EIF3K (Eukaryotic translation initiation factor 3). The 3 
most stable REF in s.c. fat were EMD, LRP10, and EIF3K; in visceral fat were POLR2A, 
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LRP10, and MARVELD1; and for all 6 adipose tissues were LRP10, EIF3K, and 
MARVELD1. When the mammary gland was added to the 6 adipose depots, at least 5 
REF (LRP10, POLR2A, EIF3K, MARVELD1, and HPCAL1) were needed to reach the 
threshold of 0.15. Addition of liver to the above-mentioned tissues increased the V value. 
The data improve the comparison of gene expression between different fat depots. In each 
case, GAPDH had the lowest stability value. 
 
Key words: reference gene, adipose tissue, normalization, cattle 
 
 
Technical Note 
 
Real-time PCR is the most accurate and fast method to analyze changes in gene 
expression, even for extremely low abundance genes (Bustin and Mueller, 2005). The 
steps from tissue sample preparation to running the real-time PCR comprise different 
kinds of technical variation (Bustin, 2010). It is possible to correct for such experimental 
inaccuracies by using at least 3 of the most stable internal control genes (reference genes, 
REF; Vandesompele et al., 2002), which are expected to be stably expressed in different 
tissues. Treatment and physiological conditions should have no effect on REF stability 
(Huggett et al., 2005). In addition, REF should not be co-regulated (Piantoni et al., 2008); 
otherwise, a bias in pairwise comparisons between REF will occur. Completely stable 
REF do not exist (Vandesompele et al., 2002) and co-regulation between REF cannot be 
entirely excluded. Recently, it was recommended that REF be chosen from microarray 
databases (Hruz et al., 2011) or studies involving wide screen gene expression profiling 
(Kadegowda et al., 2009) due to the broader view of genes stably expressed in different 
tissues. Subsequent verification by real-time PCR has a higher chance of achieving valid 
results. 
Scientists have attempted to define some REF in subcutaneous (s.c.) tail head and 
mesenterial adipose tissue (AT; Mukesh et al., 2010), liver (Janovick-Guretzky et al., 
2007), and the mammary gland (Kadegowda et al., 2009) in cattle. However, well-
defined, appropriate REF for comparing different bovine tissues, especially AT from 
different locations, are lacking. The objective was to introduce a set of REF for studies on 
different tissues of dairy cows evaluating potential effects of supplementation with 
conjugated linoleic acid (CLA). The basic animal experiment was described previously 
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(von Soosten et al., 2011). In brief, 5 of 25 Holstein dairy heifers were slaughtered at 1 
DIM and the remainder (n = 20) were allocated randomly to either a control fat 
supplement (non-CLA FA mixture: Silafat, BASF, Ludwigshafen, Germany) or CLA 
supplementation (Lutrell Pure, BASF) at 100 g/d starting from 1 DIM until slaughter. 
Five heifers per group were slaughtered at 42 and 105 DIM. Samples from 3 visceral 
(v.c.) AT (omental, mesenterial, and retroperitoneal), 3 s.c. AT (tail head, withers, and 
sternum), liver, muscle (semitendinosus), pancreas, and mammary gland were 
immediately dissected after slaughter. The samples were snap-frozen in liquid nitrogen 
and stored at −80°C. Complete details about RNA extraction and purification and 
respective quality controls, cDNA synthesis, and relative quantification using real time 
PCR can be found in the supplemental materials (available at http://www. 
journalofdairyscience.org/). 
Three REF (EMD, emerin; MARVELD1, marvel domain containing 1; and EIF3K, 
eukaryotic translation initiation factor 3, subunit K; Kadegowda et al., 2009) were 
selected on the basis of a previous bovine microarray study. The other REF (LRP10, 
lipoprotein receptor-related protein 10; POLR2A, RNA polymerase II; and HPCAL1, 
hippocalcin-like 1; Hosseini et al., 2010) were selected based on previous experiments in 
our laboratories. Leptin, as an exemplary gene of interest, and GAPDH, as one of the 
commonly used REF, were also analyzed, as described in Table 1. 
The quantification cycle values were imported to qBASE
plus
 version 2.0 (Biogazelle, 
Ghent, Belgium) and all subsequent calculations and data quality controls were done 
based on this software (Hellemans et al., 2007). Average expression stability (M) and 
pairwise variation (V) values for determination of stable REF and number of REF were 
calculated using geNorm
plus
 (Biogazelle). Reference genes should have M and V values 
below the threshold levels of 1.5 and 0.15, respectively (Vandesompele et al., 2002). 
Ingenuity Pathways Analysis (Ingenuity, Redwood City, CA) was used to examine 
potential relationships between the chosen REF in the present study. 
Non-normalized data (relative quantities based on amplicon standard curves) were 
analyzed by using the general linear model in SPSS 17.0 (SPSS Inc., Chicago, IL) to 
assess fixed effects of treatment, DIM, and the respective interaction on the relative 
mRNA abundance of each REF. Means were compared using the Tukey test with 
Bonferroni adjustment for multiple comparisons (P < 0.05). To compare total RNA 
concentrations harvested from different tissues at different DIM, the model was limited to 
the control group (a trend was defined at 0.1 > P ≥ 0.05). Leptin mRNA abundance was 
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analyzed using the same general linear model or nonparametric test based on results of 
homogeneity of variances. Pearson correlation was used to assess the relation between 
REF (P < 0.05). 
The RNA integrity number was around 7.27 ± 0.12 for all fat tissues, liver, muscle, and 
the mammary gland, whereas the quality of RNA extracted from pancreas was poor 
(RNA integrity number = 2). Therefore, the data for pancreas are not shown. Table 1 
shows the coefficients of variation (8.19 ± 0.36%) of the real-time PCR replicates per 
gene. The efficiency of the real-time PCR reactions was close to 100%, with R
2
 values 
close to 1 (Table 1). 
The M values of all analyzed REF in each individual tissue were below the defined 
threshold of 1.5 (Table 2); 20% of the M values exceeded 0.5, but none were higher than 
0.79. Combining data from all s.c. fat samples and recalculating REF gene expression 
stability resulted in similar M values as reported for individual tissues. Combining v.c. 
AT or all fat depots led to increased M values up to 0.84. Adding mammary gland and 
liver to the fat tissue data resulted in an upper range of M values of 0.94 and 1.09, 
respectively. The highest M value was consistently observed for GAPDH. 
To determine the optimal number of REF necessary for normalization of the gene of 
interest for individual tissues or a combination of tissues, V values were ascertained 
(Table 3). The 3 most stable REF in individual fat tissues were EMD, POLR2A, and 
LRP10; the addition of the fourth and fifth REF reduced V values by up to 0.03. For 
muscle tissue, a set of the 3 most stable REF comparable to that for individual fat tissues 
could be used, but the V value was 0.03 to 0.04 units higher. The 3 most stable REF for 
mammary gland were MARVELD1, EMD, and LRP10, and those for liver were HPCAL1, 
LRP10, and EIF3K. Addition of the next REF in each case reduced the corresponding V 
value (by 0.03 and 0.12, respectively). Combining different tissues increased the V 
values. In case of AT (6 fat depots, 3 s.c. AT or 3 v.c. AT), 3 REF were sufficient to 
achieve a V value <0.15 (as shown in Table 3), although the V value was higher compared 
with those of the individual fat depots. In these cases, addition of the next REF improved 
the V value, especially in case of v.c. AT (by 0.05 units). Addition of mammary gland 
data to the 6 different AT required the use of at least 5 REF to reach the threshold V value 
of 0.15. Liver included in the panel of tissues resulted in a V value of 0.155 by 
incorporation of the first 4 stable REF, and addition of fifth and sixth REF resulted in no 
improvement. 
The advantage of using the most appropriate REF based on a lower V value is shown in 
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Figure 1A. The highest technical SE occurred when GAPDH was used for normalization. 
Using EIF3K as the most stable REF improved the technical SE. In each case, the lowest 
V value using 6 REF resulted in the lowest technical SE and addition of a seventh REF 
(GAPDH) increased the V value and led to additional technical SE. As shown in Figure 
1B and 1C, the example for leptin as a gene of interest, using inappropriate REF biased 
the relative abundance of leptin in different treatments or tissues. For each sampling date, 
a numerically higher or lower (omental or s.c. sternum, respectively) abundance of leptin 
mRNA was obtained when GAPDH was used for normalization compared with other 
individual REF or sets of REF used for normalization. This difference was significant at 
42 DIM within the CLA group when comparing GAPDH with EIF3K as the most stable 
REF. The SEM for leptin mRNA abundance by ANOVA was lower if the geometric 
mean of the 6 most stable genes was used instead of GAPDH in all fat depots, but not in 
mesenterial AT. 
Statistical analysis of non-normalized relative quantities demonstrated that CLA had no 
effect on REF relative quantities in any of the tissues examined. Individual relative 
quantities of REF were selectively regulated by DIM. This regulation was limited to 
statistical differences between d 1 and d 42 or d 105 and in only some of the tissues. In 
mesenterial, omental, retroperitoneal, and s.c. sternum AT, no effect of DIM was 
observed. In s.c. tail head, EIF3K, HPCAL1, and POLR2A showed different values within 
DIM. In s.c. withers, all REF except MARVELD1 and GAPDH were regulated by DIM. 
All REF were stable at d 1, 42, and 105 in liver tissue, except MARVELD1, which showed 
a significant difference between d 1 and d 42 or d 105. In the mammary gland and muscle 
tissue, all REF were regulated by DIM, except MARVELD1 in the mammary gland and 
GAPDH and HPCAL1 in muscle tissue. 
Pathway analysis showed that HPCAL1 directly regulates GAPDH via protein–protein 
interaction and POLR2A regulates GAPDH via protein–DNA interaction. Furthermore, 
GAPDH showed self-activation and protein–protein interaction. The remaining REF 
exhibited no direct co-regulation. 
Purified RNA (ng/mg of tissue) was plotted against DIM (Figure 2). Total RNA yield was 
higher (P < 0.05) in samples from mesenterial AT, s.c. sternum AT, and from muscle 
tissue obtained on 105 DIM compared with that obtained on d 1 and 42. For 
retroperitoneal AT and mammary gland tissue, this difference was seen as a trend (0.1 > 
P ≥ 0.05). 
In general, the statistical analysis of raw data to detect a time effect was not suited for 
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selection of appropriate REF for longitudinal-type experiments (Bionaz and Loor, 2007). 
Therefore, the significant differences between d 1, 42, and 105 could be due to the 
reported RNA dilution effect described by Bionaz and Loor (2007), depending on 
differences in gene expression of other genes directly after parturition. In spite of the fact 
that the RNA extraction protocol we used was not optimized for this kind of comparison, 
effects of time of lactation on RNA yield were detected for mesenterial AT, s.c. sternum 
AT, and skeletal muscle. As demonstrated herein, the lack of CLA effect on all REF 
indicates that a simple statistical test is insufficient to evaluate REF stability. Taken 
together, these results support the need for pairwise comparisons of REF to assess the 
appropriate REF. 
Only a few bovine AT mRNA expression studies (Hosseini et al., 2010; Mukesh et al., 
2010) have described the use of more than 1 REF. Mukesh et al. (2010) introduced a 
panel of REF for s.c. tail head and mesenterial AT extracted from a microarray 
experiment on s.c. AT, in which the highest M value was 0.47. For s.c. and retroperitoneal 
AT, Hosseini et al. (2010) introduced some additional REF to the commonly used REF. 
The highest M value was around 0.5. Therefore, the list of stable REF recommended by 
our study is suitable for normalization of AT mRNA expression because the M value was 
around 0.31. Decreasing SEM for leptin mRNA data that were normalized based on the 
geometric mean of 6 most stable REF compared with GAPDH supports the finding that 
this set of 6 REF yields a more accurate normalization of the gene of interest. In addition, 
we introduced a panel of REF for s.c. withers, s.c. sternum, and omental AT, which have 
not been intensively explored for stable REF. Both experiments (Hosseini et al., 2010; 
Mukesh et al., 2010) demonstrated that the resulting pairwise variation (V value) was 0.20 
when comparing the 2 fat depots (s.c. and retroperitoneal AT or s.c. and mesenterial AT, 
respectively), which is relatively high. By using the panel of REF illustrated here for 3 
s.c., 3 v.c., or all 6 AT together, the pairwise variation would be 0.14 or 0.11, using the 3 
or 4 most stable REF. This gives an opportunity to isolate physiologically important 
differences that might be lost because of technical SE. 
The REF suggested herein for bovine liver mRNA expression, although not derived from 
microarray studies, were stable enough to be recommended for normalization. Therefore, 
in addition to Janovick-Guretzky et al. (2007), who selected ribosomal protein S9 out of 4 
commonly and 4 less used REF, our results extend the pool of stable REF for liver. For 
fat tissues, it is possible to use the stable REF identified for mammary gland by 
Kadegowda et al. (2009), but they cannot be used for liver. 
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The REF EMD, MARVELD1, and EIF3K, which were recommended by Kadegowda et al. 
(2009), were reconfirmed in the current study as stable REF for the bovine mammary 
gland. In addition, LRP10, POLR2A, and HPCAL1 had M values close to those of EMD 
and MARVELD1 but were lower than that for EIF3K, and adding LRP10, POL2A, and 
HPCAL1 to the panel reduced the pairwise variation. In addition to the useful stable REF 
provided by Perez et al. (2008) and Graugnard et al. (2009), the proposed REF were 
stable in muscle tissue with respect to M and V values. 
In normalization processes, how many REF to use is an important consideration. 
Increasing the number of stable REF will result in lower V and M values and will thus 
lower the technical SE. Reducing the technical SE will result in lower standard error of 
mean. Herein, we demonstrate a new set of REF for gene expression profiling in bovine 
tissues. The key difference compared with previous studies is the greater stability of REF 
in the current study, which permits isolation of small but physiologically important 
differences. This study allows comparison between different tissues by providing 
adequate stable REF. Moreover, REF were suggested for some of the adipose depots for 
which stable REF have not yet been investigated. We suggest abandoning the use of 
GAPDH as the sole REF if its stability is not approved by one of the known algorithms 
such as geNorm. 
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Table 1. Characteristics of the primers and the real-time PCR conditions 
Primers
1
 Sequence (5'-3') 
NIH GenBank 
accession no. 
bp
2
 
Amount 
(nmol) 
Mean Cq 
value
3
 
Annealing
4
 R
2
 Efficiency 
Mean CV 
(%) 
EIF3K
 
Forward  
Reverse  
 
CCAGGCCCACCAAGAAGAA 
TTATACCTTCCAGGAGGTCCATGT 
NM_001034489 125 400 22.87 45 s at 59˚C 0.99 97.54 9.52 
LRP10
 
Forward  
Reverse  
 
CCAGAGGATGAGGACGATGT 
ATAGGGTTGCTGTCCCTGTG 
Bc149232 139 400 21.90 30 s at 61˚C 0.99 101.1 7.95 
POLR2A
 
Forward  
Reverse  
 
GAAGGGGGAGAGACAAACTG 
GGGAGGAAGAAGAAAAAGGG 
X63564 86 800 23.86 60 s at 60˚C 0.98 97.4 7.97 
GAPDH
 
Forward  
Reverse  
 
AATGGAAAGGCCATCACCATC 
GTGGTTCACGCCCATCACA 
U85042 204 400 19.02 75 s at 59˚C 0.99 98.2 6.57 
EMD  
Forward  
Reverse  
 
GCCCTCAGCTTCACTCTCAGA 
GAGGCGTTCCCGATCCTT 
NM_203361 100 400 22.07 45 s at 59˚C 0.99 101.7 9.11 
MARVELD1 
Forward  
Reverse  
 
GGCCAGCTGTAAGATCATCACA 
TCTGATCACAGACAGAGCACCAT 
NM_001101262 100 400 22.61 45 s at 59˚C 0.99 101.2 8.28 
HPCAL1 
Forward  
Reverse  
 
CCATCGACTTCAGGGAGTTC 
CGTCGAGGTCATACATGCTG 
NM_001098964 99 400 23.98 30 s at 60˚C 0.99 97.9 7.96 
Leptin 
Forward  
Reverse  
 
GACATCTCACACACGCAG 
GAGGTTCTCCAGGTCATT 
U62123 183 400 29.23 30 s at 60˚C 0.99 88.6 7.45 
1EIF3K: Eukaryotic translation initiation factor 3, subunit K; LRP10: Lipoprotein receptor-related protein 10; POLR2A: RNA polymerase II; GAPDH: Glyceraldehyde-phosphate-
dehydrogenase; EMD: Emerin; MARVELD1: Marvel domain containing 1; HPCAL1: Hippocalcin-like 1. 
8bp: base pairs.  
2Amplicon size. 
3Cq = quantification cycle; results based on slaughter experiment. 
4Initial denaturation = 10 min at 95˚C; denaturation = 30 s at 95˚C; extention = 30 s at 72˚C, except for POLR2A (60 s at 72˚C). 
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Table 2. Ranking of the most stable reference genes (M values) that can be used for normalization in different bovine tissues
1
  
Tissue                    
Reference gene
2
 
EIF3K  LRP10  POLR2A  GAPDH  EMD  MARVELD1  HPCAL1 
M Rank  M Rank  M Rank  M Rank  M Rank  M Rank  M Rank 
Fat tissue                     
Omental 0.33 4  0.30    3  0.29    2  0.54    -  0.26    1  0.36    5  0.42    - 
Mesenterial 0.37 6  0.26    1  0.30    4  0.53    -  0.26    2  0.27    3  0.34    5 
Retroperitoneal 0.35 5  0.30    3  0.30    2  0.56    -  0.28    1  0.33    4  0.41    - 
Subcutaneous tail head 0.35 5  0.26    2  0.27    3  0.53    -  0.25    1  0.31    4  0.38    6 
Subcutaneous withers 0.37    4  0.27    1  0.30    3  0.73    -  0.27    2  0.45    5  0.52    6 
Subcutaneous sternum 0.27    3  0.27    2  0.30    4  0.47    -  0.26    1  0.37    6  0.34    5 
Non fat tissues                     
Muscle 0.45 4  0.35    1  0.38    3  0.78    -  0.36    2  0.64    -  0.55    - 
Mammary gland 0.31    4  0.28    3  0.36    5  0.58    -  0.26    2  0.26    1  0.34    6 
Liver 0.38    3  0.32    2  0.33    4  0.43    5  0.50   -  0.56    -  0.28    1 
Combination of tissues                     
Subcutaneous fat 0.34    3  0.32    2  0.56    6  0.74    -  0.30    1  0.42    4  0.49    5 
Visceral fat 0.48    4  0.44    2  0.42    1  0.69    -  0.82    -  0.46    3  0.52    5 
Fat  0.51    2  0.51    1  0.56    4  0.84    -  0.72    6  0.51    3  0.63    5 
Fat + Mammary gland 0.57    3  0.55    1  0.57    2  0.94    -  0.79    6  0.65    4  0.72    5 
Fat + Mammary gland + liver 0.60    2  0.56    1  0.61    3  1.09    -  0.79    -  0.94    -  0.66    4 
1n = 25 
2See Table 1 for description of genes. 
3Dash indicates rank of the reference genes with the lowest stability that should not be used for normalization according to pairwise variation in Table 3. 
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Table 3. Proper combination of the most stable reference genes based on the pairwise 
comparisons (V values)
1
 
Tissue                    Order of reference genes stability
2
 V2/3 V3/4 V4/5 V5/6 V6/7 
Fat tissues       
Omental EMD, POLR2A, LRP10, EIF3K, MARVELD1 0.101 0.081 0.072 -3 - 
Mesenterial LRP10, EMD, MARVELD1, POLR2A, HPCAL1, EIF3K 0.088 0.072 0.071 0.061 - 
Retroperitoneal EMD, POLR2A, LRP10, MARVELD1, EIF3K 0.096 0.076 0.068 - - 
Subcutaneous tail head EMD, LRP10, POLR2A, MARVELD1, EIF3K, HPCAL1 0.091 0.081 0.069 0.067 - 
Subcutaneous withers LRP10, EMD, POLR2A, EIF3K, MARVELD1, HPCAL1 0.109 0.102 0.108 0.098 - 
Subcutaneous sternum EMD, LRP10, EIF3K, POLR2A, HPCAL1, MARVELD1 0.086 0.070 0.071 0.063 - 
Non fat tissues       
Muscle LRP10, EMD, POLR2A, EIF3K 0.136 0.119 - - - 
Mammary gland MARVELD1, EMD, LRP10, EIF3K, POLR2A, HPCAL1 0.099 0.074 0.069 0.056 - 
Liver HPCAL1, LRP10, EIF3K, POLR2A, GAPDH 0.119 0.097 0.087 - - 
Combination of tissues       
Subcutaneous fat EMD, LRP10, EIF3K, MARVELD1, HPCAL1, POLR2A 0.120 0.113 0.112 0.105 - 
Visceral fat POLR2A, LRP10, MARVELD1, EIF3K, HPCAL1 0.152 0.105 0.103 - - 
Fat  LRP10, EIF3K, MARVELD1, POLR2A, HPCAL1, EMD 0.149 0.133 0.133 0.132 - 
Fat + Mammary gland LRP10, POLR2A, EIF3K, MARVELD1, HPCAL1, EMD 0.175 0.167 0.145 0.136 - 
Fat + Mammary gland +liver LRP10, EIF3K, POLR2A, HPCAL1 0.194 0.155 - - - 
1
n = 25 
2Reference gene stability decreases from left to right. reference gene stability decreases. See Table 1 for description of 
genes. 
3Dash indicates whether inclusion of next gene increased pairwise variation values. 
  
35 
 
Manuscript 1: Technical note 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Treatments and days postpartum 
Figure 1. Technical SE in omental adipose tissue (A), and leptin mRNA abundance in omental (B) and s.c. 
sternum (C) adipose tissues of heifers supplemented with 100 g/d conjugated linoleic acids (CLA) or a 
control fat supplement (Control) on d 1, 42 and 105 postpartum. Data were normalized based on GAPDH or 
EIF3K or the geometric mean of 2 reference genes (REF; EIF3K and LRP10), 3 REF (EIF3K, LRP10, and 
MARVELD1), 6 REF (EIF3K, LRP10, MARVELD1, POLR2A, HPCAL1, and EMD), or 7 REF (EIF3K, 
LRP10, MARVELD1, POLR2A, HPCAL1, EMD, and GAPDH). Asterisk indicates differences (P < 0.05) for 
leptin mRNA abundance (mean ± SE) between different REF and groups of REF used for normalization. 
AU: arbitrary units. 
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 Days postpartum 
Figure 2. Total RNA harvested from different tissues of heifers fed with a control fat supplement from d 1 
until d 105 postpartum. Different letters designate differences (P < 0.05); trends (0.1 > P > 0.05) are 
indicated by #. 
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ABSTRACT 
The present study aimed to characterize serum haptoglobin (Hp) concentrations 
throughout an entire lactation period in both primi- and multiparous cows and to compare 
them to the Hp mRNA expression in liver and - in view of Hp being potentially an 
adipokine - also in different subcutaneous (s.c.) and visceral fat depots. In addition, 
potential anti-inflammatory effects of long-term supplementation with conjugated linoleic 
acids (CLA) were evaluated by assessing Hp. Trial 1 comprised 33 cows and 16 Holstein 
heifers from day 21 ante partum until day 252 postpartum. The animals received 100 or 
50 g/day CLA or a control fat supplement. Blood samples and biopsy (tail head fat and 
liver) samples were collected. Trial 2 included 25 Holstein heifers, 5 animals were 
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slaughtered on the day of parturition, the remaining animals were allocated to either CLA 
(100 g/day, n = 10) or control fat supplement (n = 10) and slaughtered on days 42 and 105 
postpartum, respectively. At slaughter, fat samples were collected from 3 different 
visceral depots, 3 s.c. depots and from liver tissue. Results indicated no effects of CLA on 
serum Hp and liver Hp mRNA for both trials and on Hp mRNA in biopsies from s.c. tail 
head fat. In omental and s.c. withers fat from trial 2, CLA reduced Hp mRNA on both day 
42 and day 105. Hp mRNA was detectable in fat tissues from both trials with abundance 
values being significantly lower than in liver. The Hp mRNA abundance in the s.c. fat 
depots was generally higher than in the visceral depots. Haptoglobin mRNA abundance in 
the different tissues from trial 2 was correlated whereby all s.c. depots were interrelated. 
The evidence of Hp mRNA expression in adipose tissues and the presence of Hp-immune 
staining in histological fat sections confirm that Hp can be classified as a bovine 
adipokine. The lack of an evident relationship between circulating Hp concentrations and 
normal body fat portions in dairy cattle demonstrates that varying degrees of adiposity are 
not confounding factors when using Hp as inflammatory marker. The physiological 
changes in serum Hp concentration seem to be limited to parity and parturition. In view of 
the lack of effects of CLA on serum Hp concentrations, the observed reaction in two out 
of six different fat depots seems of marginal importance for the organisms as an entity.  
 
Key words: Adipose tissue, Conjugated linoleic acids, Dairy cow, Haptoglobin.  
 
1. Introduction 
Haptoglobin (Hp) is a major acute phase protein (APP) in cattle with serum 
concentrations < 20 μg/mL in healthy animals and 100 to 1000-fold increases in response 
to immune stimulation (Skinner et al., 1991; Godson et al., 1996). In dairy cows, Hp has 
been used as a marker for various diseases including typical production diseases such as 
mastitis and fatty liver syndrome (Eckersall and Bell, 2010). Haptoglobin is produced 
mainly by the liver, but extrahepatic expression such as mammary gland, leukocytes, 
forestomach and abomasum has also been demonstrated in cattle (Thielen et al., 2005; 
Thielen et al., 2007; Dilda et al., 2011). In humans, serum Hp concentrations are 
increased in obese and diabetic patients (Engstroem et al., 2003), correlate with body fat 
content in obese states (Chiellini et al., 2004; Doumatey et al., 2009), and white adipose 
tissue has indeed been identified as a site of Hp expression in several monogastric 
species, e.g. in mice, dogs and pigs (Friedrichs et al., 1995; Eisele et al., 2005; Ramsay et 
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al., 2010) and in man (Fain et al., 2004). Haptoglobin can thus also be classified as an 
adipokine in these species. The term adipokine comprises proteins synthesized and 
secreted from adipose tissue (AT) such as classical cytokines, growth factors, hormones, 
and also APP. Adipokines exert pleiotropic functions, mainly related to energy 
metabolism and the immune system. The increased production of inflammatory cytokines 
and APP by AT in obesity is commonly related to localized events within the expanding 
fat depots (Trayhurn and Wood, 2004) whereby differences between visceral (v.c.) and 
s.c. depots exist (Fain et al., 2010). Although obesity rarely occurs in dairy cows it is 
known that overconditioned cows are more likely to develop reproductive problems 
(Gearhart et al., 1990) and that massive mobilization of white AT fat mass during the 
transition from pregnancy to peak lactation is linked to a period of insulin resistance, 
reduced feed intake, negative energy balance, hypocalcaemia and reduced immune 
function (LeBlanc, 2010). A direct involvement of AT into immune function in cows is 
likely since expression of proinflammatory cytokines and of another APP, serum amyloid 
A3, has recently been demonstrated for both s.c. and mesenterial fat depots together with 
their in vitro responsiveness towards a proinflammatory stimulus (Mukesh et al., 2010). 
In view of the established diagnostic relevance of serum Hp concentrations, we aimed to 
elucidate their relation with body condition and with the potential expression of this APP 
in different adipose depots, thus pointing out the importance for Hp being a bovine 
adipokine. We therefore characterized the Hp concentrations throughout an entire 
lactation period in both primiparous and multiparous cows and compared them to the Hp 
mRNA expression in liver as well as in six different s.c. and v.c. fat depots. Using 
immunohistochemistry, we extended the Hp analyses in AT to the protein level. In 
addition to the physiological changes during lactation, we also tested the effects of dietary 
supplementation with conjugated linoleic acids (CLA) on Hp in serum, liver and fat. 
Supplements containing rumen-protected formulations of CLA mainly contain the cis-9, 
trans-11 and trans-10, cis-12 CLA isomers (Kramer et al., 2004), and reduce milk fat 
synthesis whereas the effects on body fat seem to be mostly limited to monogastric 
species since indicators related to lipolysis and energy homeostasis (non esterified fatty 
acids (NEFA), leptin, insulin-like growth factor 1, adrenergic responsiveness) reportedly 
remain mostly unchanged in CLA supplemented dairy cows (Bauman et al., 2008). 
However, recent reports indicate that adipocyte size in dairy cows is decreased in 
response to CLA (Akter et al., 2011) whereas fat mass was only affected in the 
retroperitoneal depot (von Soosten et al., 2011). Based on results from monogastric 
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species, CLA might also exert immunomodulatory actions by attenuating the 
proinflammatory state in adipose tissue that predisposes to insulin resistance and by 
suppressing inflammatory responses as demonstrated in a variety of animal models in an 
isomer specific manner (Hontecillas et al., 2002; Jaudszus et al., 2008; Moloney et al., 
2007). In context with these immunomodulatory actions of CLA, decreased blood 
concentrations of Hp were demonstrated in obese, insulin-resistant rats (Noto et al., 
2007). In our study we aimed (1) to assess whether Hp can be designated as an adipokine 
in cattle, (2) to compare Hp expression in different fat depots, (3) to test for relations 
between Hp serum concentrations and Hp expression in liver and adipose tissues and (4) 
to evaluate potential effects of CLA supplements on circulating Hp concentration and Hp 
tissue expression.  
 
2. Materials and methods 
2.1. Animals, trials and treatments  
 
The regulations of the German Animal Welfare Act (TierSchG) in its respective 
current edition were met. All animal experiments were approved by the lower saxony 
state office for consumer protection and food safety (LAVES, file no. 33.11.42502-04-
071/07, Oldenburg, Germany). All animals were housed in free stall barns and milked 
twice daily in a milking parlor at the experimental station of the Friedrich Loeffler 
Institute, Federal Research Institute for Animal Health, Braunschweig, Germany. Two 
trials were performed in this study, and all the diets were formulated according to the 
recommendation of the German Society of Nutrition Physiology (GfE, 2001) and are 
described in detail by Pappritz et al. (2011, trial 1) and von Soosten et al. (2011, trial 2). 
If signs of disease were noted during milking by the milking staff or during the daily 
animal control by the stockmen and the veterinarian, respectively, they were filed in a list. 
When indicated, the cows were attended by the veterinarian. For the present evaluation, 
diagnostic findings were only classified as positive (diseased) or negative (non-diseased).  
 
2.1.1. Trial 1  
German Holstein-Friesian cows (n=33) and heifers (n=16) were studied from day 
21 ante partum until day 252 of the subsequent lactation. The animals were fed ad libitum 
over the entire experimental period with a partial mixed ration (PMR) consisting of 63% 
silage and 37% concentrate (6.8 MJ NEL/kg DM) on dry matter (DM) basis. On day 1 
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after calving, the animals were randomly allocated to three groups balanced for lactation 
number (average 1.9 ± 0.1). For the cows, the milk yield of the previous lactation (5797 ± 
122 kg, 200 days in milk) and live weight (627 ± 9 kg) were also considered. The animals 
received 4 kg of additional concentrate (8.8 MJ NEL/kg DM) containing either 100 g/day 
of a lipid encapsulated CLA supplement (Lutrell
®
 Pure, BASF SE, Ludwigshafen, 
Germany; CLA-100: 11 cows and 5 heifers) or 50 g CLA supplement and 50 g of a 
control fat supplement (Silafat
®
, BASF SE; CLA-50: 11 cows and 6 heifers). The control 
group received 100 g of control fat supplement (CTR: 11 cows and 5 heifers). The 
animals of the CLA-50 group consumed 4.3 and 4.0 g/day of the trans-10, cis-12 and cis-
9, trans-11 CLA isomers, respectively (calculated, based on the analyzed proportions in 
the concentrate). In the CLA-100 group, the animals consumed 7.6 g/day each of the 
trans-10, cis-12 and cis-9, trans-11 CLA isomers. In the CTR fat supplement these 
isomers were substituted by stearic acid. Supplements were fed from day 1 until day 182 
postpartum. 
Blood samples were obtained from each animal via jugular venipuncture on days -21, -14, 
-7, 1, 7, 14, 21, 35, 49, 70, 105, 140, 182, 189, 196, 210, 224, 238 and 252 relative to 
parturition. After centrifugation (10 min, 3000 × g, 4°C), serum was stored at -80°C until 
analyzed. The body condition score (BCS) of each animal was recorded at each blood 
sampling time using a five-point system (Edmonson et al., 1989). The mean BCS of the 
animals was 3.1. Biopsies were collected from s.c. fat at the tail head and from liver tissue 
at days -21, 1, 21, 70, 105, 182, 196, 224 and 252 relative to parturition with the 
following procedure: after local anesthesia (Procaine 2%, CP-Pharma, Burgdorf, 
Germany) using Tru-Cut
®
 biopsy needles (Traveno Laboratories Inc, IL, USA, Ø 2.2 
mm), liver was transcutaneously biopsied under ultrasound control using an automatic 
device (BARD
®
, Tempe, AZ). For the biopsies from s.c. AT, the skin adjacent to the tail 
head was incised (2 cm) with a scalpel under sacrococcygeal epidural anesthesia (6 ml 
2% Procaine) at the contralateral side of the preceding sampling. Adipose tissue was then 
excised, frozen in liquid nitrogen, and stored at -80°C. The skin wounds were treated with 
a ceftiofur hydrochloride antibiotic (Excenel
®
, Pharmacia, Erlangen, Germany) and 
closed.  
 
2.1.2. Trial 2  
German Holstein-Friesian heifers (half siblings, all raised under the same 
conditions, n = 25) with an average age at first calving of 23 ± 0.2 months and a mean 
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BCS of 3.0 were used. The study is described in detail by von Soosten et al. (2011). 
Before calving the heifers were kept in group pens and were fed ad libitum with a PMR 
(60% corn silage and 40% grass silage (6.7 MJ NEL/kg DM) and 2 kg concentrate (6.7 
MJ NEL/kg DM per day). The PMR fed postpartum (13.5 MJ NEL/kg DM) comprised 
25% grass silage, 38% corn silage and 37% concentrate on a DM basis. In addition, 4 kg 
concentrate containing the fat supplements were fed daily. On the day of parturition, 5 
animals were slaughtered for determining body composition, the weights of various 
organs and of s.c. and v.c. fat depots and for sample collection. The remaining animals 
were shifted to the postpartum diet and were randomly allocated to either CLA 
supplementation (100 g/day, n = 10) or CTR fat supplement (CTR, n = 10). Supplemental 
fats were as described for trial 1. The animals of the CLA group consumed 6.0 g/day of 
the trans-10, cis-12 and 5.7 g/day cis-9, trans-11 of CLA isomer. Five animals of each 
group were then sacrificed on day 42 and 105 postpartum. Blood samples were collected 
on days -21, -14, -7, -3, 1 (n = 25), 7, 14, 28, 42 (n = 20) and 105 (n = 10) relative to 
parturition. At slaughter, fat samples were collected from 3 different v.c. depots (omental, 
mesenterial and retroperitoneal) and 3 s.c. depots (beside the tail head, above withers and 
sternum) and from liver tissue. The samples were snap-frozen in liquid nitrogen and 
stored at -80°C; for immunohistochemistry the samples were immediately fixed in 4% 
paraformaldehyde overnight. 
 
2.2. Determination of serum Hp, NEFA and ß-hydroxybutyrate concentrations 
 
 An ELISA as described by Hiss et al. (2009) was used. The serum used as 
standard had been calibrated against a standard obtained from a European Union 
Concerted Action on the standardization of animal APP (QLK5-CT-1999-0153, Skinner, 
2001). The limit of detection was 0.07 µg/mL. The intra- and interassay coefficients of 
variation were 3.9% and 12.2%, respectively.  
Blood samples were analyzed for NEFA and ß-hydroxybutyrate concentrations with 
commercial kits (NEFA-C, Wako Chemicals GmbH, Neuss and RANBUT, Randox 
Laboratories GmbH, Wülfrath, Germany).  
 
2.3. Immunohistochemistry for Hp in AT 
 
The tissue samples from trial 2 were immediately fixed overnight in 4% 
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paraformaldehyde (Roth, Karlsruhe, Germany) in phosphate buffered saline (PBS pH 
7.4), dehydrated in ascending grades of isopropanol (Roth) (40%, 70%, 80%, 96%, and 
100%), cleared in Roti
®
-Histol (Roth), and infiltered with a mixture of Roti
®
-Histol and 
melted paraffin (1:1, vol/vol) at 60°C. Finally, the samples were embedded in paraffin 
wax. The samples were cooled with cryo-spray (Roth), sections (10 μm) were cut using a 
rotation microtome (SLEE, Mainz, Germany), mounted on SuperFrost
®
plus slides 
(Menzel, Braunschweig, Germany) and finally dried at 60°C for 2 h and thereafter at 
37°C overnight. Sections were deparaffinized in Roti
®
-Histol, then gradually rehydrated 
in descending grades of isopropanol (100%, 96%, 80%, 70%, and 40%) and washed with 
distilled water. Antigen retrieval was performed with citrate buffer (0.01 mM, pH 6) in a 
microwave oven three times for each 5 min at 700 W, and then the sections were allowed 
to cool at room temperature for 30 min and washed with distilled water. Elimination of 
endogenous peroxidase activity was done using 3% H2O2 for 15 min, the sections were 
washed three times for each 5 min with PBS (pH 7.2, 0.05% Tween 20), and unspecific 
binding was blocked with normal goat serum (1:10) for 20 min. Thereafter, the sections 
were incubated with a polyclonal rabbit antiserum against bovine Hp (Hiss et al., 2004) 
1:2000, in PBS for 15 h. The sections were subsequently incubated with goat anti-rabbit 
IgG coupled with horseradish peroxidase (HRP; 1:200 in PBS, Southern Biotech, 
Birmingham, AL) for 30 min. The sections were then stained with 3-amino-9-
ethylcarbazole (Biozol, Eching, Germany) as a substrate and counterstained in Mayer’s 
Haematoxylin (Merck Eurolab GmbH, Darmstadt, Germany). After washing with tap 
water for 10 min, the sections were mounted with Kaiser’s glycerol gelatine (Merck 
Eurolab GmbH). Based on previous findings that Hp mRNA is expressed in bovine 
leukocytes (Thielen et al., 2005), bovine lymph nodes were used as positive and negative 
controls (sections thickness 6 μm). For negative controls, the primary antibody was 
replaced with non-immune rabbit serum. The sections were evaluated through a Leica 
DMLB microscope (Leica Microsystems, Wetzlar, Germany) at 200 x magnification and 
photographed with a digital camera (JVC, Hachioji Plant of Victor Company, Tokyo, 
Japan). 
 
2.4. Quantification of Hp mRNA abundance in tissues  
 
Liver and s.c. fat biopsies from CTR cows at days -21, 1, 21, 70, 105, 182, 196, 
224, and 252 and from CLA cows, at days -21, 21, 105, 196 and 252 were homogenized 
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using liquid nitrogen, mortar and pestle in case of samples from CLA cows receiving 100 
g CLA/day from trial 1, and using the Precellys
®
24 system (peQLab Biotechnology, 
Erlangen, Germany) for all the samples from trial 2. Total RNA was extracted from the 
homogenates using Trizol (Invitrogen, Karlsruhe, Germany) and purified using spin 
columns (RNeasy
®
 Mini Kit, Qiagen, Hilden, Germany) after DNase (Qiagen) digestion 
in solution. The concentration of RNA and the purity were controlled by absorbance 
readings at 260 nm and 280 nm using the Nanodrop 1000 (peQLab Biotechnology). The 
integrity of the RNA was assessed using ethidium bromide denaturing RNA gel 
electrophoresis and rechecked in selected samples from each tissue by microcapillary 
electrophoresis using the Bioanalyzer 2100 and RNA 6000 Nano Kit system (Agilent, 
Waldbronn, Germany) to determine RNA Integrity Number (RIN = 7.27 ± 0.12). For 
cDNA synthesis, a reverse transcription of 250 ng total RNA per 20 µL reaction volume 
was performed with RevertAid™ reverse transcriptase (Fermentas, St Leon-Rot, 
Germany) according to the manufacturer’s instructions, except that only 1 µL of dNTP 
Mix (10 mM of each dNTP, Fermentas) was used, with a Multicycler PTC 200 (MJ 
Research, Watertown, Mass.). Each run comprised a negative template control and a no 
reverse transcriptase control. Inter run calibrator was prepared using aliquots from each 
cDNA reaction per trial separately. To reduce the variation in cDNA synthesis, reverse 
transcription was performed in duplicates from each tissue which were then combined for 
quantitative PCR. Selection of the most stable reference genes (REF) was done out of 7 
different REF following a similar procedure as described by Hosseini et al. (2010); for 
trial 1, Glyceraldehyde-phosphate-dehydrogenase (GAPDH), Lipoprotein receptor-related 
protein 10 (LRP10) and RNA polymerase II (POLR2A) and Eucariotic translation 
initiation factor 3 (EIF3K), LRP10, POLR2A were selected for s.c. fat and liver, 
respectively, using the geNorm program (Vandesompele et al., 2002). Triplicates with 2 
µL cDNA (diluted 1:4) as template and 5 µL SYBR Green Jump Start Taq Readymix 
(Sigma-Aldrich, Steinheim, Germany) in a total volume of 10 µL were run in an 
Mx3000P cycler (Stratagene, Amsterdam, Netherlands). 
For the samples from trial 2, 7 REF [EIF3K, LRP10, POLR2A, GAPDH, Emerin 
(EMD), Marvel domain containing 1 (MARVELD1) and Hippocalcin-like 1 (HPCAL1)] 
were measured in all samples and the most stable set of REF was selected for 
normalization. Co-regulation between the REF was evaluated using the ingenuity 
pathway analysis (IPA, Redwood City, CA). The REF used for the different tissues or 
tissue sets are summarized together with the time-temperature conditions and primers 
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characteristics in Table 1. The reaction efficiency for each gene and tissue is listed in 
Table 2. All reactions contained a negative template control for quantitative PCR, a 
negative template control and no reverse transcriptase control of cDNA. Quantification of 
the cycle values was converted to relative values based on the efficiency calculated per 
gene out of standard 1 to 10 serial dilutions of PCR amplicons with known 
concentrations. Quantities were normalized based on the geometric mean of REF and 
then calibrated based on the inter-run calibration proposed by Hellemans et al. (2007). 
 
2.5. Statistical Analyses 
 
All statistical analyses were performed using SPSS (version 17.0, SPSS Inc., 
Chicago, IL). For trial 1, the mixed model procedure was used each for serum Hp and Hp 
mRNA as dependent variable. Treatment (CTR, CLA-50 and CLA-100) was considered 
as fixed factor, and sampling dates (time) as a repeated effect, and the respective 
interaction was included into the model. Any clinical observations (only classified as 
positive or negative findings) were considered in the model as random effect to take 
disease specific variations between groups into account. For serum Hp, but not for mRNA 
analyses which were limited to the cows from trial 1, parity (cows or heifers) was 
considered as fixed effect together with its interaction with treatment. The covariance 
structure heterogeneous first-order autoregressive and Bonferroni correction were used 
for serum data, while component symmetry was used for mRNA data. 
For trial 2 in which the repeated design was not applicable, all data were tested for 
homogeneity of variances (P < 0.1). With regard to the homogeneity of variances, 
differences between CTR and CLA group were pairwise compared by Students´ t-test (P 
< 0.05; each time point for serum Hp concentrations and mRNA data). In a GLM model, 
clinical observations (diseased or not diseased) were considered as random effect to test 
for possible disease specific variations between groups. Correlations were calculated 
using Pearson correlation coefficient at P ≤ 0.05; reported correlations herein are limited 
to r > 0.4. All data are presented as mean ± SEM. 
 
3. Results 
3.1. Serum Hp concentrations  
 
The time dependent changes of the serum Hp concentrations from the entire 
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experimental period (day -21 to day 252 of lactation) in trial 1 are shown in Fig. 1 for 
both heifers and cows. During the first week after calving, Hp concentrations were 
increased compared to the preceding values, then decreased again and remained relatively 
constant thereafter until the end of the observation period. When considering all animals 
during the time relevant for CLA treatment, i.e., excluding the post treatment and 
prepartum interval, only sampling time, parity (cows versus heifers) and the interaction 
between parity and treatment were significant. These findings were confirmed when 
considering heifers and cows separately and were also observed in trial 2 (data not 
shown).  
When testing for potential relationships between serum Hp values and estimates of 
body fat (BCS), recordings of body weight, fat mass and body fat portion, no correlations 
were neither observed during the entire experimental period nor at certain dates. For 
NEFA and ß-hydroxybutyrate, indicators of lipolysis and production of ketone bodies, 
quantified in the serum samples of both trials (Pappritz et al., 2011; von Soosten et al., 
2011), moderate correlations were observed, in particular when limiting the data to the 
time during which the probability for metabolic stress is highest (days -21 to 49 
postpartum): the correlations (P < 0.01) between the serum Hp concentrations and NEFA 
in primiparous cows were r = 0.47 in trial 1 and r = 0.54 in trial 2. For the pluriparous 
cows from trial 1, the association was less strong (r = 0.24); the correlations between Hp 
and ß-hydroxybutyrate were consistently below r = 0.4.  
 
3.2. Haptoglobin mRNA abundance in liver and AT  
 
In trial 1, haptoglobin mRNA abundance in AT was considerably lower (P < 0.05) 
than in liver. In comparison to s.c. and v.c. fat depots, Hp mRNA abundance in liver was 
201 and 602 fold greater in trial 2. In about 50% of the AT biopsies from s.c. tail head fat 
collected in trial 1, Hp mRNA was below the limit of detection of the qPCR system. 
When assessing the relationship between serum Hp concentrations and Hp mRNA 
abundance in liver, positive correlations (P < 0.001) were established for both the 
biopsies (trial 1; r = 0.65) and the post mortem samples (trial 2; r = 0.67).  
In biopsies collected from the cows in trial 1, time dependent changes (P < 0.05) 
were observed for Hp mRNA abundance reaching greatest values in liver at the day of 
calving and on day 21 in s.c. fat, respectively (Fig. 2). Two weeks after the end of the 
CLA supplementation period, Hp mRNA abundance in liver exceeded the values 
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recorded during the preceding supplementation period reaching the level of significance 
when compared against day 21. However, this increase after the supplementation period 
was also visible in the animals receiving the CTR fat supplement. In contrast, Hp mRNA 
abundance in AT biopsies remained at a relatively constant level after day 21 throughout 
the further observation period.  
For the liver samples collected in trial 2 after the animals were killed, the greatest 
Hp mRNA abundance was seen on day 1 after calving (Fig. 3); the values obtained at 
days 42 and 105 of lactation were about 8-fold less than this initial value. Similar time 
dependent patterns were obtained for AT samples collected from 3 different s.c. and 3 v.c. 
depots (Fig. 4), however, in mesenterial fat, the time effect was insignificant; in s.c. fat 
from the sternum area, the time difference was limited to day 1 versus day 105. Treatment 
with CLA yielded no significant effects on Hp mRNA abundance in the different fat 
depots, with the exception of omental fat and s.c. fat from the withers area in which Hp 
mRNA abundance was lower (P < 0.05) in the CLA supplemented heifers than in the 
CTR animals on days 42 and 105. The Hp mRNA abundance in the s.c. fat depots was 
generally higher than in the v.c. depots (P < 0.05). Subcutaneous fat from the tail head 
had the greatest and mesenterial fat had the lowest values. Haptoglobin mRNA 
abundance in the different tissues from trial 2 was correlated, whereby all s.c. depots were 
interrelated. In contrast, significant correlations (P < 0.01) between the v.c. depots were 
limited to mesenterial and retroperitoneal fat. Each s.c. fat depot was correlated to 
mesenterial and retroperitoneal fat, but for omental fat, there was a moderate correlation 
only with tail head fat. Correlations between liver and fat Hp mRNA abundance were 
limited to omental fat and s.c. fat from withers area.  
 
3.3. Immunohistochemical detection of the Hp protein in different fat depots 
 
Haptoglobin immune reactive staining was detectable in both the lymph node 
sections used as positive controls and in all s.c. and v.c. fat depots. The localization and 
staining intensity in the different fat depots is exemplified in Figure 5. Haptoglobin 
immunoreactivity was limited to the adipocytes, whereas the cells of the stromal-vascular 
fraction were all negative. Within the adipocytes, Hp immune signals were observed 
along the cytoplasmic rim surrounding the large fat droplet.  
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4. Discussion 
4.1. Haptoglobin as an adipokine in cattle 
 
The evidence of Hp mRNA expression in AT and the presence of Hp-immuno 
staining in histological sections from different fat depots confirm that this APP can be 
classified as an adipokine in the bovine species, too. Based on the results from 
immunohistochemistry, the expression of Hp is likely attributable to the adipocytes. 
Moreover, when using cultivated adipocytes derived from isolated primary bovine 
preadipocytes as described by Hosseini et al. (2011), we were able to qualitatively detect 
Hp mRNA both in undifferentiated and differentiated adipocytes (Saremi et al., 2010). In 
humans, different Hp mRNA abundances in different fat depots have previously been 
reported whereby epicardial fat had 48 to 111-fold higher values than 3 different s.c. 
depots but only 1.6-fold higher Hp mRNA expression than omental fat (Fain et al., 2010). 
When ranking the different bovine depots from our study according to their Hp mRNA 
abundance values across all sampling dates, we did not observe a difference between the 
3 s.c. depots and omental fat, but the Hp mRNA abundance in s.c. depots was higher than 
in retroperitoneal and mesenterial fat. 
Like other inflammatory biomarkers, Hp has been suggested as being linked to 
obesity, insulin resistance, and the metabolic syndrome in humans. Based on the 
associations between body fat and serum Hp and on the evidence of Hp mRNA and 
protein in biopsies from s.c. abdominal fat as well as the release of Hp from s.c. and v.c. 
human AT explants (Fain et al., 2004) from obese subjects, a contribution of body fat to 
circulating Hp concentrations was concluded and Hp was proposed as adiposity marker in 
humans (Chiellini et al., 2004). In view of the low Hp mRNA abundance we observed in 
AT as compared to liver, we speculate that AT borne Hp will not significantly contribute 
to Hp serum concentrations. Due to the fact that we have no quantitative data on Hp 
protein concentration in AT, we did a rough estimation from our mRNA data to give an 
idea about the quantitative relationships which is based on three assumptions (1) mRNA 
concentration would be directly corresponding to protein secretion, (2) concentrations of 
total RNA per g of tissue would parallel the yields of extraction achieved in fat and liver 
tissue and (3) expression within the fat depots and within the entire liver would be 
homogenous. Doing so we took the tissue masses (von Soosten et al., 2011) and mRNA 
yields per g of tissue into consideration. Accordingly, the relative contribution of v.c. fat 
would be 2.8 fold greater compared to s.c. fat. In comparison to liver, the Hp production 
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from all v.c. and s.c. depots would amount to only 0.02% of the hepatic one. 
In our studies, we did not see any relation between serum Hp and BCS, body mass 
and fat portion in late pregnant or lactating heifers and cows. The question as to whether 
Hp in serum might increase in cattle if fat mass exceeds a certain level remains yet 
unresolved but appears to be of minor relevance for dairy cows anyway; the animals 
enrolled in our studies were definitely neither obese nor overconditioned. Nevertheless, 
the lack of an evident relationship between circulating Hp concentrations and normal 
body fat portions in dairy cattle demonstrates that variation in the degree of adiposity 
does not itself influence serum Hp concentrations and thus does not confound the use of 
Hp as an inflammatory marker. The correlations observed between serum Hp and NEFA 
point to the relation between the development of fatty liver and induction of Hp. An 
increased release of NEFA from adipose tissue knowingly might exceed the liver’s 
capacity for fatty acid oxidation and discharge into circulation thus leading to fatty liver 
(Katoh, 2002), which might induce increased Hp concentrations.  
 
4.2. Physiological changes of serum Hp concentrations and Hp mRNA abundance in liver 
and fat throughout lactation 
 
The longitudinal characterization of the serum Hp concentrations throughout 
lactation as done in trial 1 indicates that apparently physiological changes seem to be 
limited to parity, parturition and, to a lesser extent, late lactation. The reason for the 
higher Hp concentrations observed in heifers than in cows during the first week after 
parturition in trial 1 are not clear, but were also reported by Cullens (2005) indicating that 
parturition may elicit a higher acute phase reaction in primiparous than in multiparous 
cows. The peripartal peak in Hp concentrations observed in both trials is in accordance 
with several other reports in cattle (Ametaj, 2005; Humblet et al., 2006; Hachenberg et 
al., 2007; Tóthová et al., 2008) and is probably due to parturition-related tissue lesions 
and inflammatory reactions of the genital tract. In addition, this increase might be 
influenced by metabolic stress (Katoh, 2002; Bionaz et al., 2007; Hachenberg et al., 
2007). The notion of liver being the main source of circulating Hp was confirmed by the 
time dependent pattern of hepatic mRNA abundance in both trials being largely 
analogous to the serum values. In view of the low Hp mRNA abundance in fat tissues as 
compared to liver, a substantial contribution of AT to serum Hp seems improbable. 
Nevertheless, the observation of similar time dependent patterns, i.e., highest abundance 
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values on day 1 after calving in both liver and fat depots indicates similar regulatory 
pathways in both tissues. Parturition is accompanied by comprehensive endocrine 
changes, e.g., a rise of glucococorticoids (Hoffmann et al., 1973) and the final stages of 
cervical ripening and parturition have been suggested to resemble an inflammatory 
process with increased release of proinflammatory cytokines (van Engelen et al., 2009). 
Indeed, Lee et al. (2010) have recently shown that Hp gene expression was induced by 
the synthetic glucocorticoid dexamethasone in both s.c. and omental human fat.  
 
4.3. Effects of supplementation with CLA on serum Hp concentrations and tissue mRNA 
abundance 
 
The efficacy of the current CLA supplementation in terms of milk fat reduction 
has been reported earlier for both trials (Pappritz et al., 2011; von Soosten et al., 2011). 
Supplementation with CLA may have anti-inflammatory and/or immune-ameliorating 
effects (Yu et al., 2002), whereby cis-9, trans-11 CLA is supposed to be responsible for 
the anti-inflammatory effect attributed to CLA as recently reviewed by Reynolds and 
Roche (2010). In contrast, trans-10, cis-12 CLA has been demonstrated to promote 
inflammation in primary cultures of differentiated human adipocytes (Martinez et al., 
2010). It is likely that dose, duration, and isomeric composition of CLA each impact the 
effects of CLA supplementation regimes. So far no studies have been published on the 
effects of long term CLA supplementation on inflammatory markers in ruminants. For 
Hp, Noto et al. (2007) showed that Zucker rats fed with mixed CLA isomers for 8 week 
had lower serum Hp concentrations than untreated controls. However, for another APP 
i.e. for C-reactive protein, increased concentrations were reported in nonobese humans 
and in patients affected with the metabolic syndrome when supplemented with CLA as 
mixed isomers (cis-9, trans-11 and trans-10, cis-12) (Riserus et al., 2004; Smedman et 
al., 2005). In the trials we performed, serum Hp concentrations were not affected by CLA 
treatment. When considering Hp mRNA abundance in liver, again no effect of the CLA 
supplementation could be identified thus disagreeing with the notion that CLA isomer 
mixture used in this study may exert systemic anti-inflammatory effects. However, the 
observation of reduced Hp mRNA abundance in CLA versus CTR animals in another s.c. 
depot (from withers) and one v.c. depot, i.e. omental fat, may indicate a locally divergent 
responsiveness of AT towards CLA. In view of the lack of effects on serum Hp 
concentrations, the observed reaction in two out of six different fat depots seems of 
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marginal importance for the organisms as an entity. 
 
5. Conclusions 
 
Haptoglobin mRNA and protein expression in adipose tissue qualified this acute 
phase protein as adipokine in cattle. The differences in Hp mRNA abundance between 
different subcutaneous and visceral depots indicate that biopsies from subcutaneous depot 
are not necessarily representative when aiming to characterize adipose regulation. Dietary 
CLA supplementation had no effect on serum Hp and thus anti-inflammatory effects of 
the CLA supplementation protocol used herein are not supported. However, the function 
of Hp expression in AT for both local and systemic homeostatic or homeorhetic 
adaptations in lactating dairy cows remains to be elucidated.  
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Table 1 (A): List of the tissue specific sets of reference genes identified as being most 
stable and thus used for normalization. (B): Characteristics of the primers and the real-
time PCR conditions  
(A): 
Individual or combined tissues Reference genes used 
Omental and retroperitoneal adipose tissues (AT) EIF3K, LRP10, POLR2A, EMD, MARVELD1 
Liver EIF3K, LRP10, POLR2A, GAPDH, HPCAL1 
Individual tissues: 
EIF3K, LRP10, POLR2A, EMD, MARVELD1, HPCAL1 
- Mesenterial AT 
- Each s.c. AT (Tail head, Withers, Sternum) 
Combinations of: 
All AT depots 
All AT depots and liver
*
 EIF3K, LRP10, POLR2A, HPCAL1 
 
(B):  
Primers Sequence (5'-3') 
NIH Genbank 
accession 
number 
bp
9
 
Amount 
(nmol) 
Mean 
Cq
10
 
value
11
 
Annealing
12
 
(sec/˚C) 
Haptoglobin
1 
Forward  
Reverse 
 
GTCTCCCAGCATAACCTCATCTC 
AACCACCTTCTCCACCTCTACAA 
AJ271156 174 800 25.37 30/58 
EIF3K
2 
Forward 
Reverse 
 
CCAGGCCCACCAAGAAGAA 
TTATACCTTCCAGGAGGTCCATGT 
NM_001034489 125 400 22.87 45/59 
LRP10
3 
Forward 
Reverse 
 
CCAGAGGATGAGGACGATGT 
ATAGGGTTGCTGTCCCTGTG 
Bc149232 139 400 21.90 30/61 
POLR2A
4 
Forward 
Reverse 
 
GAAGGGGGAGAGACAAACTG 
GGGAGGAAGAAGAAAAAGGG 
X63564 86 800 23.86 60/60 
GAPDH
5 
Forward 
Reverse 
 
AATGGAAAGGCCATCACCATC 
GTGGTTCACGCCCATCACA 
U85042 204 400 19.02 75/59 
EMD
6
  
Forward 
Reverse 
 
GCCCTCAGCTTCACTCTCAGA 
GAGGCGTTCCCGATCCTT 
NM_203361 100 400 22.07 45/59 
MARVELD1
7
 
Forward 
Reverse 
 
GGCCAGCTGTAAGATCATCACA 
TCTGATCACAGACAGAGCACCAT 
NM_001101262 100 400 22.61 45/59 
HPCAL1
8
 
Forward 
Reverse 
 
CCATCGACTTCAGGGAGTTC 
CGTCGAGGTCATACATGCTG 
NM_001098964 99 400 23.98 30/60 
1
Hiss et al., 2004. 
2
EIF3K: Eucariotic translation initiation factor 3, subunit K (Kadegowda et al., 2009). 
3
LRP10: Lipoprotein receptor-related protein 10 (Hosseini et al., 2010). 
4
POLR2A: RNA polymerase II (Hosseini et al., 2010).
 
5
GAPDH: Glyceraldehyde-phosphate-dehydrogenase (Hosseini et al., 2010). 
6
EMD: Emerin (Kadegowda et al., 2009). 
7
MARVELD1: Marvel domain containing 1 (Kadegowda et al., 2009). 
8
HPCAL1: Hippocalcin-like 1 (Hosseini et al., 2010). 
9
bp: base pairs.  
10
Cq: Quantification cycle. 
11
Based on post mortem samples from trail 2. 
12
Initial denaturation (min/˚C) 10/95, Denaturation (sec/˚C) =30/95, Extention (sec/˚C) =30/72; for RNA 
polymerase extention conditions were 60/72. 
* For selection of stable reference genes, mammary gland (data not shown) was also included in the tissue 
set. 
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Table 2. Efficiency of real-time PCR per tissue defined by amplicon standard curves
*
  
Genes 
Trial 1  Trial 2 
s.c. 
tail 
liver 
 s.c. 
sternum 
s.c. 
wither 
s.c. 
tail 
mesenterial omental retroperitoneal liver 
Haptoglobin 94.9 93.6  85.2 88.4 97.6 102.9 97.4 93.9 98.1 
EIF3K
 
--- 93.3  95.3 95.3 95.0 97.5 95.9 93.3 94.3 
LRP10
 
102.4 102.4  94.2 93.5 91.1 93.9 92.3 92.6 96.1 
POLR2A
 
90.3 92.1  92.7 97.9 93.4 97.5 96.4 97.5 93.5 
GAPDH
 
84.7 ---  82.8 93.7 91.4 90.0 89.5 89.2 91.0 
EMD --- ---  97.1 96.5 96.6 94.2 94.2 97.4 97.6 
MARVELD1 --- ---  95.0 97.7 94.0 90.3 98.3 96.1 97.0 
HPCAL1 --- ---  92.3 89.6 91.3 86.5 87.4 90 92.2 
*Standard curves consist of 5 point 10-fold dilution series. 
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Fig. 1. Serum haptoglobin concentrations (means ± SEM) in cows and heifers receiving 
conjugated linoleic acids (CLA, Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) at 50 
or 100 g/day or a control fat supplement (Silafat
®
, BASF SE) from day 1 until day 182 
postpartum in trial 1. The statistical results included in the graph comprise the treatment 
and post treatment period (day 1 to 252); all animals and samples were included in the 
figure. The concentrations of haptoglobin in cows versus heifers were different (P<0.05). 
[Control (○): cows n = 11, heifers n = 6; CLA-50 (□): cows n = 11, heifers n = 5; CLA-
100 (∆): cows n = 11, heifers n = 5]. n: number of animals. ns: not significant. 
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Fig. 2. Haptoglobin mRNA abundance (means ± SEM) in liver (A) and in subcutaneous 
tail head fat (B) tissue in cows receiving conjugated linoleic acids (CLA, Lutrell
®
 Pure, 
BASF SE, Ludwigshafen, Germany) at 100 g/day CLA or a control fat supplement 
(Silafat
®
, BASF SE) from day 1 until day 182 postpartum in trial 1. Samples for mRNA 
analyses were limited to cows thus excluding heifers and to the CLA dose of 100g/d thus 
excluding the 50g CLA/d group. Samples from days 1, 70, 182, and 224 were also 
restricted to the control cows. [Control (○): n = 11, CLA-100 (∆): n = 11]. Different 
letters indicate significant (P<0.05) differences between the different days. ns: not 
significant. Data are normalized based on the geometric mean of Glyceraldehyde-
phosphate-dehydrogenase (GAPDH), Lipoprotein receptor-related protein 10 (LRP10) 
and RNA polymerase II (POLR2A) for subcutaneous tail head fat and Eucariotic 
translation initiation factor 3 (EIF3K), LRP10, and POLR2A for liver. 
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Fig. 3. Haptoglobin mRNA abundance (means ± SEM) in liver tissue of heifers receiving 
conjugated linoleic acids (CLA, Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) at 
100 g/day or a control fat supplement (Silafat
®
, BASF SE) from day 1 until day 105 
postpartum in trial 2. Significant time effect is between day 1 and day 42 and 105, 
respectively. Health as random effect was insignificant. ns: not significant. Data are 
normalized based on the geometric mean of the reference genes listed in table 1.  
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Fig. 4. Haptoglobin (Hp) mRNA abundance (means ± SEM) in three visceral (upper 
panels) and three subcutaneous (s.c.) fat depots (lower panels) in heifers supplemented 
with 100 g/day conjugated linoleic acids (CLA, Lutrell
®
 Pure, BASF SE, fLudwigshafen, 
Germany) or a control fat supplement (Silafat
®
, BASF SE) from day 1 until day 105 
postpartum. On day 1, Hp mRNA abundance was higher (P<0.05) than on day 42 and on 
day 105; only in s.c. fat from sternum the difference was limited to day 1 versus day 105. 
Health as random effect was insignificant. The effects of CLA treatment were limited to 
s.c. fat from withers and omental v.c. fat in which reduced Hp mRNA abundance was 
observed. ns: not significant. Data are normalized based on the geometric mean of the 
reference genes listed in table 1.  
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Fig. 5. Examples of haptoglobin immunoreactivity in histological sections from different 
bovine adipose tissues (A, B and C) and lymph nodes (D, E). Representative positive 
cells appear as red staining in the cytoplasm near adipocyte nuclei (marked with arrow 
heads) of subcutaneous sternum (A) and tail head (B) fat depots as well as along the 
whole cytoplasmic rim of mature adipocytes from mesenteric fat depots (C). Bovine 
lymph nodes were used as positive (D) and negative (E) controls. Original magnification: 
200-fold. Scale bars represent 20 µm. 
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ABSTRACT 
Serum amyloid A3 (SAA3) is the predominant SAA isoform secreted by mammary 
epithelial cells in dairy cows; it is also expressed in bovine adipose tissue (AT). The 
adipokine SAA3 is linked to obesity and insulin resistance of AT and the respective 
inflammatory response, at least in mice. Dietary treatment with conjugated linoleic acids 
(CLA) reportedly affects also insulin sensitivity and inflammatory status in monogastrics. 
Both SAA3 and CLA thus seem to alter similar functions. Based on changes in insulin 
sensitivity and the inflammatory status throughout lactation, we hypothesized that the 
mRNA abundance of SAA3 in various tissues might be regulated as well and that CLA 
could be a modulator of SAA3 mRNA expression. In two trials, 21 pluriparous and 25 
primiparous Holstein cows were fed with 100 g/d of a CLA or a control fat supplement 
from d 1 until d 182 or d 105 postpartum (p.p.), respectively. Biopsies from liver and 
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subcutaneous (s.c.) AT from pluriparous cows and samples from 3 different visceral (v.c.) 
AT and 3 s.c. AT, muscle, mammary gland, and liver tissue from slaughtered primiparous 
cows were obtained. In an adipocyte cell culture system, cell samples were collected 
during differentiation of bovine preadipocytes at d 0, 2, 6, 8, 10, 12, and 13 relative to the 
onset of differentiation. The SAA3 mRNA abundance in tissues and in differentiating 
bovine preadipocytes was measured by real-time PCR. The presence of the SAA protein 
was confirmed by Western blotting. Treatment with CLA yielded only few and 
inconsistent effects on SAA3 mRNA abundance. In both trials, SAA3 mRNA peaked at d 1 
p.p. in all tissues except in mesenteric AT in which the change was not significant. The 
highest SAA3 mRNA expression was observed in the mammary gland, followed by 
omental AT. The SAA protein was present in the v.c. and s.c. AT depots investigated. 
Adipocytes as one source of SAA3 were confirmed by the SAA3 mRNA profile in 
differentiating adipocytes. The longitudinal changes observed point to SAA3 being 
involved in the inflammatory situation around parturition.   
 
Key words: SAA3, CLA, adipose tissue, dairy cow. 
 
INTRODUCTION 
Serum amyloid A (SAA) is a major acute phase protein in cattle and has proved as 
diagnostic marker (Eckersall and Bell, 2010). The biological functions identified until 
now include cholesterol transport as well as modulation of immune reaction (Ceciliani et 
al., 2012). Acute-phase SAA comprises two closely related isoforms, SAA1 and SAA2, 
which are expressed mainly in the liver in response to proinflammatory stimuli; further 
members of the SAA family are SAA3 and SAA4, whereby SAA3 is mainly 
extrahepatically expressed under proinflammatory conditions in several mammalian 
species (Uhlar and Whitehead, 1999). The isoform SAA4 is constitutively expressed and 
responds only moderately to inflammatory stimuli (de Beer et al., 1996). Due to its 
synthesis and secretion from adipose tissue (AT), SAA3 was also classified as an 
adipokine (Lin et al., 2001) and the circulating concentrations of SAA correlate with 
obesity and insulin resistance in humans (Ebeling et al., 1999, Yang et al., 2006). 
However, using tandem mass spectrometry, no SAA3 protein was observed in circulating 
high density lipoproteins, albeit secretion of SAA3 from cultured adipocytes was 
confirmed. Thus the increased SAA blood concentrations in obesity and insulin resistant 
states result rather not from increased SAA3 secretion by AT (Chiba et al., 2009).  
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In cattle, SAA proteins were characterized in 1988 (Husebekk et al., 1988) and SAA3 is 
the predominant SAA isoform secreted by mammary gland epithelial cells in response to 
gram-negative (Larson et al., 2005) or gram-positive bacteria (Weber et al., 2006). Based 
on its mammary localization it is also termed mammary SAA3 (McDonald et al., 2001) 
and is assumed to protect the mammary tissue during remodeling and infection (Molenaar 
et al., 2009). The SAA3 mRNA has been detected in bovine AT, but its expression is 
apparently not upregulated by lipopolysaccharide (Mukesh et al., 2010; Berg et al., 2011). 
Remarkably, SAA is regulated by nutritional changes, since caloric restrictions are 
associated with down-regulation of SAA, both at the mRNA and the protein level (Poitou 
et al., 2005). Conjugated linoleic acids (CLA) are compounds, which are discussed to be 
related to insulin sensitivity and inflammatory status of the body. The cis-9,trans-11-CLA 
isomer (c9,t11-CLA) improves insulin sensitivity and reduces proinflammatory cytokines 
(Reynolds and Roche, 2010); the trans-10,cis-12-CLA isomer (t10,c12-CLA) adversely 
promotes inflammation in human adipocytes (Martinez et al., 2010) and induces lipolysis 
and insulin resistance (Rubin et al., 2012). Dietary CLA supplements alter lipid 
metabolism: in dairy cows the t10,c12-CLA has been reported to specifically target the 
mammary gland reducing milk fat synthesis (Baumgard et al., 2001), whereas c9,t11-
CLA had less effect (Perfield II et al., 2007). In contrast to other monogastric species, 
body fat mass has been shown to be largely unaffected by CLA treatment in dairy cows 
(von Soosten et al., 2012), however we recently observed that fat cell size in primiparous 
cows receiving a 1:1 mixture of c9,t11-CLA and t10,c12-CLA was decreased when 
compared against a control group (Akter et al., 2011). 
The energy requirements for milk yield and maintenance exceed energy intake by 
voluntary feed intake during the first weeks of lactation, in particular in high yielding 
dairy cows. Prioritizing milk secretion, the insulin sensitivity of peripheral tissues other 
than the mammary gland is decreased and body reserves mainly from AT are mobilized 
and imply an increased risk for metabolic diseases, mainly ketosis and fatty liver. 
Reducing the energy output via milk by decreasing the milk fat content through feed 
supplements containing CLA may attenuate the negative energy balance during this 
period (Bauman et al., 2011). However, based on increasing milk yield, Hutchinson et al. 
(2012) observed no differences in milk energy output. In contrast, Castañeda-Gutiérrez et 
al. (2005) reported a dose dependent reduction of milk energy output whereby energy 
balance was not altered. In view of the connection between SAA3 expression and lipid 
metabolism, we aimed to characterize the changes of SAA3 mRNA in AT and other 
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metabolically important tissues throughout lactation. In particular, we aimed to compare 
SAA3 mRNA abundance in different visceral (v.c.) and subcutaneous (s.c.) fat depots and 
to qualitatively characterize the SAA protein expression in these depots. Moreover, to 
confirm adipocytes as a SAA3 producing cell type of AT, we quantified SAA3 mRNA in 
differentiating bovine preadipocytes. In addition, we tested for potential CLA effects on 
SAA3 mRNA.  
 
MATERIAL AND METHODS 
The experiments and treatments of the animals were approved by the competent 
authority, the Lower Saxony state office for consumer protection and food safety 
(LAVES, file no. 33.11.42502-04-071/07, Oldenburg, Germany). The regulations of the 
German Animal Welfare Act (TierSchG) in its respective current edition were met. All 
animals were housed at the experimental station of the Friedrich Loeffler Institute, 
Federal Research Institute for Animal Health, Braunschweig, Germany.  
Animal experiments 
Trial 1. German Holstein pluriparous cows (n = 21) were fed ad libitum in the entire 
experimental period according to the recommendations of the German Society of 
Nutrition Physiology (GfE, 2001). Details and outcomes in terms of diet, performance, 
metabolite concentrations and milk fat fatty acid profile from this experiment are 
described by Pappritz et al. (2011). From d 1 postpartum (p.p.) the animals were allocated 
to 2 groups: a CLA and a control group (10 and 11 cows, respectively) each receiving 100 
g/d fat supplement during supplementation period from d 1 to d 182 p.p. The animals of 
the CLA group received encapsulated CLA (Lutrell Pure, BASF, Ludwigshafen, 
Germany). The control group received an analogous isoenergetic fatty acid mixture 
(Silafat, BASF) in which CLA were substituted by stearic acid. The animals of the CLA 
group consumed 7.6 g/d each of t10,c12-CLA and c9,t11-CLA (calculated, based on the 
analyzed proportions in the concentrate) and expectedly responded with reduced milk fat 
content to the CLA treatment whereas energy balance was not altered during most of the 
supplementation period (Pappritz et al., 2011). Liver and s.c. AT from the tail head region 
were biopsied as described earlier (Saremi et al., 2012a) on d -21, 1, 21, 70, 105 182 196, 
224, and 252 from control cows and d -21, 21, 105, 196, and 252 from CLA cows relative 
to parturition.  
Trial 2. German Holstein primiparous cows (n = 25, average age at parturition: 23 
months) were fed ad libitum according to the recommendations of the German Society of 
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Nutrition Physiology (GfE, 2001). Five animals were slaughtered 1 d p.p. and the 
remaining cows (n = 20) were allocated randomly to either control or CLA fat supplement 
similar to Trial 1 starting from d 1 p.p. until slaughter. Additional information about the 
diets and the main outcomes in terms of body composition is available elsewhere (von 
Soosten et al., 2011). Five animals per group were slaughtered p.p. at d 42 and 105. 
Samples from 3 v.c. AT (omental, mesenteric and retroperitoneal), 3 s.c. AT (tail head, 
withers and sternum), liver, M. semitendinosus, pancreas, and mammary gland were 
collected immediately after slaughter. In general, efficacy of the CLA treatment in terms 
of milk fat reduction was demonstrated but the calculated energy balance was not 
significantly altered by CLA treatment. Neither NEFA serum concentrations nor BCS 
indicated an effect of the CLA treatment on lipolysis and body fat. However, back fat 
thickness was decreased in the CLA group (d 42 to 105 interval; von Soosten et al., 2011) 
and adipocyte sizes were decreased in 2 and 4 out of 6 different fat depots on d 42 and d 
105, respectively (Akter et al., 2011).  
Culture and differentiation of bovine preadipocytes  
In a separate experiment, s.c. AT around sternum was obtained from 3 additional Holstein 
dairy cows at slaughter. Tissue treatment, cell separation, culture, and differentiation 
conditions are described in detail by Hosseini et al. (2012). Isolated stromal vascular cells 
of the 3 cows were pooled and differentiated. Cell samples of preadipocytes were taken at 
d 0, 2, 6, 8, 10, 12, and 13 relative to the onset of differentiation. Primary cell samples 
from the given d of differentiation were assayed in triplicates. 
The samples from both trials were snap-frozen in liquid nitrogen. The samples from the 
cell culture experiment were preserved in Trizol (Invitrogen, Karlsruhe, Germany). All 
samples were stored at -80 °C until further use.  
RNA extraction, cDNA synthesis, and relative quantification by real-time PCR 
Handling of samples in order to quantify mRNA using real-time PCR was described in 
detail earlier (Saremi et al., 2012a; Saremi et al., 2012b). The SAA3 primers (forward: 
GGGCATCATTTTCTGCTTCCT and reverse: TGGTAAGCTCTCCACATGTCTTTAG) 
were as described by Mukesh et al. (2010) and the primer amount used was 8 pmol per 
reaction. PCR conditions were 10 min at 95 °C for initial denaturation, 30 s at 95 °C for 
denaturation, 60 s at 60 °C for annealing, and 30 s at 72 °C for extension. A PCR amplicon 
standard curve was used to estimate PCR efficiency per each real-time PCR run. Two µL 
cDNA (diluted 1 to 4) as template and 5 µL SYBR Green JumpStart Taq Readymix 
(Sigma-Aldrich, Steinheim, Germany) in a total volume of 10 µL were run in an Mx3000P 
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real-time PCR instrument (Agilent, Santa Clara, CA). For normalization of the efficiency 
corrected data, reference genes from the following panel were selected and used, 
depending on the trial and the tissues in comparison (Saremi et al., 2012a, 2012b). For 
Trial 1, GAPDH, lipoprotein receptor related protein 10 (LRP10), RNA polymerase II 
(POLR2A) and eucariotic translation initiation factor 3 (EIF3K), LRP10, POLR2A were 
selected for s.c. fat and liver, respectively. For Trial 2, EIF3K, LRP10, POLR2A, Emerin, 
Marvel domain containing 1 and Hippocalcin-like 1 were used. The data used for statistics 
was generated by geNorm
plus
 as a part of qBASE
plus
 version 2.0 (Biogazelle, Ghent, 
Belgium). 
Western blot analysis 
Omental, mesenteric, retroperitoneal, and tail head AT and liver samples (d 105 p.p.) 
from a control cow in Trial 2 were exemplarily used for characterizing the SAA protein in 
these tissues. Tissues were homogenized in HEPES buffer (10 mM pH 7.4) using a 
Precellys® system (Peqlab, Erlangen, Germany). The total protein content was quantified 
by the bicinchoninic acid method (BCA, Sigma-Aldrich) and equal amounts of protein 
(15 μg) were loaded in 16% tris-tricine-SDS gels. After electrophoresis, the gels were 
blotted onto polyvinyl difluoride membranes (GE Healthcare Bio-Science GmbH, 
Munich, Germany). The membranes were immunolabelled for the presence of SAA using 
a rabbit anti-bovine SAA antibody (10.1 mg/mL) diluted 1:4000 and the antibody-antigen 
complexes were tagged with horseradish peroxidase coupled to a secondary goat anti-
rabbit IgG antibody (SouthernBiotech, Birmingham, AL). Detection was carried out by 
enhanced chemiluminescence (GE Healthcare UK limited, Buckinghampshire, UK). To 
confirm that an equal amount of protein was loaded on each lane, membranes were 
stripped and immuno-labelled with a mouse anti-human ß-actin antibody (0.5 mg/mL), 
1:2000 dilution (BioVision, Mountain view, CA) and horseradish peroxidase -labelled 
goat anti-mouse IgG (SouthernBiotech). 
Statistical analyses 
All statistical analyses were performed using SPSS (version 20, SPSS Inc., Chicago, IL). 
For Trial 1, the mixed model procedure was used. Treatments (Control and CLA) were 
considered as fixed factor, and sampling dates (time) as a repeated effect; the respective 
interaction was also included into the model. The covariance structure component 
symmetry and Bonferroni correction were used. For Trial 2, all data were tested for 
homogeneity of variances (P < 0.1). Homogeneity of variances was significantly 
different. Thus, non-parametric tests (Kruskal-Wallis or Mann-Whitney) were used. A P 
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value < 0.05 was considered significant. 
 
RESULTS  
Trial 1. Liver SAA3 mRNA abundance was maximal at the day of parturition (8 fold 
higher in comparison to the mean of the other d antepartum and p.p. but remained fairly 
stable throughout all the other days (Figure 1). In s.c. AT from tail head, the day of 
parturition was significantly different in comparison to 196 and 252 d p.p. (7.7 fold higher 
SAA3 mRNA abundance). Supplementation with CLA in comparison to the control group 
yielded no significant effects on SAA3 mRNA abundance in liver and s.c. AT. To be able 
to compare SAA3 mRNA in s.c. AT and liver tissue a similar set of reference genes was 
needed. Therefore, geometric mean of POLR2A and EIF3K was used. Taking into account 
all data across times and treatment, the SAA3 mRNA abundance was slightly higher (1.25 
fold) in s.c. tail head AT than in liver. 
Trial 2. Decreasing mRNA abundance of SAA3 from d 1 to d 42 and 105 was observed in 
all fat tissues except mesenteric AT in which SAA3 was constantly expressed (Figure 2). 
The decrease of SAA3 mRNA abundance in liver and muscle tissues was significant 
between d 1 and d 42 and in mammary gland was similar to the AT depots (Figure 3). In 
pancreatic tissue, the presence of SAA3 mRNA was confirmed (data not shown), but due 
to the low quality of the RNA extracted no statistics were done for this tissue. The decline 
in SAA3 mRNA abundance from d 1 to d 42 and 105 was different between tissues: s.c. 
AT from tail head, retroperitoneal, s.c. AT from sternum, s.c. AT from withers, omental, 
and mesenteric AT had 44.1 > 31.5 > 21.8 > 7.67 > 5.9 > 1.8 fold higher SAA3 mRNA 
abundance at d 1 in comparison to the mean of d 42 and 105, respectively. In case of 
mammary gland, muscle, and liver tissues, the reduction was 34.4 > 7.5 > 1.0 fold, 
respectively. Supplementation with CLA caused a reduction in the abundance of SAA3 
mRNA in comparison to control group i.e. in s.c. withers AT at d 42 p.p. (5.8 fold 
decrease), in s.c. AT from sternum at d 105 p.p. (3.33 fold decrease), and in muscle tissue 
at d 105 p.p. (7.98 fold decrease).  
We pooled the data from different days (1, 42, and 105 p.p.) and treatments per tissue to 
be able to compare the SAA3 mRNA abundance between different tissues i.e. mammary 
gland, liver and the 6 different AT using the adequate panel of reference genes (Figure 4). 
The SAA3 mRNA had its highest expression in mammary gland i.e. 20 fold higher 
expression in comparison to the mean of AT and 33 fold higher than liver tissue. The 
second highest mRNA expression was in omental AT that was 2 to 26 fold greater than in 
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the other 5 fat depots (Figure 4). Depending on the fat depot, the SAA3 mRNA 
abundance in AT was either greater or smaller than in liver: the values in two s.c. depots 
(from tail head and from sternum) and in omental fat exceeded the ones from liver by a 
factor of 2.4, 1.4, and 5.3, respectively. The values in the remaining depots amounted to 
20% (s.c. from withers and retroperitoneal AT) and 40% (mesenterial AT) of the ones in 
liver.  
Culture and differentiation of bovine preadipocytes.  
The SAA3 mRNA expression in an adipose cell culture system was low in non-
differentiated adipocytes (d 0) compared to other stages of differentiation. At d 2 of 
differentiation, SAA3 mRNA increased by a factor of 91 in comparison to d 0. Thereafter 
(at d 6, 8, 10, 12, and 13), SAA3 mRNA abundance decreased to values that were still 10, 
3.9, 4, 1.6, and 1.3 fold higher than on d 0 of differentiation (Figure 5). 
Detection of the SAA protein in adipose tissues 
Expression of SAA protein was confirmed by Western blot analysis in different bovine fat 
depots (Figure 6). Immunoreactive bands were mainly detected as a 14 kDa monomer. In 
addition, bands of about 26-28 kDa and 52-56 kDa likely to be the SAA dimer and 
tetramer were observed. Other faint bands of higher molecular weight probably result 
from the association of SAA with other proteins e.g. albumin. 
 
DISCUSSION 
Expression of SAA3 mRNA in adipose tissue, mammary gland and liver 
When ranking the different tissues investigated herein according to their SAA3 mRNA 
abundance, mammary gland had the highest values and was followed by some AT depots 
exceeding the abundance in liver, whereas other AT depots ranked below liver. This 
indicates that SAA3 might be important for AT functions. However, secretion of SAA3 
from AT yet needs to be clarified. There is no data available showing contribution of 
mammary SAA3 to blood; it is mainly secreted to colostrum and milk (Molenaar et al., 
2009). Secretion of SAA3 into the medium of a murine adipocyte culture was already 
shown, but a significant contribution to circulating SAA from AT was considered 
improbable (Chiba et al., 2009). In murine AT, SAA3 was identified as the major SAA 
isoform (Sommer et al., 2008). However, there is no selective antibody for bovine SAA3 
available; using the anti-bovine SAA antibody, a SAA monomer of comparable size as 
shown by Dilda et al. (2012) was detectable in different AT at the protein level. Different 
bands in addition to the monomer are probably related to multimerization and association 
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with other proteins. Indeed, SAA may form polymers during storage and 
freezing/thawing of samples (Molenaar et al., 2009). Other factors that might affect 
structure and stability of SAA are different metal ions and their concentration at least in 
in vitro conditions (Wang and Colón, 2007).  
The abundance of SAA3 mRNA varied considerably between the different bovine AT 
investigated herein, but explanations for the underlying reasons and functions are lacking. 
There was no general difference between s.c. and v.c. fat depots and neither the portion of 
the fat depots nor their readiness for mobilization as concluded from body weight 
composition at the different sampling days (von Soosten et al., 2011) seem to be related 
with SAA3 mRNA abundance.  
Expression of SAA3 mRNA during differentiation of primary bovine preadipocytes 
In both undifferentiated and differentiating preadipocytes from s.c. AT of dairy cows, 
SAA3 mRNA was expressed at low abundance, whereas a peak value was observed at the 
onset of differentiation at d 2. We speculate that high expression of SAA3 in AT, but not 
in differentiated preadipocytes, might be related to the maturity of the preadipocytes and 
the degree of fat accumulation. However, our cell culture data support that SAA3 can 
indeed be classified as an adipokine originating from adipocytes. 
Dexamethasone, one of the components of the differentiation medium, is known to 
stimulate SAA3 mRNA (Fasshauer et al., 2004). The increase in SAA3 mRNA abundance 
in differentiating bovine preadipocytes at d 2 supports that SAA3 is positively regulated by 
glucocorticoids. Thus it might be similarly linked to insulin sensitivity in bovine AT as 
demonstrated in murine adipocytes by Fasshauer et al. (2004). 
To date the biological significance of SAA expression in AT is largely unknown and 
remains speculative: SAA is an apolipoprotein and is thus involved in binding, transport 
and targeting of NEFA mobilized during the peripartum-related lipolysis. Besides, SAA 
may exert direct metabolic effects on human adipocytes by decreasing lipogenesis 
through an extracellular signal-regulated kinase dependent pathway. In particular, SAA 
down regulated peroxisome proliferator activated receptor gamma, CCAAT/enhancer 
binding protein alpha and sterol regulatory element binding protein-1c, which in turn are 
related to adipocyte differentiation and lipid synthesis (Faty et al., 2012). 
Association of SAA3 mRNA with the inflammatory reaction in dairy cows 
In both trials, the maximum expression of AT SAA3 mRNA was observed in all analyzed 
tissues at the day of parturition. For liver, we confirmed the recent observation of highest 
SAA3 mRNA abundance around parturition in cows (Graugnard et al., 2013). Delivery 
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related stress, tissue lesions, and inflammatory reactions of the genital tract have been 
suggested as possible explanations for the acute phase reaction commonly observed at 
that time (Murata, 2007; Humblet et al., 2006). The involvement of AT in this reaction 
might thus be due to a systemic stimulation of acute phase protein that occurs in all 
tissues. Albeit the contribution of SAA3 from AT to the circulating SAA concentrations 
seems less probable (Chiba et al., 2009), increased SAA3 expression in AT might have a 
local importance: inflammatory reactions with increased SAA3 in AT have been 
demonstrated to be related to reduced insulin sensitivity in obese mice (Lin et al., 2001, 
Reigstad et al., 2009). As mentioned previously, reduced peripheral insulin sensitivity is a 
common feature in early lactating dairy cows and might be at least partly attributable to 
the locally elevated concentrations of SAA3.  
Supplementations with CLA are discussed to be related to inflammatory response and 
insulin sensitivity (Reynolds and Roche, 2010). The sparse effects of CLA treatment on 
SAA3 mRNA abundance observed herein in some fat depots and in muscle were 
inconsistent with regard to time, tissue and direction of change. Nevertheless, the 
differences established herein indicate that there might be local effects of CLA in these 
tissues. Both SAA3 mRNA and protein are induced during adipocyte hypertrophy and 
development of obesity in mice (Han et al., 2007; Chiba et al., 2009; Scheja et al., 2008). 
In view of the effects of CLA reported in rodents and humans, i.e. reducing body fat and 
fat cell size, a CLA-induced down-regulation of SAA3 in AT was anticipated. However, 
from all fat depots investigated herein, the s.c. fat had the lowest share of these depots and 
the CLA treatment largely yielded no effects on fat depot masses (von Soosten et al., 
2011). We observed reduced fat cell sizes in both s.c. and v.c. depots from the CLA 
treated primiparous cows investigated herein as compared to the controls (Akter et al., 
2011). However, this CLA related decrease of cell size coincided with decreased SAA3 
mRNA abundance solely in one of the fat depots investigated, and thus provides only 
little support for SAA3 being involved in adipose cellularity. As to whether the CLA effect 
will remain on the level of the SAA protein remains to be clarified since the expression of 
SAA protein in different AT of dairy cows was demonstrated in a qualitative but not a 
quantitative manner. 
For cattle, the presence of SAA3 mRNA shown herein in pancreatic tissues of dairy cows 
corroborates earlier studies (Lecchi et al., 2012), however, the functional role of SAA3 in 
pancreas remains to be investigated.  
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CONCLUSIONS 
Herein, we defined SAA3 as a new bovine adipokine. Longitudinal characterization of the 
SAA3 mRNA in AT but also in non-fat tissues during late pregnancy and the subsequent 
lactation yielded a peripartal peak. The sparse effects observed for the CLA treatment on 
SAA3 mRNA abundance in s.c. AT and in muscle tissue do not consistently support that 
local anti-inflammatory effects of CLA might occur, however, this option can also not be 
entirely ruled out. To clarify potential effects of CLA in this respect, isomer specific 
treatments would be more meaningful; however, our results for the CLA isomer mixture 
from this study and from a previous one about another acute phase protein i.e. 
haptoglobin (Saremi et al., 2012) imply that this form of CLA supplementation that is 
available in the field, leaves the major bovine acute phase proteins largely unaffected.  
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Figure 1. Serum amyloid A3 (SAA3) mRNA abundance (means ± SEM) in liver and in 
subcutaneous tail head fat of pluriparous cows. Based on the lack of significant treatment 
effects, data were pooled from cows receiving conjugated linoleic acids (CLA, Lutrell
®
 
Pure, BASF SE, Ludwigshafen, Germany; n = 11) at 100 g/d and from cows receiving a 
control fat supplement (Silafat
®
, BASF SE; n = 10) from d 1 until d 182 postpartum in 
Trial 1. Samples from d 1, 70, 182, and 224 were limited to the control cows. In liver, # 
defines a significant difference in comparison to all the other sampling dates (P < 0.05). 
Different letters indicate significant differences between d relative to parturition (P < 
0.05). Data are normalized based on the geometric mean of 3 most stable reference genes: 
lipoprotein receptor-related protein 10 (LRP10), RNA Polymerase II (POLR2A) and 
eukariotic translation initiation factor 3 (EIF3K) in liver and LRP10, glyceraldehyde-
phosphate-dehydrogenase (GAPDH), and POLR2A in s.c adipose tissue. A.U.: arbitrary 
units. 
Liver
s.c. tail head fat
Liver
s.c. tail head fat
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Figure 2. Serum amyloid A3 (SAA3) mRNA abundance (means ± SEM) in three visceral 
(upper panels) and three subcutaneous fat depots (lower panels) in primiparous cows 
supplemented with 100 g/d conjugated linoleic acids (CLA, Lutrell
®
 Pure, BASF SE, , 
Ludwigshafen, Germany) or a control fat supplement (Silafat
®
, BASF SE) from d 1 until 
d 105 postpartum. Within the control group, SAA3 mRNA abundance was higher (P < 
0.05) on d 1 than on d 42 and d 105 in retroperitoneal and omental fat. In subcutaneous 
fat (s.c.) from sternum, withers, and tail head the difference was limited to d 1 vs. d 42 
and in omental fat there was an additional decrease from d 42 to 105. The effects of CLA 
treatment were limited to s.c. fat in which reduced SAA3 mRNA abundance was observed 
at d 42 and 105 in s.c. fat from withers and sternum, respectively. ns: not significant. Data 
are normalized based on the geometric mean of the most stable reference genes: 
Eukariotic translation initiation factor 3 (EIF3K), Lipoprotein receptor-related protein 10 
(LRP10), RNA polymerase II (POLR2A), Emerin (EMD), Marvel domain containing 1 
(MARVELD1), and Hippocalcin-like 1 (HPCAL1) for each s.c. fat and mesenteric fat 
depots and EIF3K, LRP10, POLR2A, EMD, and MARVELD1 for omental and 
retroperitoneal fat depots. A.U.: arbitrary units. 
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Figure 3. Serum amyloid A3 (SAA3) mRNA abundance (means ± SEM) in liver, M. 
semitendinosus, and mammary gland of primiparous cows receiving conjugated linoleic 
acids (CLA, Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) at 100 g/d or a control fat 
supplement (Silafat
®
, BASF SE) from d 1 until d 105 postpartum. Significant differences 
between sampling dates within tissue of the control group were between d 1 and d 42 in 
liver, muscle, and mammary gland (P < 0.05). At d 105, SAA3 mRNA abundance 
remained low in mammary gland, but increased to the values of d 1 in liver and muscle 
tissue. Effects of CLA were limited to d 105 postpartum in muscle tissue. Data are 
normalized based on the geometric mean of the most stable reference genes: Hippocalcin-
like 1 (HPCAL1), Lipoprotein receptor-related protein 10 (LRP10), RNA polymerase II 
(POLR2A), Eukariotic translation initiation factor 3 (EIF3K), Glyceraldehyde-phosphate-
dehydrogenase (GAPDH) for liver, LRP10, Emerin (EMD), POLR2A, EIF3K for muscle, 
and Marvel domain containing 1 (MARVELD1), EMD, LRP10, EIF3K, POLR2A, 
HPCAL1 for mammary gland tissue. A.U.: arbitrary units. 
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Figure 4. Serum amyloid A3 (SAA3) mRNA abundance (means ± SEM) in different fat 
and non-fat tissues of primiparous cows across all sampling dates and treatments. 
Different letters specify the differences between the individual fat depots (P < 0.05). Data 
are normalized based on the geometric mean of 4 most stable reference genes: Eukariotic 
translation initiation factor 3 (EIF3K), Lipoprotein receptor-related protein 10 (LRP10), 
RNA polymerase II (POLR2A), and Hippocalcin-like 1 (HPCAL1). A.U.: arbitrary units. 
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Figure 5. Timely changes of Serum amyloid A3 (SAA3) mRNA abundance in bovine 
preadipocytes differentiating for 13 d. Primary cells were obtained from 3 individuals and 
were pooled; samples from the given days of differentiation were assayed in triplicates. 
The mRNA quantities were normalized to the geometric mean of two reference genes: 
Glyceraldehyde-phosphate-dehydrogenase (GADPH) and Lipoprotein receptor-related 
protein 10 (LRP10). A.U.: arbitrary units. 
  
85 
 
Manuscript 3: Serum amyloid A3 
 
Figure 6. Tris-tricine-SDS gel and Western blot analysis of adipose tissue homogenates 
from different fat depots. Equal amounts of total protein (15 μg) of each tissue 
homogenate were loaded. SAA was detected using a rabbit anti-bovine SAA antibody. 
Bovine serum was used as a positive control. To confirm that an equal amount of protein 
was loaded on each lane, membranes were stripped and immuno-labelled with a mouse 
anti ß-actin antibody. AT: adipose tissue. 
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Abstract 
In dairy cows the milk associated output of energy in early lactation exceeds the input via 
voluntary feed intake. To spare glucose for mammary synthesis of lactose, insulin 
sensitivity (IS) in peripheral tissues is reduced and the mobilization of body reserves, 
mainly body fat, is stimulated. For these processes a link between IS and the endocrine 
functions of adipose tissue (AT) is likely and we thus aimed to characterize the time 
course of mRNAs from bovine AT derived proteins and receptors related to IS in 
metabolic active tissues as well as systemic IS throughout lactation. Conjugated linoleic 
acids (CLA) reduce milk fat thus decreasing the milk drain of energy and potentially 
dampening lipolysis, but may also affect IS. Biopsies (subcutaneous (s.c.) AT and liver) 
of pluriparous cows receiving a control fat or a CLA supplement (each at 100 g/day from 
1 to 182 days in milk) covering 3 weeks antepartum until 36 weeks postpartum as well as 
samples from liver, mammary gland, skeletal muscle and 3 visceral and 3 s.c. AT were 
obtained from primiparous cows treated analogously and slaughtered on days in milk 1, 
42 or 105. Tissue samples were assayed for mRNA abundance of adiponectin, its 
receptors, leptin, leptin receptor, PPARγ and PPARγ2, IL-6, and TNF-α.  
For most of the targets, changes throughout lactation, albeit heterogeneous, were 
observed. The gene expression was different between AT depots. In s.c. AT of 
pluriparous cows most mRNAs decreased peripartum, except TNF-α. In primiparous 
cows most changes were related to adiponectin receptor 1, with lowest expression on 1 
day in milk. In primiparous cows, CLA effects were largely limited to decreased PPARγ2 
mRNA abundance in the mammary gland. In pluriparous cows, systemic IS was reduced 
by CLA treatment but without consistent changes in tissue mRNA abundance of the 
target genes.  
 
Introduction 
Late pregnancy and lactogenesis are linked to comprehensive endocrine and metabolic 
changes of the female. Homeorhetic adaptations are necessary to accomplish the nutrient 
drain towards the mammary gland. They are associated with decreasing peripheral insulin 
sensitivity (IS) in peripheral tissues other than the mammary gland in dairy cattle [1] just 
as in other mammalian species like humans [2]. Nevertheless, genetic selection for milk 
synthesis in dairy cattle results in a particular distinctive negative energy balance (NEB) 
which is often associated with metabolic diseases like fatty liver [3].  
Messenger molecules derived from adipose tissue (AT), i.e. adipokines, are important 
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metabolic regulators and modulate IS [4].This is well known for monogastric species in 
contrast to ruminants. The adipokines are related to energy metabolism (e.g. adiponectin 
(ADIPOQ) and leptin (LEP)) as well as inflammation (e.g. tumor-necrosis factor-α (TNF-
α) and interleukin-6 (IL-6) [5]. The adipokine ADIPOQ reduces gluconeogenesis, leading 
to decreased hepatic glucose release; glucose uptake as well as beta-oxidation by liver 
and muscle is also increased [6,7]. Activation of inflammatory pathways in AT and 
release of inflammatory cytokines from AT can affect IS directly at the level of insulin 
sensing, e.g. reduced phosphorylation of insulin receptor and insulin receptor substrate-1 
lead to decreased glucose uptake as shown for TNF-α [8] and IL-6 [9].  
The transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) is a 
central regulator of genes related to insulin sensitivity, including ADIPOQ, IL-6 and 
TNF-α [10,11]. In dairy cattle it was shown that gene expression of PPARγ is linked to 
lipogenic gene expression in mammary gland [12] and the PPARγ agonist 2,4-
thiazolidinedione increases plasma glucose [13]. In cattle, two isoforms of PPARγ 
(PPARγ1 and PPARγ2) sharing 90% identity are described [14]. In general, the PPARγ2 
isoform is highly expressed in AT; it plays an important role in adipocyte differentiation 
and regulates IS [15].  
As recently reviewed, AT from different areas of the body display distinct structural and 
functional properties including adipokine secretion. In humans and rodents, visceral (v.c.) 
AT feature higher lipogenic and lipolytic activities and produce more pro-inflammatory 
cytokines, while subcutaneous (s.c.) AT are the main source of LEP and ADIPOQ, and 
thus have disparate roles, amongst others in IS [16]. So far, studies in dairy cows were 
mostly limited to s.c. fat which can readily be biopsied.  
Linoleic acid and their derivatives like conjugated linoleic acids (CLA) are ligands for 
PPARs [17,18]. In 3T3L1 adipocytes trans-10, cis-12 CLA decreases ADIPOQ in both 
PPARγ dependent and independent mechanisms in vitro [19]. CLA is also a ligand for 
free fatty acid receptor 1 and activation of the receptor increases glucose stimulated 
insulin secretion in mice [20]. From rodent studies using high doses (up to 1% of the diet) 
of trans-10, cis-12 CLA, dramatic loss of AT, inflammation, insulin resistance and 
hepatic steatosis are reported [21]; however, when using lower doses, the effects were 
largely limited to reduced AT lipogenesis. In dairy cattle, CLA may act energy-sparing as 
the trans-10, cis-12 CLA isomer is related to milk fat depression whereas whole body 
seems largely unaffected during both short and long-term treatments with this CLA 
isomer [22]. Milk fat depression may improve NEB in dairy cows but the effects are not 
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conclusive yet as discussed by Hötger et al. [23]. This group has shown that the main 
isomers (trans-10, cis-12 CLA, cis-9, trans-11 CLA) decreases endogenous glucose 
production and milk fat synthesis but increases plasma glucose, whereby it had no effect 
on insulin secretion in cows during their second lactation.  
Knowledge on IS related gene expression in relevant tissues involved in energy 
metabolism in dairy cattle may help to reduce the incidence for metabolic diseases in 
future. Therefore we aimed to characterise the time course of the expression of IS related 
genes during lactation in different AT of v.c. and s.c. localisations in addition to muscle, 
liver and mammary gland. Based on the potential of CLA on energy-sparing in addition 
to affect glucose metabolism and possibly IS, we supplemented primiparous and 
pluriparous Holstein cows’ diet with a 1:1 mixture of trans-10, cis-12 CLA and cis-9, 
trans-11 CLA which is registered as feed supplement in the EU. Subcutaneous AT can 
readily be biopsied, and therefore we were particularly aiming to compare the mRNA 
expression between different s.c. and v.c. AT depots available through timed slaughter of 
primiparous cows. The target genes we selected herein are related to IS, and we therefore 
aimed to test not only tissue mRNA expression but also to estimate systemic IS using the 
“Revised Quantitative Insulin Sensitivity Check Index” (RQUICKI) that was suggested 
for use in dairy cows [24]. 
 
Materials and Methods 
The experiments and treatments of the animals were approved by the competent 
authority, the lower saxony state office for consumer protection and food safety (LAVES, 
file no. 33.11.42502-04-071/07, Oldenburg, Germany). The regulations of the German 
Animal Welfare Act (TierSchG) in its respective current edition were met. All animals 
were housed in free stall barns at the experimental station of the Friedrich Loeffler 
Institute, Federal Research Institute for Animal Health, Braunschweig, Germany.  
 
Animals, diets and treatments 
Trial 1. German Holstein pluriparous (n = 21) and primiparous (n = 10) cows were fed a 
partial mixed ration consisting of 38% grass silage, 25% corn silage and 37% concentrate 
on a dry matter basis for ad libitum intake over the entire experimental period. Diets were 
formulated according to the recommendations of the German Society of Nutrition 
Physiology [25]. More details about the experiment and the outcomes in terms of 
performance, metabolite concentrations and milk FFA profile from this experiment are 
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described by [26]. On DIM 1 the animals were allocated to 2 groups: a CLA group (11 
pluriparous and 5 primiparous cows) and a control group (10 pluriparous and 5 
primiparous cows). During the supplementation period (from 1 to 182 DIM), the animals 
received 4 kg of additional concentrate containing the fat supplements. The animals of the 
CLA group received 100 g/d encapsulated CLA (Lutrell Pure, BASF, Ludwigshafen, 
Germany). The control group received 100 g/d of a control fat supplement (Silafat, 
BASF) in which CLA were substituted by stearic acid. In the CLA group, the animals 
consumed 7.6 g/day each of the trans-10, cis-12 and cis-9, trans-11 CLA isomers. Liver 
and s.c. AT from tail head were biopsied on d 21 before calving and on DIM 1, 21, 70, 
105 182 196, 224, and 252. The biopsy procedures were previously described in detail by 
Saremi et al. [27]. For gene expression analyses, samples were restricted to the 
pluriparous cows of the control group (all sampling dates) and of the CLA group (d -21, 
21, 105, 196, and 252) as the focus of the study was related to changes throughout 
lactation and the capacity of handling the samples was limited. Jugular blood samples 
were collected on d - 21, - 14, - 7, 1, 7, 14, 21, 35, 49, 70, 105, 140, 182, 189, 196, 210, 
224, 238, and 252 relative to calving.  
Trial 2. German Holstein primiparous cows (n = 25, average age at calving was 23 
months) were fed a partial mixed ration (ad libitum) according to the recommendations of 
the German Society of Nutrition Physiology [25]. The ration consisted of 63% silage 
(60% corn silage, 40% grass silage) and 37% concentrate on a dry matter basis. Five 
cows were slaughtered on 1 DIM and the remaining animals (n = 20) were randomly 
allocated to either receive 100 g/d of the control fat supplement (Silafat, BASF) or of 
CLA (Lutrell Pure, BASF) starting from 1 DIM. All experimental details and main 
outcomes in terms of performance, adipose depot and organ weights, body composition, 
body fat mobilization, protein accretion, and energy utilization were reported by von 
Soosten et al. [28,29]. Five cows per group were slaughtered at 42 and 105 DIM. Samples 
from 3 v.c. AT (omental, mesenteric, and retroperitoneal), 3 (tail head, withers, and 
sternum), liver, M. semitendinosus, pancreas, and mammary gland were taken 
immediately after slaughter. Blood samples were collected from V. jugularis on d - 21, - 
14, - 7, - 3, 1 (n = 25), 7, 14, 28, 42 (n = 20), and 105 (n = 10) relative to parturition. 
The tissue samples from both trials were snap-frozen in liquid nitrogen and stored at - 80 
°C for RNA extraction and analysis. The blood samples were collected in different tubes 
to obtain sodium fluoride/ EDTA plasma, heparin plasma or serum. Plasma samples were 
stored at - 20 °C and sera at - 80 °C until analysed. 
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Relative quantification by real-time PCR 
Preparation of samples including RNA extraction and cDNA synthesis together with real-
time PCR and reference genes characteristics, selection, and measurements are described 
in detail by Saremi et al. [27,30]. Relative quantification of the target genes was 
performed as summarized in table 1. Amplicon standard curve was used except for 
PPARγ2 in Trial 1 and 2 and LEPRB and TNF-α in Trial 1 where cDNA standards curve 
was used. The standard curve was used to correct data based on PCR efficiency per run. 
Two µL cDNA (diluted 1 to 4) as template and 5 µL SYBR Green JumpStart Taq 
Readymix (Sigma-Aldrich, Steinheim, Germany) in a total volume of 10 µL were run in 
an Mx3000P real-time PCR cycler (Stratagene, Amsterdam, Netherlands and Agilent, 
Santa Clara, CA).  
 
Reference gene stability and data analysis  
In each individual case, comparing treatment effects within a single tissue or comparing 
different tissues, an adequate panel of reference genes was selected according to Saremi 
et al. [27,30]. 
Trial 1. The reference genes used were low density lipoprotein receptor-related protein 
10 (LRP10), glyceraldehyde-phosphate-dehydrogenase (GAPDH), and RNA Polymerase 
II (POLR2A) for s.c. AT and LRP10, POLR2A, and eukariotic translation initiation factor 
3, subunit K (EIF3K) for liver tissue according to Saremi et al. [27]. The geometric mean 
of the reference gene abundances was used for normalization. Data are presented as ratio 
of the copy numbers of genes of interest and the geometric mean of the corresponding 
reference genes. 
Trial 2. The quantification cycle values were imported to qBASE
plus
 version 2.0 
(Biogazelle, Ghent, Belgium) and all subsequent calculations and data quality controls 
were done based on this software [31]. Reference genes were tested per tissue and the 
lowest V value obtained for the number of reference genes needed for normalization as 
described by Saremi et al. [30]. Briefly, for normalization of the efficiency corrected data 
the reference genes EIF3K, LRP10, POLR2A, Emerin, Marvel domain containing 1 and 
Hippocalcin-like 1 were selected and used, depending on the tissues being compared [30] 
were used. The data used for statistics was generated by geNorm
plus
 as a part of qBASE
plus
 
version 2.0 (Biogazelle, Ghent, Belgium).  
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Analysis of NEFA, BHBA, LEP, and insulin in blood samples 
Glucose was measured in sodium fluoride/ EDTA plasma, for quantification of insulin, 
NEFA, and BHBA heparinized plasma was used. The plasma concentrations of glucose, 
NEFA, and BHBA were determined by an automatic analyser (Cobas Mira Plus System 
from Roche Diagnostica Ltd, Basel, Switzerland) using commercial test kits (Glucose: 
Glucose Hexokinase Fluid 5+1, MTI Diagnostics GmbH, Idstein, Germany; NEFA: 
HR(2) R1+R2 Set, WAKO Chemicals GmbH, Neuss, Germany; BHBA: RANBUT, RB 
1008, Randox Laboratories GmbH, Wülfrath, Germany). LEP concentrations were 
determined in serum by ELISA [32]. The intra and inter assay coefficients of variations 
were 6.3% and 13.9%, respectively, the limit of detection was 0.3 ng/mL. The 
concentrations of insulin in plasma were measured using a commercially available double 
antibody radioimmunoassay (DSL-1600, Diagnostic Systems Laboratories, Inc., TX). The 
intra and inter assay coefficients of variation were 6.3% and 8.8%, respectively. 
 
Calculations and statistical analyses  
The RQUICKI was calculated based on the concentrations of plasma glucose, NEFA, and 
insulin (Perseghin et al., 2001) as previously used to estimate IS in dairy cows [24] by the 
following equation: 
RQUICKI = 1 / [log(glucose) + log(insulin) + log(NEFA)]. 
All statistical analyses were performed using SPSS (version 20, SPSS Inc., Chicago, IL). 
For Trial 1, the mixed model procedure was used. Treatment (control and CLA) was 
considered as fixed factor, sampling dates (time) as repeated effect, and the respective 
interaction was included in the model. For serum LEP, but not for mRNA analyses which 
were limited to the cows from Trial 1, parity (cows or heifers) was considered as fixed 
effect together with its interaction with treatment. The covariance structure heterogeneous 
first-order autoregressive and Bonferroni correction were used for serum data, while 
component symmetry was used for mRNA data. 
For Trial 2 in which the repeated design for tissue samples was not applicable, all data 
were tested for homogeneity of variances (P < 0.1). Accordingly the general linear model 
with the fixed effects of treatment, dates, and the respective interaction, or non parametric 
tests (Kruskal-Wallis or Mann-Whitney) were applied (P < 0.05). All data are presented 
as mean ± SEM.  
For both trials P < 0.05 was considered significant. 
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Results 
Trial 1 
During the transition from late pregnancy to early lactation (transition period) in 
pluriparous cows, in the majority of the cases the mRNA abundance of the target genes 
was decreased in s.c. AT (Figures 1, 2, and 3). In detail, the mRNA abundance for LEP, 
LEPR, ADIPOQ, ADIPOR1, ADIPOR2, PPARγ, and PPARγ2 was decreased in s.c. AT. 
Similarly, the amount of PPARγ and IL-6 mRNA in liver was reduced. In contrast, the 
quantity of LEPR and LEPRB as well as ADIPOR2 mRNA in liver increased during the 
transition period. The mRNAs for PPARγ, PPARγ2 and LEPR in s.c. AT were lower 
throughout the analysed time period up to 252 DIM, compared to a.p.. The abundance of 
LEPR and LEPRB mRNA in liver was higher up to day 196 DIM compared to a.p., and 
decreased thereafter to values comparable to the situation a.p., but remained higher at day 
252 in case of LEPR. The mRNA quantity for ADIPOR2 in liver was higher at 21 DIM 
vs. -21 DIM and decreased to the end of the analysed period. No peripartal and lactation 
related differences were observed for TNF-α in liver and s.c. AT. The pattern of serum 
LEP followed roughly the mRNA throughout the transition period but these changes were 
not significant (Figure 2). 
Supplementation with CLA only sporadically increased or decreased the expression of 
few genes at discrete time points in liver and s.c. AT; however, no consistent changes 
were observed. Treatment with CLA increased the mRNA abundance of LEPRB and 
TNF-α mRNA abundance in liver, whereas PPARγ mRNA was lower in CLA cows as 
compared to the controls at defined time points throughout lactation. Lower values than in 
the control group were also observed at 196 DIM i.e. beyond the supplementation period 
in case of PPARγ2 in s.c. AT of CLA cows (Figure 3). 
Analysing CLA effects on insulin, glucose, and NEFA, and for comparing RQUICKI 
values in primiparous vs. pluriparous cows, CLA effects were evident only in pluriparous 
cows. In these animals insulin concentrations were greater and RQUICKI data were lower 
(8% or 17% during supplementation and depletion period, respectively) compared to the 
control group (Figure 4).  
 
Trial 2 
Comparing time related changes throughout lactation in different adipose depots, liver, 
muscle, and mammary gland of primiparous cows (Table 2 and 3), the most temporal 
changes were observed for ADIPOR1. In mammary gland and all fat depots except 
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omental AT, the receptor mRNA abundance was increased with DIM. In contrast, the 
amount of this mRNA was decreased in muscle or reduced at d 42 in liver tissue. The 
mRNA abundance of ADIPOR2 was increased with DIM in retroperitoneal AT and 
higher at d 105 vs. d 42 in mammary gland. ADIPOQ mRNA abundance increased in two 
v.c.AT (omental and retroperitoneal) with DIM. LEPRB mRNA abundance was 
decreased with DIM in all v.c.AT and in the mammary gland. No changes were found for 
LEP mRNA in primiparous cows throughout lactation. The mRNA abundance for PPARγ 
and PPARγ2 changed in some tissues but not consistently. For PPARγ an increase over 
time was detected in omental AT, and for PPARγ2 in retroperitoneal AT. In addition, an 
increase was observed in liver for both transcripts. The amount of TNF-α mRNA 
increased in all of the s.c. AT  and in liver; in mammary gland and in retroperitoneal AT, 
a decrease with DIM was observed. IL-6 mRNA was decreased in s.c. AT from tail head 
and withers but increased in liver over the time.  
Supplementation with CLA only had few and inconsistent effects on gene expression in 
primiparous cows. The mRNA abundance of TNF-α mRNA was reduced at 42 DIM in 
mesenteric AT, the ADIPOQ and ADIPOR2 mRNA abundance was declined at 105 DIM 
in omental and retroperitoneal AT, respectively. The mRNA abundance of PPARγ2 was 
reduced by CLA only in the mammary gland but at both time points after parturition: 
DIM 42 and DIM 105. 
 
Differences in gene expression of target genes between adipose tissue depots and in 
relation to other tissues 
The mRNA abundance of the target genes was compared between different AT from Trial 
2 irrespective of treatment and DIM (Figure 5). Differences between the different AT 
depots were seen for all target mRNAs except ADIPOR2. In addition, the mRNA 
abundance of most target genes was different when comparing only within v.c. depots or 
within s.c. depots.  
By the real-time PCR protocol applied, ADIPOQ mRNA in the mammary gland was 
detectable only in one third of the samples. The abundance was about 900 times lower 
than in AT. For ADIPOR1, a 2 fold lower abundance was observed in the liver than in the 
average of all AT whereas in muscle the values were 3.7 fold higher than in AT. The 
abundance of ADIPOR2 mRNA in muscle was higher than in liver. In both tissues the 
abundance was mostly in the same range as in the different AT depots although liver and 
muscle had lower and higher ADIPOR2 mRNA abundance in comparison to 
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retroperitoneal and mesenteric AT, respectively. Compared to AT, there was about 100 
fold less PPARγ2 mRNA in liver, 79 fold less in muscle and 17.4 times less in mammary 
gland. PPARγ mRNA abundance in liver was 109 fold lower in comparison to the mean 
of AT. LEP mRNA abundance was low in muscle and mammary gland in comparison to 
the mean of fat depots (171 and 353 fold lower, respectively). In liver, 34.4 times more 
LEPRB mRNA abundance than in AT was observed. About 5 fold more TNF-α mRNA 
was observed in liver compared to AT, but IL-6 mRNA abundance was 8.3 times lower in 
liver as compared to AT.  
 
Discussion 
The incidence for metabolic diseases (e.g. ketosis and fatty liver) during early lactation in 
dairy cattle is high. The animals pass a period of enormous lipolysis and substantial 
insulin resistance [3]. Increasing information about the regulation of IS associated genes 
may help to optimize management strategies improving the health status of the animals in 
future. In this study, we focused on the mRNA abundance of different genes related to IS 
in early lactation of primiparous cows and throughout a whole lactation cycle in 
pluriparous cows in a descriptive manner. The aim was to broaden the knowledge about 
the regulation of these genes depending on the lactational stage. Differences in gene 
expression between different AT depots, even between individual s.c. AT localisations 
were disclosed. The physiological significance of functional differences between s.c. and 
v.c. AT localisations and its impact on metabolism by its expression profiles were 
discussed in a broad manner in monogastrics [33]. In humans, v.c. AT compared to s.c. 
AT is preferably lost during energy restriction and exercise. Nevertheless,  differences 
regarding to mobilisation were described for s.c. localisations, too [34] but especially 
visceral AT mass is correlated with IS [16]. However, data on gene expression in AT 
samples of dairy cattle during lactation are mostly restricted to s.c. AT and commonly to 
a single localisation, typically tail head in case of repeated biopsy sampling. 
Supplementation with CLA (50% of each cis-9, trans-11 and trans-10, cis-12 CLA), 
which is discussed to affect IS in monogastrics [35] and is known to decrease milk fat 
synthesis in ruminants [22], was used to check their ability to influence IS related genes 
in dairy cattle. We herein aimed to test whether CLA treatment as management strategy 
to reduce milk fat might alter the expression of IS related genes in various tissues and also 
the systemic IS. We analysed different s.c. AT depots as well as different v.c. AT depots 
in dairy cattle to get a broad overview about the flexibility of AT responses in dairy 
96 
 
 
Saremi et al. 
cattle.  
 
Gene expression of the ADIPOQ and LEP system during lactation  
The adipokines LEP and ADIPOQ increase IS. LEP is positively and ADIPOQ is 
negatively linked with body fat content [7,36]. LEP mainly exerts its effects through 
LEPRB [37] and ADIPOQ via ADIPOR1 and ADIPOR2, as observed in humans [6]. The 
blood concentrations of LEP in dairy cattle are low in early lactation [38]; for ADIPOQ 
less information is available in cattle but decreased concentrations were recently 
documented using semiquantitative Western blots [39,40] and a new bovine specific 
ELISA [40]. 
Recently, Koltes and Spurlock [41] observed a decrease of the ADIPOQ mRNA 
abundance in s.c. AT from tail head throughout the transition period. This result is 
comparable to our observation in Trial 1 about ADIPOQ mRNA expression in 
pluriparous cows and relevant for further genes of the ADIPOQ and LEP system in s.c. 
AT but also for others like PPARγ and PPARγ2 during the peripartal period. For the 
LEPR mRNA in s.c. AT, our present results are not in line with data published by our 
group and others [42,43]. In these two studies, an increase in LEPRB and LEPR mRNA, 
respectively was observed and explained by Thorn et al. [43] at least partly by the low 
insulin concentrations during early lactation. As expected, we also observed low insulin 
concentrations after calving. Other factors might contribute to the regulation of LEPR, 
which have to be explored in future.  
In monogastrics, ADIPOQ and its receptors are inversely related to body fat mass; both 
receptors but also serum ADIPOQ are down-regulated by insulin in lean men [6,44]. 
Therefore, the reduction in mRNA abundance of the ADIPOQ system we observed 
during the transition period in s.c. AT of pluriparous cows in Trial 1 indicates an 
uncoupling between energy balance and the ADIPOQ system as they were not regulated 
contrary to the energy status and insulin values as shown in monogastrics [6,44]. In 
addition, ADIPOQ is associated with lipogenesis and differentiation during adipogenesis 
at least in murine 3T3-L1 adipocytes [45]. Therefore, the decreased ADIPOQ mRNA 
abundance in AT during early lactation might be related to reduced lipogenesis and 
adipogenesis during NEB in discrete AT depots. The regulation of both receptors in liver 
differs from s.c. AT as the ADIPOR1 mRNA abundance was stable and the one for 
ADIPOR2 increased in liver during the transition period. Based on ADIPOQ signal 
transduction in liver as discovered in a mouse model with targeted disruption of the 
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ADIPORs [46], reduced ADIPOQ serum concentrations during the transition period may 
enhance gluconeogenesis. The mRNA of ADIPOR2 increased after parturition. 
Comparable observations are reported by Loor et al. [47]. In their study, the expression of 
the receptor mRNA was further increased by feed restriction a.p. In addition, growth 
hormone (GH) might be related to this observation: GH knowingly peaks around 
parturition in dairy cattle [48] and ADIPOR2 but not ADIPOR1 was shown to be 
upregulated by GH in liver of mice [49]. Signalling by ADIPOR2 is associated with the 
reduction of oxidative stress in liver [46], and oxidative stress is increased by NEFA as 
shown in human hepatocytes [50]. During NEB in early lactation, NEFA concentrations 
increase [3]. Based on the fact that targeted receptor disruption in liver of mice increases 
oxidative stress parameters [46], upregulation of the receptor may help to mitigate 
oxidative stress in liver of dairy cows. 
In Trial 2, the most changes throughout lactation occurred for ADIPOR1 mRNA in 
several adipose depots, in particular in the s.c. AT depots of these primiparous cows in 
which the abundance increased with DIM. As mentioned earlier, this might be also 
related to the effects of ADIPOQ on adipogenesis and lipogenesis [45] which are down-
regulated during NEB in contrast to lipolysis [51]. As discussed by Dagon et al. [52] and 
Rossmeisl et al. [53], AMPK is an important mediator of hormonal and nutritional effects 
on AT and is thus related to the control of body fat mass. Its activation involves the 
down-regulation of lipogenic and adipogenic genes like PPARγ. Both ADIPORs are 
linked to AMPK activation but ADIPOR1 to a higher extent than ADIPOR2, which is 
more associated with PPARα signalling, at least in liver [46]. Therefore, an increase in 
abundance of ADIPOR1 up to peak lactation might be related to an increase in AMPK 
activity, controlling lipolysis tightly in retroperitoneal AT and in different s.c. AT of 
primiparous cows. Based on recent studies, the energy sensor AMPK may act 
antilipolytic and inhibit hormone sensitive lipase transport to the lipid droplet [54], which 
is in line with our observation of increasing ADIPOR1 mRNA abundance in AT. 
Therefore, AMPK may protect the adipocyte against energy depletion as discussed by 
Gauthier et al. [55]. Antilipolytic effects of AMPK were also addressed for dairy cows 
based on increasing phosphorylation of AMPKα1 after parturition [56]. Summarising, 
increasing ADIPOR1 mRNA throughout lactation might be associated with reduced 
lipolysis in dairy cows by increasing AMPK activity which would be in line with positive 
effects of ADIPOQ on lipid accumulation in AT [45] and lowest ADIPOQ concentrations 
after parturition in dairy cows [40]. 
98 
 
 
Saremi et al. 
 
Gene expression of PPARγ and PPARγ2 throughout lactation 
The transcription factor PPARγ is a key regulator of IS and adipogenesis [57]. Targeted 
deletion of PPARγ in murine liver decreased hepatic triglyceride content and impaired 
systemic IS [58]. Therefore, regulation of PPARγ around parturition may affect insulin 
responsiveness of bovine tissues. Like in other species, two PPARγ isoforms are defined 
in cattle i.e. PPARγ1 and PPARγ2 [14]. In vitro, the isoform PPARγ2 has stronger 
adipogenic activity compared to the isoform PPARγ1 [59]. 
In the pluriparous cows of Trial 1, PPARγ was reduced in s.c. AT and in the liver after 
parturition. Due to technical reasons which might be related to the amount of total RNA 
used for cDNA synthesis it was not possible to quantify PPARγ2 mRNA abundance in 
liver of all samples but we observed a curve shape comparable to PPARγ in s.c. AT. We 
suggest that the expression patterns of PPARγ and PPARγ2 mRNA, with highest values 
a.p. compared to postpartum in AT, are possibly associated to other genes we analysed 
throughout lactation. One example might be the regulation of ADIPOQ whose gene 
expression and plasma concentrations are induced by PPARγ ligands [60]. Lower values 
in PPARγ mRNA abundance in liver were also reported 3 wk after parturition as 
compared to the first wk of lactation [61]. Therefore, we expect a nadir of PPARγ 
expression in AT but also in liver in wk 3 postpartum. This observation is in contrast to 
PPARα which is upregulated after parturition [62]. As discussed by Lee et al. [63], the 
uppermost expression for PPARγ is found in AT, where it is related to adipogenesis and 
IS. In liver, it is linked to fatty acid uptake, lipid storage, and reduced gluconeogenesis. 
High abundance of PPARγ mRNA in s.c. AT during late pregnancy might be related to 
energy accretion by AT. In liver, the decreased abundance of PPARγ during early 
lactation may result in increased gluconeogenic capacity.  
In Trial 2, no changes in PPARγ and PPARγ2 were observed in s.c. AT after parturition, 
which is in line with the results obtained in s.c. AT from Trial 1. In liver of the 
primiparous cows, both transcripts were increased with DIM and are thus in line with our 
observations in liver of the pluriparous cows from Trial 1. In addition to the potential 
effects of PPARγ on gluconeogenesis, the incidence for fatty liver might be reduced by 
decreasing expression of PPARγ2 after parturition: inactivation of PPARγ2 may improve 
fatty liver induced by high fat diet in mice [64].  
For the mammary gland, Bionaz and Loor [65] reported that PPARγ is upregulated at the 
onset of lactation in comparison to 15 DIM. We analysed PPARγ2, which was not 
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regulated throughout lactation in mammary gland. Also in another study, no differences 
for PPARγ2 were observed in this tissue [66]. 
 
Gene expression of the pro-inflammatory proteins IL-6 and TNF-α 
The adipokines IL-6 and TNF-α are related to insulin resistance [67]. In dairy cows, 
plasma TNF-α is reduced after parturition [68] and high TNF-α serum concentrations are 
associated with insulin resistance and fatty liver 1 to 2 wk after calving [69]. For serum 
IL-6, no differences were observed at different stages of lactation [70]. Limited data is 
available about the mRNA expression of both adipokines in bovine AT, but liver TNF-α 
mRNA abundance is higher compared to the one of IL-6 [71]. 
In Trial 1, we observed no changes of TNF-α mRNA throughout lactation in liver and in 
s.c. AT thus confirming earlier reports focusing on the transition period [61,72] and also 
extending the data base to the following periods of lactation. In contrast, IL-6 mRNA was 
reduced in liver during the transition period. IL-6 not only has adverse effects on liver 
metabolism but also stimulates proliferation and prevents hepatocyte damage [73]. The 
reduction around parturition might be related to a higher susceptibility for metabolic 
health disorders during early lactation [74]. The abundance of IL-6 mRNA in s.c. AT of 
pluriparous cows was too low for valid quantification by our protocol and was not 
detectable in each sample. By our data we were not able to confirm quantitative data on 
TNF-α mRNA from another study in pluriparous dairy cows where two peak were 
observed at 1 and 49 DIM [62].  
In primiparous cows (Trial 2), we observed an increase in TNF-α mRNA abundance in all 
s.c. AT, at least in one of the sampling dates after parturition, which is different from the 
studies of Sadri et al. [72] and van Dorland et al. [61] reporting no changes during early 
lactation in pluriparous cows. In retroperitoneal AT, TNF-α mRNA was less abundant at 
105 than on 1 DIM. In contrast to pluriparous cows, we observed an increase in the TNF-
α mRNA abundance in liver. Therefore, we suggest that differential expression of TNF-α 
in primiparous vs. pluriparous cows and between different AT of primiparous cows 
occurs. Differences between the different AT depots might be related to local regulation 
of IS in either a paracrine or autocrine manner.  
As discussed by Alluwaimi [75], TNF-α is suggested to maintain and regulate 
immunological function within the mammary gland and its expression is elevated 
throughout lactation, with a further increase in late vs. mid-lactation. In contrast, we 
observed a decrease of TNF-α mRNA in the mammary gland of primiparous cows during 
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the first 105 DIM.  
The IL-6 mRNA in s.c. AT from tail head and withers was reduced from 1 to 105 DIM. 
Therefore, the regulation of the pro-inflammatory proteins IL-6 and TNF-α seems 
different at least at the level of the mRNA in these AT depots. In contrast, the IL-6 
mRNA in liver was increased during this time. This observation might be related to an 
improved protective and regenerative capacity related to IL-6 at this stage of lactation 
[73] in primiparous, and, to a lower extent, in pluriparous cows, where only a numerical 
increase was observed. On the other hand, IL-6 is associated with reduced IS [67]. 
Network analysis in cows revealed that IL-6 is related to many liver specific pathways 
e.g. lipoprotein metabolism and fatty acid oxidation and increases during ketosis [76]. 
Therefore, lower abundance in liver around parturition and early lactation might be 
advantageous in relation to IS but the protection of the liver against oxidative stress 
during this time period might be reduced. This assumption is based on the positive effects 
of IL-6 regarding to liver cell damage and proliferation [73]. 
 
Effects of CLA supplementation on gene expression 
In general, effects of CLA supplementation were not consistent between genes, tissues 
and time points throughout lactation. Effects of CLA were only observed in few cases, in 
which the abundance of the respective target mRNA was always decreased, with only one 
exception (LEPRB in liver of pluriparous cows). The ADIPOQ mRNA was reduced in 
omental and the ADIPOR2 mRNA in retroperitoneal AT at 105 DIM. In addition, lower 
TNF-α mRNA abundance was observed in mesenteric AT of the CLA group, although 
only at 42 DIM. Comparable to a study of Sigl et al. [77] using primiparous Brown Swiss 
cows, we detected no CLA effect on PPARγ mRNA abundance in liver of primiparous 
German Holstein cows but in pluriparous animals. CLA are ligands for PPARs [17,18]. 
Nevertheless, the effects of CLA in primiparous dairy cattle may differ from the effects of 
the PPARγ agonist 2,4-thiazolidinedione observed in bulls where a decrease of PPARγ 
mRNA expression was detected in liver, after treatment with this compound [78]. 
However, the effects of 2,4-thiazolidinedione were not consistent in bulls comparable to 
our CLA effects observed in primiparous and pluriparous cows. In bulls, PPARγ mRNA 
decreased by treatment with 2,4-thiazolidinedione in liver, increased in s.c. AT as a trend 
but had no effect in muscle. Therefore, inconsistency for PPARγ agonists like 2,4-
thiazolidinedione and CLA between different tissues or AT depots and parity in cattle 
may exists, which is different to mice, were broad consistency was observed regarding to 
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the effects of both compounds on glucose and lipid metabolism [79]. 
For the mammary gland, we suggest that the impact of CLA supplementation is most 
important compared to all other analysed tissues. Treatment with CLA decreased PPARγ2 
mRNA at both time points investigated in primiparous cows, accounting for 2 of 5 CLA 
effects we observed in total. PPARγ agonists have been demonstrated to stimulate lipid 
synthesis in a mammary epithelial cell line [12]. We observed lower PPARγ2 mRNA 
abundance at 42 and at 105 DIM in the animals treated with CLA as compared to the 
cows receiving the control fat supplement. The mammary gland is an important target for 
CLA; as discussed by Bauman et al. [22], milk fat depression by CLA treatment is well 
established. PPARγ was suggested by Kadegowda et al. [12] to be an important regulator 
of milk fat synthesis. It was shown that in parallel to PPARγ, lipogenic genes like 
stearoyl-CoA desaturase, diacylglycerol O-acyltransferase 2 and fatty acid synthase were 
down regulated during the peripartal period [80]. We suggest that reduced receptor 
capacity of the PPARγ2 isoform might be responsible for milk fat depression by CLA.  
 
CLA supplementation and systemic insulin sensitivity 
In pluriparous cows, no CLA effects were observed on NEFA and BHBA concentrations 
[81]. Nevertheless, different to primiparous cows of Trial 1, insulin and glucose 
concentrations were higher and the RQUICKI index was reduced by 8 % during the 
supplementation period and by 17 % during the depletion period after 182 DIM in CLA 
treated cows vs. control cows. This indicates a CLA-induced reduction of IS in 
pluriparous cows. Comparable effects on insulin concentrations using a similar CLA 
mixture were also observed in a mouse model, in which the results were explained by an 
increase in ß-cell mass and number [82]. In contrast to our results, Hötger et al. [23] 
observed an increase of plasma glucose by CLA treatment in dairy cows during second 
lactation but not of insulin which might be related to the shorter supplementation period 
of 9 weeks compared to 26 weeks in our study. Insulin is a central regulator of energy 
metabolism and different responses to CLA between primiparous and pluriparous cows 
might be related to differences in basal insulin secretion which may influence the 
pancreatic response capacity to CLA treatment. Primiparous cows have higher insulin 
concentrations than pluriparous cows during the first 50 DIM [83], comparable to our 
data up to 182 DIM. Recently, it was shown that CLA is a ligand for the free fatty acid 
receptor 1 but only the trans-10, cis-12 in contrast to the cis-9, trans-11 CLA isomer 
increases glucose stimulated insulin secretion via this receptor [20]. Differences in its 
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expression in pancreatic ß-cells between primiparous vs. pluriparous cows might be 
interesting to explore in future as information on this issue may help to explain 
differences between these two groups. 
However, albeit the effects of CLA treatment on IS were significant, it remains open 
whether this might imply adverse effects on animal health. The values recorded herein to 
characterise IS were comparable to earlier reports [84], but currently no reference values 
for healthy versus diseased cows are available to allow for a final judgment.  
 
Conclusion 
Studying primiparous and pluriparous cows, we observed changes in the mRNA 
abundance of different modulators of IS like the ADIPOQ and LEP system in different 
tissues focusing on AT and liver. Differences between different AT depots, even of s.c. 
origin should be considered for further studies. Our results revealed few individual 
differences between primiparous and pluriparous cows. Potential insulin desensitizing 
effects of CLA supplementation, as reported in monogastric animals, were observed in 
few selected tissues of dairy cows but there was no consistency regarding to the analysed 
parameters. Supplementation of cows with CLA reduced systemic IS significantly in 
pluriparous cows but not in primiparous cows. Finally, we showed that PPARγ2, as a 
regulator of milk fat synthesis in cattle, is reduced in mammary gland by CLA 
supplementation which might be a direct link to CLA induced milk fat depression. 
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Table 1. Characteristics of the primers and the real-time PCR conditions 
Primers Sequence (5'-3') 
NIH Genbank 
accession 
number 
bp
11
 
Concen-
tration 
(nmol) 
Mean 
Cq
12
 
value
13
 
Annealing
14
 
(sec/˚C) 
ADIPOQ
1
 
Forward  
Reverse  
 
CTGGAGAGAAGGGAGAGAAAG 
TGGGTACATTGGGAACAGTG 
NM_174742 204 800 24.9 75/60 
ADIPOR1
2
 
Forward  
Reverse  
 
GCTGAAGTGAGAGGAAGAGTC 
GAGGGAATGGAGTTTATTGCC 
XM_593692 118 800 22.3 45/60 
ADIPOR2
3
 
Forward  
Reverse  
 
GGCAACATCTGGACACATC 
CTGGAGACCCCTTCTGAG 
XM_580459 200 400 21.5 45/60 
LEP
4
 
Forward  
Reverse  
 
GACATCTCACACACGCAG 
GAGGTTCTCCAGGTCATT 
U62123 183 400 25.4 30/60 
LEPRB
5
 
Forward  
Reverse  
 
ACCACACCTTCCGTTCTCAG 
GGGACAACACTCTTGACTC 
AB199589 164 400 28.8 30/60 
LEPR
6
 
Forward  
Reverse  
 
CCACTGTTGCTTTTGGAGCGAGGA 
TGTTCCAGTTTGCACCTGTTTGCT 
NM_001012285 125 100 23.0
15
 60/62 
PPARγ27 
Forward  
Reverse  
 
ATTGGTGCGTTCCCAAGTTT 
GGCCAGTTCCGTTCAAAGAA 
Y12420 57 400 21.0 60/60 
PPARγ8 
Forward  
Reverse  
 
AGGATGGGGTCCTCATATCC 
GCGTTGAACTTCACAGCAAA 
Y12420 121 800 25.3 60/61 
IL-6
9
 
Forward  
Reverse  
 
TGCAGTCTTCAAACGAGTGG 
TAAGTTGTGTGCCCAGTGGA 
BC123577 182 400 26.6 60/30 
TNF-α10 
Forward  
Reverse  
 
TGCCTGCTGCACTTCGGGGTA 
CCTGGGGACTCTTCCCTCTGGGG 
EU276079 50 800 28.8 60/60 
1
 Adiponectin, [42] 
2 
Adiponectin receptor 1, [42] 
3 
Adiponectin receptor 2, [42] 
4
 Leptin, [85] 
5 
Leptin receptor isoform b, [42] 
6 
Leptin receptor 
7
 Peroxisome proliferator-activated receptor gamma2  
8
 Peroxisome proliferator-activated receptor gamma, [86] 
9 
Interleukin-6
 
10 
Tumor necrosis factor-α 
11 
bp: base pairs.  
12 
Cq: Quantification cycle. 
13 
Based on slaughter experiment. 
14 
Initial denaturation = 10 min at 95°C; denaturation = 30 s at 95°C; extension = 30 s at 72°C, except for 
TNF-α, PPARγ2, PPARγ, LEPR, and LEPRB (60 s at 72°C). 
15
Based on liver and s.c. fat biopsies from Trial 1. 
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Table 2. ADIPOQ system and Peroxisome proliferator-activated receptor γ and γ2 mRNA expression in different tissues of 
primiparous cows supplemented with or without CLA in a time course of 105 days in milk (DIM) 
Gene DIM Treatment  
Tissue mRNA abundance (arbitrary unit) 
Omental Mesenteric Retroperitoneal s.c. tail 
head 
s.c. 
withers 
s.c. 
sternum 
Muscle
1
 Mammary
2
 Liver 
ADIPOQ
3
 1 Control  0.63±0.20
a
 0.69 ± 0.31 1.04±0.24
a
 1.16±0.15 1.62±0.52 0.87±0.23  0.10±0.02  
 42 Control  0.89±0.36
a
 0.41±0.12 1.05±0.20
a
 1.24±0.28 1.08±0.68 0.68±0.21  0.16±0.05  
 42 CLA  1.35±0.41 0.62±0.37 1.22±0.40
a
 0.90±0.63 1.13±0.48 0.61±0.21  0.42±0.26  
 105 Control  2.11±0.51
b
 1.14±0.58 2.86±0.49
b
 1.91±0.39 1.16±0.47 0.53±0.27  0.20±0.04  
 105 CLA  0.83±0.44 0.88±0.35 1.71±0.46
b
 1.22±0.28 1.66±0.38 1.09±0.26  0.30±0.09  
ADIPOR1
4
 1 Control  0.80±0.05 0.60±0.06
a
 0.80±0.09
ab
 0.85±0.04
a
 0.89±0.06
a
 0.84±0.05
a
 1.69±0.14
a
 0.89±0.05
a
 0.87±0.06 
 42 Control  0.87±0.18 0.62±0.03
a
 0.88±0.06
a
 0.89±0.14
a
 0.80±0.13 0.84±0.06
a
 0.94±0.06
b
 0.91±0.07
a
 0.74±0.05
a
 
 42 CLA  1.08±0.12 0.67±0.05
a
 0.79±0.04
a
 0.79±0.12 1.35±0.26 0.83±0.08
a
 1.06±0.10
b
 0.92±0.11
a
 0.75±0.07
a
 
 105 Control  1.07±0.12 0.88±0.15
b
 1.18±0.11
b
 1.34±0.16
b
 1.28±0.17
b
 1.07±0.09
b
 1.06±0.05
b
 1.15±0.08
b
 0.87±0.03
b
 
 105 CLA  0.85±0.18 0.76±0.05
b
 1.03±0.13
b
 1.06±0.14 1.28±0.15
b
 1.20±0.13
b
 0.93±0.05
b
 1.15±0.05
b
 0.88±0.04
b
 
ADIPOR2
5
 1 Control  1.70±0.60 1.97±0.70 3.65±0.80 3.23±0.76 4.51±1.64 2.64±0.90 1.35±0.08 1.43±0.53 1.62±0.39 
 42 Control  1.87±0.86 1.39±0.40 3.22±0.42
a
 3.01±1.04 2.87±2.55 1.81±0.82 1.19±0.18 0.77±0.17
a
 1.44±0.32 
 42 CLA  3.03±1.24 1.92±1.03 3.21±1.04
a
 2.68±2.04 2.88±1.38 2.32±0.86 0.99±0.08 0.95±0.30
a
 1.56±0.30 
 105 Control  3.68±1.32 2.21±1.01 5.94±1.31
b
 5.21±1.48 3.69±2.06 1.98±1.15 1.42±0.10 2.56±0.61
b
 1.29±0.15 
 105 CLA  2.02±1.02 1.37±0.57 2.56±0.70
b
 2.18±0.71 2.56±1.23 2.81±1.18 1.22±0.11 1.86±0.16
b
 1.06±0.05 
PPARγ6 1 Control  1.18±0.13a 1.58±0.27 1.76±0.30 1.97±0.32 2.34±0.26 1.57±0.28   0.65±0.11a 
 42 Control  1.50±0.45
ab
 1.57±0.28 2.94±0.35 2.45±0.50 1.57±0.48 1.74±0.17   0.78±0.05
ab
 
 42 CLA  2.04±0.34
ab
 1.92±0.24 2.45±0.30 1.59±0.22 1.82±0.42 1.29±0.34   0.76±0.07
ab
 
 105 Control  1.98±0.45
b
 2.48±0.42 3.57±0.49 2.56±0.47 2.05±0.51 1.67±0.27   0.85±0.11
b
 
 105 CLA  2.47±0.45
b
 3.25±0.66 3.32±0.78 2.53±0.53 2.99±0.52 2.34±0.38   1.10±0.12
b
 
PPARγ27 1 Control  0.88±0.15 0.87±0.25 0.92±0.25a 1.47±0.16 1.78±0.45 0.83±0.23 0.69±0.13 1.15±0.39 0.56±0.06a 
 42 Control  1.42±0.47 0.76±0.09 1.33±0.21
ab
 1.71±0.49 0.80±0.39 0.91±0.16 0.82±0.04 1.15±0.23 0.68±0.08
a
 
 42 CLA  1.76±0.32 1.14±0.25 1.19±0.06
ab
 1.13±0.31 1.17±0.31 0.62±0.14 0.82±0.16 0.68±0.05 0.65±0.08
a
 
 105 Control  1.47±0.37 1.29±0.23 1.59±0.13
b
 1.59±0.23 0.97±0.26 0.74±0.06 0.71±0.09 0.97±0.14 0.98±0.25
b
 
 105 CLA  1.24±0.33 1.11±0.20 1.45±0.24
b
 1.55±0.36 1.57±0.21 1.13±0.15 0.78±0.12 0.75±0.12 1.23±0.21
b
 
CLA: Lutrell® Pure, BASF SE, Ludwigshafen, Germany. Control: Silafat®, BASF SE. 
Significant differences (P < 0.05) between different days per tissue are defined using different letters. Significant differences (P < 0.05) between CLA and control group within day and 
tissue are depicted by bold numbers.  
Data are normalized based on the geometric mean of Eukariotic translation initiation factor 3 (EIF3K), Lipoprotein receptor-related protein 10 (LRP10), RNA polymerase II (POLR2A), 
Emerin (EMD), Marvel domain containing 1 (MARVELD1), and Hippocalcin-like 1 (HPCAL1) for each s.c. fat and mesenteric fat depots; EIF3K, LRP10, POLR2A, EMD, and 
MARVELD1 for omental and retroperitoneal fat depots; HPCAL1, LRP10, POLR2A, EIF3K, Glyceraldehyde-phosphate-dehydrogenase (GAPDH) for liver; LRP10, EMD, POLR2A, 
EIF3K for muscle, and MARVELD1, EMD, LRP10, EIF3K, POLR2A, HPCAL1 for mammary gland tissue. 
1 Semitendinosus. 2 ADIPOQ in mammary gland tissue was only detectable in one-third of the samples. 3 Adiponectin. 4 Adiponectin receptor 1. 5 Adiponectin receptor 2. 6 Peroxisome 
proliferator-activated receptor γ. 7 Peroxisome proliferator-activated receptor γ2; Means ± SE.  
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Table 3. LEP system, IL-6, and TNF-α mRNA expression in different tissues of primiparous cows supplemented with or without 
CLA in a time course of 105 DIM 
Gene DIM Treatment  
Tissue mRNA abundance (arbitrary unit) 
Omental Mesenteric Retroperitoneal s.c. tail head s.c. withers s.c. sternum Muscle Mammary Liver 
LEP
1
 1 Control  0.43±0.11 0.80±0.27 1.70±0.37 0.87±0.21 1.14±0.34 0.77±0.27 0.18±0.09 0.29±0.15  
 42 Control  0.89±0.38 0.67±0.25 1.07±0.38 1.01±0.39 0.73±0.67 1.24±0.60 0.18±0.08 0.35±0.10  
 42 CLA  1.67±0.57 0.88±0.30 1.44±0.55 0.92±0.61 1.85±1.10 1.63±0.83 0.71±0.28 0.43±0.17  
 105 Control  2.23±1.11 1.33±0.67 3.33±0.65 1.40±0.27 1.69±0.74 0.76±0.15 0.50±0.27 0.15±0.05  
 105 CLA  1.38±0.76 0.86±0.26 1.97±0.67 1.16±0.39 1.80±0.54 1.76±0.59 0.34±0.13 0.23±0.10  
LEPRB
2
 1 Control  1.57±0.41
a
 0.67±0.19 1.60±1.06
ab
 0.54±0.14 1.19±0.49 2.42±0.85 0.35±0.05 0.52±0.07
a
 1.49±0.27 
 42 Control  0.41±0.12
b
 0.67±0.20
a
 1.35±0.31
a
 0.42±0.30 0.72±0.32 2.45±1.10 0.71±0.14 0.26±0.11
ab
 1.29±0.14 
 42 CLA  0.51±0.20
b 
0.79±0.26
a
 1.57±0.53
a
 0.22±0.05 1.06±0.21 0.98±0.15 0.70±0.11 0.37±0.03
ab
 1.98±0.41 
 105 Control  0.97±0.67
b
 0.27±0.11
b
 0.54±0.17
b
 0.27±0.10 0.44±0.14 1.14±0.23 0.59±0.10 0.17±0.11
b
 1.20±0.18 
 105 CLA  0.56±0.18
b
 0.34±0.16
b
 0.58±0.21
b
 0.24±0.09 1.06±0.45 2.33±0.84 0.72±0.14 0.28±0.08
b
 1.37±0.16 
TNF-α3 1 Control  1.14±0.18 0.58±0.10 1.06±0.16 0.65±0.05a 0.58±0.09a 1.08±0.19a 0.72±0.13 1.81±0.33a 0.52±0.06a 
 42 Control  1.37±0.40 1.00±0.10 0.92±0.12
a
 1.27±0.21
b
 1.37±0.28
b
 1.45±0.36
ab
 1.03±0.16 0.81±0.14
b
 1.12±0.20
b
 
 42 CLA  1.33±0.36 0.72±0.25 1.09±0.17
a
 1.74±0.63
b
 1.06±0.22
b
 1.34±0.23
ab
 1.08±0.38 0.96±0.12
b
 1.42±0.11
b
 
 105 Control  0.83±0.27 0.84±0.11 0.64±0.16
b
 1.03±0.37
ab
 1.13±0.39
ab
 2.25±0.53
b
 0.92±0.12 0.99±0.14
b
 1.62±0.21
b
 
 105 CLA  1.70±0.43 1.12±0.37 0.69±0.11
b
 1.15±0.27
ab
 1.01±0.12
ab
 1.77±0.39
b
 0.94±0.12 0.68±0.13
b
 1.56±0.27
b
 
IL-6
4
 1 Control  2.77±1.57 0.85±0.41 1.43±0.36 4.30±2.29
a
 7.31±2.07
a
 0.52±0.13 0.85±0.20 0.68±0.14 0.36±0.08
a
 
 42 Control  0.82±0.09 0.68±0.08 0.88±0.31 1.62±0.40
ab
 2.79±1.38
b
 0.53±0.13 0.88±0.18 0.83±0.10 0.70±0.10
b
 
 42 CLA  0.74±0.06 0.79±0.31 0.70±0.07 1.38±0.55
ab
 1.68±0.36
b
 0.34±0.13 0.86±0.13 0.83±0.19 0.78±0.15
b
 
 105 Control  1.08±0.66 0.36±0.15 0.59±0.15 0.90±0.25
b
 0.69±0.36
b
 0.26±0.09 0.76±0.11 0.95±0.14 0.88±0.11
b
 
 105 CLA  3.98±1.37 1.65±0.16 2.13±1.41 3.65±2.53
ab
 2.22±0.73
b
 0.55±0.15 0.94±0.14 0.82±0.09 0.73±0.12
b
 
CLA: Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany. 
Control: Silafat
®
, BASF SE. 
Significant differences between different days per tissue are defined using different letters. Significant differences (P < 0.05) between CLA and control group within day 
and tissue are depicted by bold numbers. 
Data are normalized based on the geometric mean of Eukariotic translation initiation factor 3 (EIF3K), Lipoprotein receptor-related protein 10 (LRP10), RNA 
polymerase II (POLR2A), Emerin (EMD), Marvel domain  
containing 1 (MARVELD1), and Hippocalcin-like 1 (HPCAL1) for each s.c. fat and mesenteric fat depots; EIF3K, LRP10, POLR2A, EMD, and MARVELD1 for 
omental and retroperitoneal fat depots; HPCAL1, LRP10, POLR2A, EIF3K, Glyceraldehyde-phosphate-dehydrogenase (GAPDH) for liver; LRP10, EMD, POLR2A, 
EIF3K for muscle, and MARVELD1, EMD, LRP10, EIF3K, POLR2A, HPCAL1 for mammary gland tissue. 
1
 Leptin. 
2
 leptin receptor isoform b.
 3
 Tumor necrosis factor-α. 4 Interleukin-6; Means ± SE. 
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Figure 1. Longitudinal mRNA expression of adiponectin receptors (ADIPOR1 and ADIPOR2) in liver and 
s.c. tail head biopsies of dairy cows together with adiponectin (ADIPOQ) and interleukin-6 (IL-6) mRNA 
abundance in s.c. adipose tissue and in liver of Trial 1, respectively. Cows were fed with conjugated linoleic 
acids (CLA, Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) at 100 g/day CLA or a control fat 
supplement (Silafat
®
, BASF SE) from day 1 until day 182 postpartum in Trial 1. Primiparous cow samples 
are not included (There are no sample in the CLA group at days 1, 70, 182, and 224) [Control: n = 10, CLA: 
n = 11]. Cumulative mRNA expression of both control and CLA is shown because CLA effect was 
insignificant. For normalization, lipoprotein receptor-related protein 10 (LRP10), RNA Polymerase II 
(POLR2A) and eukariotic translation initiation factor 3 (EIF3K) in liver and LRP10, glyceraldehyde-
phosphate-dehydrogenase (GAPDH), and POLR2A in s.c. adipose tissue were used as reference genes. 
Different letters indicate significant differences between days relative to parturition (P < 0.05; mean ± 
SEM). Area between vertical lines corresponds to the CLA supplementation period. 
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Days relative to parturition 
 
 
 
Figure 2. Leptin serum concentrations (upper graph) and LEP mRNA abundance in s.c. tail head adipose 
tissue (downer graph) in pluriparous and primiparous cows receiving conjugated linoleic acids (CLA, 
Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) at 100 g/day (CLA) or a control fat supplement 
(Silafat
®
, BASF SE) from day 1 until day 182 postpartum in Trial 1. All animals and samples were included 
for serum data [Control: pluriparous cows n = 10, primiparous cows n = 5; CLA: pluriparous cows n = 11, 
primiparous cows n = 5]. For mRNA data only pluriparous cow samples from days -21, 1, 21, 70, 105 182 
196, 224, and 252 relative to parturition for control group and days -21, 21, 105, 196, and 252 for CLA 
group were analysed. For normalization, lipoprotein receptor-related protein 10 (LRP10), RNA Polymerase 
II (POLR2A) and glyceraldehyde-phosphate-dehydrogenase (GAPDH) in s.c. adipose tissue were used as 
reference genes. ns: not significant. Different letters indicate significant differences between days relative to 
parturition (P < 0.05; mean ± SEM). Area between vertical lines corresponds to the CLA supplementation 
period. A.U.: arbitrary units.  
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Figure 3. Longitudinal mRNA expression of peroxisome proliferator-activated receptor (PPAR) γ and γ2, 
leptin receptor (LEPR), leptin receptor isoform b (LEPRB), and tumor necrosis factor (TNF)-α in liver and 
s.c. tail head adipose tissue biopsies of dairy pluriparous cows fed with conjugated linoleic acids (CLA, 
Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) at 100 g/day CLA or a control fat supplement (Silafat
®
, 
BASF SE) from day 1 until day 182 postpartum in Trial 1(defined by vertical lines). Primiparous cow 
samples are not included. There are no sample in the CLA group at days 1, 70, 182, and 224 [Control: n = 
10, CLA: n = 11]. For normalization, lipoprotein receptor-related protein 10 (LRP10), RNA Polymerase II 
(POLR2A) and eukariotic translation initiation factor 3 (EIF3K) in liver and LRP10, glyceraldehyde-
phosphate-dehydrogenase (GAPDH), and POLR2A in s.c. adipose tissue were used as reference genes. 
Different letters indicate significant differences between days relative to parturition where there are 
differences otherwise no letter used. CLA effects are defined using asterisks (P < 0.05; mean ± SEM). Area 
between vertical lines corresponds to the CLA supplementation period. 
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Figure 4. Glucose and insulin concentration in serum and calculated Revised Quantitative Insulin 
Sensitivity Check Index (RQUICKI) in cows receiving conjugated linoleic acids (CLA, Lutrell
®
 Pure, 
BASF SE, Ludwigshafen, Germany) at 100 g/day or a control fat supplement (Silafat
®
, BASF SE) from day 
1 until day 182 postpartum [pluriparous cows (Control, n = 10 and CLA, n = 11) and primiparous cows 
(Control, n = 4 and CLA, n = 5)] in Trial 1. RQUICKI = 1/[log(glucose) + log(insulin) + log(NEFA)], [24]. 
Supplementation with CLA did not interfere with the parameters measured in primiparous cows. Area 
between vertical lines corresponds to the CLA supplementation period. Pooled SE for glucose, insulin, and 
RQUICKI were 0.21, 1.70, and 0.05 for heifers and 0.24, 1.86, and 0.05 for cows, respectively. 
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Figure 5. Individual fat depot differences of adiponectin (ADIPOQ), adiponectin receptors (ADIPOR1 and 
ADIPOR2), leptin (LEP), leptin receptor isoform b (LEPRB), peroxisome proliferator-activated receptor 
(PPAR) γ and γ2, tumor necrosis factor (TNF)-α, and interleukin (IL)-6 mRNA abundance [mean of d 1 (n 
= 5), 42 (n = 10), and 105 (n = 10) post partum from primiparous cows (Trial 2) fed at 100 g/day with 
conjugated linoleic acids (CLA, Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) or a control fat 
supplement (Silafat
®
, BASF SE)] in Trial 2. Different letters specify the differences within fat depots (P < 
0.05). Data are normalized based on the geometric mean of eukariotic translation initiation factor 3 
(EIF3K), lipoprotein receptor-related protein 10 (LRP10), RNA polymerase II (POLR2A), emerin (EMD), 
marvel domain containing 1 (MARVELD1), and hippocalcin-like 1 (HPCAL1) for each s.c. fat and 
mesenteric fat depots and EIF3K, LRP10, POLR2A, EMD, and MARVELD1 for omental and 
retroperitoneal fat depots. 
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7. General discussion and conclusions 
Conjugated linoleic acids are well known for their milk fat reducing effects in dairy cows. 
In the animal experiments studied herein, the efficacy of the CLA treatment was 
confirmed in this respect, i.e. milk fat percentage in both primi- and pluriparous cows was 
14% and 12% less than in the corresponding control groups, respectively (von Soosten et 
al., 2011; Pappritz et al., 2011a). This effect of CLA was evident 42 and 28 days after 
onset of the CLA treatment in primiparous and pluriparous cows, respectively. However, 
most of the CLA effects on tissues investigated herein were only seen later in lactation. 
CLA treated primiparous cows had less back fat than their control counterparts (von 
Soosten et al., 2011) and the decrease of adipocyte size was observed in 4 out of 6 
different fat depots in the CLA group at 105 days of supplementation, whereas fat cell 
size at 42 days was smaller in only 2 depots (Akter et al., 2011). Therefore, the time of 
CLA treatment seems to be an important determinant for the different effects. In addition, 
for CLA effects at the level of tissues, the dosage and the availability of the CLA isomers 
in intermediary metabolism is crucial. For the investigations of the present thesis, 100 g 
of commercially available CLA supplement were tested. For this supplement, a 10% 
content of each the cis-9, trans-11 and the trans-10, cis-12 CLA isomer and protection 
from ruminal degradation are claimed. In previous experiments feeding 25, 50 or 100 g of 
this supplement per day, the portion of trans-10, cis-12 isomer of total fatty acids from 
milk fat was 3 (0.03%), 6 (0.06%) and 12 fold higher (0.12%) than in control animals 
receiving no CLA (0.01%). For the cis-9, trans-11 isomer, the increase was less 
pronounced, i.e. 1.2 (0.55%), 1.4 (0.66%) and 1.9 fold (0.86%) higher, respectively 
(Brömmel et al., 2007; Meyer et al., 2007). Thus a significant portion of the consumed 
CLA reached the circulation and finally the mammary gland. In a more detailed approach 
using cows fitted with rumen and duodenal cannula, the portion of CLA escaping rumen 
biohydrogenation was determined to be between 5 and 16% (Pappritz et al., 2011b) and is 
thus comparable with other studies reporting 9-34% (de Veth et al., 2005). The CLA that 
reach the duodenum is mostly secreted into milk (36-48%), or is excreted via faeces (~ 
50%) and thus only a small portion, i.e. 2-14% of the CLA in the duodenum would be 
able to reach different tissues and cells (Pappritz et al., 2011b). However, when 
comparing the absolute and relative concentrations of the two main CLA isomers in the 
two animal experiments investigated herein, distinctively lower concentrations were 
observed: in the trial from which we used the pluriparous cows, the percentage of the cis-
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9, trans-11 isomer in milk fat (0.59%) was unchanged at 100 g/day vs. no CLA 
supplement (0.57%); for the trans-10, cis-12 CLA a 7.5 fold higher percentage (0.03%) 
than in the control (0.004%) was observed during the supplementation period (Pappritz et 
al., 2011a), i.e. only half of the difference reached in the earlier studies. Moreover, when 
comparing the percentage values from this with the earlier study, the content of trans-10, 
cis-12 CLA in milk fat was also less, i.e. 0.03% vs. 0.12%. Adipose tissue analyses for 
CLA contents were done for the primiparous cows from the present investigations (von 
Soosten, 2012): comparing 3 v.c. and the s.c. fat depot, the cis-9, trans-11 isomer 
concentrations were not affected by CLA treatment. For the trans-10, cis-12 CLA, 
significantly higher concentrations were reached in 2 v.c. and in the s.c. fat depot of CLA 
vs. control cows. However, the concentrations were very low and the significant 
difference was attributable to the fact that the portion of trans-10, cis-12 CLA in fat was 
below the limit of detection (<0.01% of total fatty acids) whereas the positive tissues had 
maximally 0.02%. In skeletal muscle tissue, CLA were not detectable. Overall, the 
transfer efficiencies of the consumed CLA into AT were very low, i.e. < 0.1%. 
Comparing the tissue concentration after 42 vs. 105 days of supplementation, slightly 
higher transfer efficiencies (0.18%) were observed with the 105 day treatment period. The 
low tissue concentrations reached in the current trials might thus be a reason for the rare 
and only scattered CLA effects observed in general in these two trials. When considering 
the modes of action of CLA, the focus in our works was on receptor-triggered pathways. 
An additional mechanism on how CLA may affect cells might also be of importance 
although it was beyond the scope of this thesis: CLA have been suggested to alter the 
basic properties of cell membranes when build into the lipid bilayer. As other 
polyunsaturated fatty acids, CLA seem sterically incompatible with sphingolipid and 
cholesterol; therefore, CLA appear to alter the biochemical make up of lipid 
rafts/caveolae microdomains, thereby influencing cell signaling, protein trafficking and 
cell cytokinetics (Chapkin et al., 2008). Indeed, in a recent study (Subbaiah et al., 2011) 
trans-10, cis-12 CLA was demonstrated to increase the cholesterol content of the raft 
fraction in cell culture studies. Moreover, very recently the incorporation of cis-9, trans-
11 CLA in membranes of cancer cells was shown to make the cells more susceptible to 
X-radiation and thus points to functional importance of the membrane function altering 
effects of CLA, in particular in the raft-associated proteins (Grądzka et al., 2013). As 
pointed out above, incorporation specifically in cell membranes was not assessable in the 
present cow studies. However, in the frame of the cooperative project herein, the fatty 
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acid composition of the lipid fraction of blood cells (that have very low intracellular lipid 
concentrations) was determined. The portion of trans-10, cis-12 CLA in total fatty acids 
was increased (Renner et al., 2012) although only to a similarly low extent as seen for AT 
(i.e. from undetectable portions in the controls to 0.02% of total fatty acids). For 
comparison: in the cancer cells from the aforementioned study (Grądzka et al., 2013), the 
cis-9, trans-11 CLA portion was 20% of total fatty acids. The CLA dosages commonly 
used in monogastric species are generally much higher that for dairy cows. The milk fat 
reducing effect in dairy cows is the main target trait and for this, the relatively low dosage 
is - as manifold proven including the current studies - effective. There is no conclusive 
explanation why the tissue concentrations reached in our studies were lower than in 
previous studies, albeit the same CLA preparation was used. Nevertheless, the evidence 
for the milk fat reduction observed in the current studies demonstrates that active tissue 
concentrations were indeed achieved. Future studies using higher dosages or possibly a 
more efficient mode of rumen protection to increase the amount of CLA available in the 
small intestine might yield more pronounced effects on the variables tested herein. In 
addition, the situation might be different if the CLA treatment would have been started 
already during late pregnancy as compared to the first day of lactation in the current 
studies. Moreover, in view of the fact that some of the effects of CLA i.e. increased 
insulin concentration, reduced insulin sensitivity and reduced PPARγ mRNA abundance 
in liver tissue were maintained beyond the actual time of CLA treatment, potential effects 
on cell membrane traits are supported, since both incorporation and discharge of CLA 
from cell membranes require time. The effects of CLA on cell membranes are assumed to 
last longer than the ones of other dietary polyunsaturated fatty acids such as omega-3 
fatty acids due to their differential positioning at the glycerol back bone of phospholipids 
(typical cell membrane lipids): polyunsaturated fatty acids are predominantly in the sn-2 
position of phospholipids, whereas the trans-10, cis-12 and cis-9, trans-11 CLA isomers 
are mainly in the sn-1 position on the phospholipids. The turnover of fatty acids at sn-1 
should be slower than that of sn-2 fatty acids because of the predominant occurrence of 
phospholipases A2 compared to phospholipases A1. Therefore, the effects of CLA may 
last for a longer time (Subbaiah et al., 2011).  
Even though only low CLA concentrations were reached, significant CLA effects were 
observed herein. In view of the reduced PPARγ expression in the mammary gland of 
primiparous cows after 42 or 105 days of CLA treatment, the udder as main target tissue 
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was confirmed. Moreover, the effect on PPARγ is a novel observation that adds on to our 
understanding of the mode of action CLA exert in this particular tissue. In addition, the 
alterations observed in terms of insulin sensitivity indicate that there are indeed long term 
systemic effects of the supplementation. The data base is still not solid enough for a final 
appraisal of CLA supplementation with regard to animal health, but the results elaborated 
herein, indicate that the meaning of the (subtle) decrease in insulin sensitivity requires 
further consideration.  
From the current results, several differences between the different fat depots studied were 
observed. First, s.c. and v.c. fat depots were not consistently different when taking the 
respective v.c. and s.c. fat depots together. Second, there were partly differences between 
the v.c. fat depots that might partly be explained by the different blood supply and drain. 
This is of general basic interest, however, the third finding was particularly interesting 
from a more research applied point of view: the results about differences between 
different s.c. fat depots were surprising and were observed not only at the molecular 
(mRNA) level but also on the gross tissue level: in primiparous cows 105 days of CLA 
treatment resulted in decreasing back fat thickness, but not in decreasing BCS that is 
scored at additional different locations (von Soosten et al., 2011). Another example was 
the reduction in SAA3 and haptoglobin mRNA that was exclusively observed in the s.c. 
fat depot above the withers but not around the tail head. In conclusion, the common 
practice of limiting assessments of s.c. fat depots to the tail head location limits the results 
to this very depot and does not justify extrapolation to the entire s.c. fat depots. Moreover, 
in view of the relatively low share that s.c. fat depots have in comparison to the v.c. fat 
depots investigated herein and the relatively higher mobilization from v.c. fat depots, in 
particular retroperitoneal fat, future studies addressing the metabolic and regulatory role 
of AT should take at least one of the v.c. fat depots into consideration for sampling. 
According to a recently published paper, retroperitoneal fat can indeed be sampled via 
biopsy using a novel technique for surgery (Locher et al., 2011).  
Finally, the adequacy of the control fat supplement that was used in the current studies to 
be able to provide isoenergetic rations in both the CLA and the control group finally 
requires some discussion: using stearic acid to replace CLA in the fat supplement for the 
control groups is a common practice in comparable experimental set-ups and is well 
justified to achieve isoenergetic nutrient supply. However, not only CLA but also stearic 
acid is biologically active and exerts also regulatory functions, e.g. treating murine 
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adipocytes in vitro with saturated fat vs. unsaturated fat reportedly stimulates haptoglobin 
(Bueno et al., 2010). Indeed, stearic acid as well as different isomers of linoleic acid were 
defined as ligand for a specific nutrient sensing receptor, i.e. GPR40 (Briscoe et al., 2003; 
Briscoe et al., 2006). Therefore, some of the biological activities we attributed to CLA 
herein might in fact be at least partly due to effects induced in the control group. For 
example, in a preliminary work, we have shown that GPR40 mRNA was increased in 
liver and in retroperitoneal and omental fat depots after 105 days of CLA treatment 
(Saremi et al., 2012). It is not yet known whether activation of this receptor by its ligand 
will regulate its rate of transcription, but if so, medium and long chain fatty acids have in 
general to be considered as ligands thus questioning the specificity of a CLA effect in this 
set-up of control feeding. However, alternative fatty acids for control feed supplements 
will yield similar problems and a valid solution to the problem is not conceivable. 
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8. Summary 
Dairy cows undergo a time of negative energy balance during the first weeks of lactation 
and have to mobilize body reserves mainly body fat to cover the needs of milk 
production. Orchestrated hormonal and metabolic changes support the homeorhetic 
adaptations whereby the drain of nutrients towards the mammary gland is accomplished 
by decreasing the sensitivity for insulin in other peripheral organs. However, the role of 
newly discovered adipokines (i.e. messenger molecules secreted from adipose tissue) and 
their respective receptors as well as of nuclear receptors as key regulators of gene 
expression was only scarcely investigated in dairy cows. In particular, studies about the 
regulatory function of adipose tissue (AT) for metabolism were largely limited to 
subcutaneous (s.c.) fat depots that is accessible using biopsies. Based on data from 
monogastric species, differences between s.c. and visceral (v.c.) fat depots are probable, 
but the respective data in cattle were lacking. The present studies were thus carried out to 
survey the factors related to insulin sensitivity (IS) in dairy cows; based on the link 
between local inflammatory reactions and decreased IS in AT, pro-inflammatory 
cytokines and acute phase proteins were additionally addressed. In addition, potential 
effects of a dietary supplementation with conjugated linoleic acids (CLA) that knowingly 
reduces milk fat and might thus alleviate the negative energy balance at the onset of 
lactation were tested.  
In two trials, Holstein cows were allocated to either a CLA group (100 g/d of a fat 
supplement containing 12% each of the cis-9, trans-11 and the trans-10, cis-12 isomer) or 
a control group (100 g/d of a control fat in which CLA was substituted by stearic acid). In 
trial 1, liver and s.c. fat depot from tail head as well as blood samples were collected from 
pluriparous cows from d -21 to d 252 relative to calving whereby the supplements were 
fed from d 1 to d 182. In trial 2, primiparous cows were accordingly treated and tissue 
samples were collected at slaughter on days 1, 42 and 105 p.p. Samples were collected 
from liver, mammary gland, M. semitendinosus, pancreas, and 3 different v.c. fat depots 
(omental, mesenterial, and retroperitoneal) and from 3 s.c. locations (tail head, withers 
and sternum) of AT.  
The main focus of this thesis was on gene expression and therefore appropriate reference 
genes (REF) had to be established in first place. From 7 REF measured, the most stable 
ones were identified using geNorm
PLUS 
(manuscript 1) for comparisons within tissues 
and for tissue combinations. By providing both new and stable REF, the current status of 
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normalization in gene expression analysis in different tissues of dairy cows could thereby 
be improved. Moreover, REF were suggested for some of the adipose depots for which 
stable REF have previously not been investigated at all, i.e. for 2 s.c. locations, i.e. above 
withers and sternum, and in omental fat. Indeed, the results explicitly discourage from 
using GAPDH as the sole REF if its stability is not approved by one of the known 
algorithms such as geNorm. 
Within manuscript 2, we aimed to characterize the lactational changes of the major 
bovine acute phase protein, i.e. haptoglobin (Hp), in serum and its mRNA expression in 
different tissues of dairy cows considering also potential effects of CLA supplementation. 
At the day of parturition, Hp concentrations and tissue mRNA expression were increased 
compared to a.p. values; thereafter they decreased and remained stable until the end of the 
observation. Based on the presence of Hp-immuno staining in histological sections from 
different fat depots and Hp mRNA expression in AT and differentiated and 
undifferentiated adipocytes, Hp was established as an adipokine for the bovine species. In 
view of the low Hp mRNA abundance in ATs as compared to liver and the correlation 
between tissue mRNA abundance and Hp serum concentrations that was limited to liver, 
Hp from AT will not or only marginally contribute to the circulating Hp concentrations. 
Our data are thus in support of the liver being the main site of Hp expression and 
secretion. In humans, Hp was suggested as marker of adiposity, but the mRNA abundance 
values and the lack of correlations between Hp and body weight, body fat mass or body 
condition score observed herein, are not in support of a relation between serum Hp 
concentrations and body fat content. The moderate correlation between Hp and NEFA 
and BHB concentrations in serum underpins the relationship between hepatic lipidosis 
and Hp secretion. Hp in serum was not affected by supplementation or withdrawal of 
CLA. Based on the observation that the Hp mRNA abundance in 2 out of 6 different fat 
depots was reduced in CLA treated primiparous cows as compared to the control group, 
CLA might exert local anti-inflammatory effects within AT. To address such effects in 
more detail, future studies might be extended to the level of the protein. 
In an analogous study (manuscript 3), another major acute phase protein, serum amyloid 
A (SAA) was investigated in different tissues of dairy cows taking into account potential 
changes with time of lactation and effects of dietary supplementation with CLA. The 
focus was on fat depots from different localizations. The pattern of SAA3 (one of the SAA 
isoforms) mRNA abundance throughout lactation was similar to Hp with maximal 
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abundances around parturition. We demonstrated the presence of SAA3 mRNA in 
different v.c. and s.c. fat depots as well as in cultured bovine preadipocytes and 
differentiating adipocytes. Moreover, the presence of SAA in AT was confirmed at the 
level of the protein thus confirming that SAA3 - similar to Hp - is an adipokine in cattle, 
too. The highest SAA3 mRNA expression was observed in the mammary gland; AT 
ranked second whereas liver seems not to be a major site of expression of the SAA3 
isoform. CLA treatment reduced the SAA3 mRNA abundance in 2 s.c. fat depots and in 
muscle tissue. Therefore, a similar local anti-inflammatory effect as mentioned for Hp 
may also exist in case of SAA3. As to whether this effect will be seen at the level of 
plasma or at the level of tissue protein expression remained to be clarified. 
In manuscript 4, the mRNA expression profiles of genes related to IS were characterized 
encompassing an entire lactation cycle in pluriparous cows and the first 105 d in milk in 
primiparous cows. The studied genes include adiponectin (ADIPOQ), leptin (LEP), their 
receptors (LEPR, LEPRB, ADIPOR1, and ADIPOR2), two nuclear receptor isoforms 
(PPARγ and PPARγ2) and 2 pro-inflammatory cytokines (TNF-α and IL-6). To be able to 
relate these data to whole-body IS, an index (RQUICKI) was calculated from the serum 
concentrations of glucose, insulin, and NEFA. In pluriparous cows, the mRNA expression 
of the aforementioned genes was mostly decreased from d -21 a.p. to day 21 p.p. in s.c. 
fat depot with the exception of TNF-α which was stably expressed. In liver, increases 
were observed for LEPR, LEPRB and ADIPOR2, and decreases for all other hepatic target 
mRNAs except TNF-α and ADIPOR1 which remained constant in this time. In later 
lactation, a.p. values were reached again and were largely maintained until d 252 p.p. A 
reduction in IS was confirmed after parturition using RQUICKI index lasting even after 
withdrawal of CLA. The groups treated with CLA vs. control fat had lower mRNA 
expression of PPARγ in liver and PPARγ2 in s.c.AT. In addition, CLA vs. Control group 
had higher expression of LEPRB and TNF-α in liver. Cows of the CLA group had also 
higher insulin concentrations and reduced systemic IS as estimated by the RQUICKI 
index persisting after the end of CLA supplementation similar to PPARγ mRNA in liver. 
In primiparous cows, changes with the duration of lactation were observed for most of the 
target mRNAs, except LEP, but not in all tissues investigated; time course and direction 
of change were partly divergent between the different tissues. In both trials, the observed 
shifts in the mRNA expression of modulators of IS like the ADIPOQ and the LEP system 
in different tissues of cows were in accordance to the known reduction in IS during the 
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Summary 
transition period and its improvement thereafter. CLA treatment for 105 days decreased 
the mRNA abundance of ADIPOQ, ADIPOR2, and TNF-α in v.c. fat depots and of 
PPARγ2 in the mammary gland. The results of these studies provide expression profiles 
of genes that are particularly related to the heterogeneous, i.e. depot-specific, regulatory 
functions of AT in lactating dairy cows. The known effect of CLA inhibiting milk fat 
synthesis might at least be partly explained by the down-regulation of PPARγ2 in the 
mammary gland observed herein. Moreover, the results summarized herein support the 
notion that CLA treatment indeed decreases IS in dairy cows. The importance of the CLA 
induced effects on IS for animal health can presently not be finally assessed due to lack of 
validated reference values for IS in high yielding dairy cows. However, the reduced IS 
indicated by the RQUICKI estimates needs substantiation by direct assessments e.g. 
hyperinsulinemic euglycemic clamp. Besides the comprehensive longitudinal 
characterization of the mRNA expression of genes linked to IS and to inflammatory 
reactions, the works of this thesis support both local and systemic effects of CLA 
treatment on IS, and point to rather local than systemic anti-inflammatory effects. These 
findings should be further substantiated at the level of the protein. 
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9. Zusammenfassung 
Während den ersten Wochen der Laktation befinden sich Milchkühe in einer Phase der 
negativen Energiebilanz. Der Austrag von Energie über die Milch, der durch die 
demgegenüber nur langsame Steigerung der Futteraufnahme noch nicht ausgeglichen 
werden kann, macht die Mobilisierung von Körperreserven, primär von Fett notwendig. 
Hormonelle und metabolische Veränderungen ermöglichen über eine verringerte IS der 
peripheren Organe den Fluss der Nährstoffe zur Milchdrüse und unterstützen somit die 
homöorethische Anpassung. Die Bedeutung von neu entdeckten Adipokinen (vom 
Fettgewebe sekretierte Botenstoffe), deren entsprechenden Rezeptoren sowie von 
Kernrezeptoren als Schlüsselregulatoren der Genexpression wurde bei Milchkühen bisher 
kaum untersucht. Insbesondere Studien zur regulatorischen Funktion des Fettgewebes auf 
den Stoffwechsel bezogen sich hauptsächlich auf das mittels Biopsie erreichbare 
subkutane Fettgewebe. Daten basierend auf Untersuchungen von Monogastriern weisen 
aber auf Unterschiede zwischen subkutanen und viszeralen Fettdepots hin; entsprechende 
Daten fehlten jedoch weitestgehend für Wiederkäuer und somit auch für das Rind. Ziel 
der vorliegenden Studien war die Untersuchung von Faktoren, die bei Milchkühen mit IS 
in Verbindung stehen. Aufgrund der Verbindung zwischen lokalen 
Entzündungsreaktionen und verminderter Insulinsensitivität (IS) im Fettgewebe wurden 
auch pro-inflammatorischer Zytokine sowie Akut Phase Proteinen (APP) berücksichtigt. 
Darüber hinaus wurde der Einfluss konjugierter Linolsäuren (CLA) untersucht, welche 
den Milchfettgehalt reduzieren und dadurch die negative Energiebilanz zu Beginn der 
Laktation mindern könnten. 
In zwei Versuchen wurden Holstein Kühe in eine CLA-Gruppe (100 g Fettsupplement 
pro Tag mit je 10% cis-9, trans-11 und trans-10, cis-12 Isomer) oder eine Kontrollgruppe 
(100 g Fettsupplement pro Tag, Ersatz der CLA durch Stearinsäure) eingeteilt. In Versuch 
1 erfolgte die Supplementation bei pluriparen Kühen im Zeitraum zwischen Tag 1 und 
182 nach der Kalbung; Biopsien von Leber, subkutanem Fett sowie Blutproben wurden 
zwischen Tag 21 a.p. und Tag 252 p.p. entnommen. In Versuch 2 erfolgte eine 
entsprechende Fütterung von primiparen Kühen. An Tag 1, 42 und 105 p.p. wurden bei 
der Schlachtung der Tiere Proben von Leber, Milchdrüse, M. semitendinosus, Pankreas, 
drei verschiedenen subkutanen Fettdepots (an Schwanzansatz, Widerrist und Sternum) 
sowie von drei viszeralen Depots (omental, mesenterisch und retroperitoneal) genommen.  
Der Schwerpunkt dieser Arbeit lag auf der Analyse der Genexpression; aufgrund dessen 
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erfolgte im ersten Schritt die Etablierung geeigneter Referenzgene (REF). Aus sieben 
gemessenen REF wurden mittels geNorm
PLUS
 (Manuskript 1) die stabilsten Gene 
ausgewählt und damit Vergleiche innerhalb und zwischen den einzelnen Geweben 
ermöglicht. Durch die Bereitstellung stabiler REF konnte der gegenwärtige Status der 
Normalisierung in verschiedenen Geweben von Milchkühen verbessert werden. Darüber 
hinaus wurden für das subkutane Fettgewebe an Widerrist und Sternum sowie für das 
omentale Fett gänzlich neue REF eingemessen. Die Ergebnisse weisen darauf hin, dass 
GAPDH nicht als alleiniges REF verwendet werden sollte, da dessen Stabilität nicht mit 
einem bekannten Algorithmus, wie z.B. geNorm, bestätigt werden konnte. 
In Manuskript 2 erfolgte die Darstellung der laktationsbedingten Veränderungen eines 
bedeutenden bovinen APP, des Haptoglobins (Hp), im Serum sowie dessen mRNA-
Expression in verschiedenen Geweben von Milchkühen unter Berücksichtigung 
möglicher Effekte einer CLA-Supplementation. An Tag 1 nach der Geburt zeigten sich 
sowohl erhöhte Hp-Konzentrationen im Serum als auch eine erhöhte mRNA-Expression. 
Anschließend sanken die Werte wieder auf ein annähernd konstantes Niveau bis zum 
Ende der Untersuchungsphase. Auf Basis der positiven Hp-Immunfärbung von 
Adipozyten in histologischen Gewebeschnitten aus verschiedenen Fettdepots, der Hp 
mRNA-Expression in verschiedenen Fettdepots sowie in differenzierten und 
undifferenzierten (Prä-) Adipozyten konnte Hp beim Rind als ein Adipokin eingeordnet 
werden. In Anbetracht der nur geringen Hp mRNA-Expression im Fettgewebe im 
Vergleich zur Leber und der Korrelation der Hp-Serumkonzentration, die nur für die Hp 
mRNA-Expression in der Leber, nicht aber in den Fettgeweben bestand, ist die Leber als 
Hauptort der Hp-Expression und -Sekretion bestätigt. Beim Menschen wurden Hp-
Blutwerte als Marker für Adipositas diskutiert. Nach den hier vorgelegten Daten trägt Hp 
aus dem Fettgewebe beim Rind aber vermutlich nicht oder nur zu einem geringen Anteil 
zu den zirkulierenden Hp-Konzentrationen bei. Die hier ermittelten mRNA-
Verteilungswerte sowie die fehlende Korrelation zwischen Hp und Körpergewicht, 
Körperfettmasse und BCS lassen bei Milchkühen keine Beziehung zwischen Hp-
Serumkonzentrationen und Körperfettgehalt vermuten. Die mittlere Korrelationen 
zwischen Hp und den NEFA- sowie BHB-Konzentrationen im Serum bestätigen den 
Zusammenhang zwischen hepatischer Lipidose und Hp-Sekretion. Die Supplementierung 
mit CLA hatte keinen Einfluss auf die Hp-Serumkonzentrationen. Aufgrund der 
Beobachtung, dass die Hp mRNA-Expression in zwei der sechs untersuchten Fettdepots 
in CLA-behandelten, primiparen Kühen im Vergleich zur Kontrollgruppe reduziert war, 
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könnte CLA lokal anti-inflammatorische Effekte im Fettgewebe ausüben. Um diese 
Effekte genauer bewerten zu können, sollte in zukünftigen Studien zusätzlich zur mRNA 
auch das Protein berücksichtigt werden.  
In einer analogen Studie (Manuskript 3) erfolgte die Untersuchung des APP Serum 
Amyloid A (SAA) in verschiedenen Fettgeweben von Milchkühen unter Berücksichtigung 
möglicher laktationsbedingter Veränderungen sowie einer CLA-Supplementation. Die 
Expressionsrate der SAA3-mRNA (einer SAA Isoform) während der Laktation entsprach 
der von Hp und zeigte die höchsten Werte um den Zeitraum der Geburt. Zudem konnte 
die SAA3-mRNA in verschiedenen subkutanen und viszeralen Fettdepots sowie in 
Präadipozyten und differenzierten Adipozyten aus Zellkultur nachgewiesen werden. 
Diese Ergebnisse konnten auf Proteinebene bestätigt werden und beweisen somit, dass 
SAA3 beim Rind ein Adipokin ist. Die höchste SAA3 mRNA-Expression wurde in der 
Milchdrüse gefunden, gefolgt vom Fettgewebe. Die Leber scheint hingegen keinen 
Hauptexpressionsort der SAA3-Isoform darzustellen. Die CLA-Behandlung verringerte 
die SAA3- mRNA-Expression in zwei subkutanen Fettgeweben sowie im Muskelgewebe. 
Somit könnte SAA3 einen ähnlichen lokalen, anti-inflammatorischen Effekt haben wie 
Hp. Ob dieser Effekt auch auf systemisch auf Ebene des Proteins existiert, bleibt zu 
klären. 
In Manuskript 4 erfolgte die Charakterisierung der mRNA-Expressionsprofile von 
Genen, die im Zusammenhang mit der IS stehen. Die Untersuchungen umfassten einen 
vollständigen Laktationszyklus bei pluriparen Milchkühen sowie die ersten 105 
Laktationstage bei primiparen Kühen. Die mRNA folgender Gene wurde quantifiziert: 
Adiponektin (ADIPOQ), Leptin (LEP), deren Rezeptoren (LEPR, LEPRB, ADIPOR1, 
ADIPOR2), zwei Kernrezeptorisoformen (PPARγ und PPARγ2), sowie zwei pro-
inflammatorische Zytokine (TNF-α und IL-6). Um diese Daten mit der IS in Beziehung 
setzen zu können, erfolgte die Berechnung eines Indexes (RQUICKI) aus den 
Serumkonzentrationen von Glucose, Insulin und NEFA. Bei pluriparen Kühen zeigten die 
zuvor genannten Gene im subkutanen Fettgewebe eine verringerte mRNA-Expression 
zwischen Tag 21 a.p. und 21 Tage p.p. Einzige Ausnahme stellte TNF-α dar, dessen 
mRNA unverändert blieb. In der Leber konnten Erhöhungen für LEPR, LEPRB und 
ADIPOQ sowie Verringerungen für die übrigen hepatischen Zielgene mit Ausnahme von 
TNF-α und ADIPOR1 nachgewiesen werden. TNF-α und ADIPOR1 zeigten ein 
konstantes Expressionsniveau. In der späten Laktation erreichten die Werte wieder das 
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vorgeburtliche Niveau und verblieben weitgehend konstant bis Tag 252 p.p. Nach der 
Geburt zeigte sich anhand des RQUICKI eine Reduktion der IS, die über den Zeitraum 
der CLA-Supplementation hinausging. Die CLA-Gruppen wiesen im Vergleich zu den 
Kontrollgruppen eine niedrigere mRNA-Expression von PPARγ in der Leber und PPARγ2 
im subkutanen Fettgewebe auf, zudem verfügten sie über eine höhere Expressionsrate von 
LEPRB und TNF-α in der Leber. Die Tiere der CLA-Gruppe zeigten, gemessen am 
RQUICKI-Index, des weiteren höhere Insulinkonzentrationen sowie eine reduzierte 
systemische IS, die über das Ende der CLA-Supplementation hinausging. Bei den 
primiparen Tieren unterlagen die meisten Parameter zeitlichen Veränderungen, jedoch 
nicht in allen Geweben und mit Ausnahme von LEP. Der zeitliche Verlauf sowie die 
Änderungsrichtung stellten sich teilweise gegenläufig zwischen den Geweben dar. In 
beiden Versuchen entsprachen die Änderungen der mRNA-Expressionen von 
Modulatoren der IS wie ADIPOQ und dem LEP-System der Reduktion der IS während 
der Transitionsperiode und der Verbesserung danach. Die CLA-Supplementation über 
einen Zeitraum von 105 Tagen verringerte die mRNA-Expression von ADIPOQ, 
ADIPOR2 und TNF-α im viszeralen Fettgewebe und von PPARγ2 in der Milchdrüse. Die 
Ergebnisse dieser Studie stellen Expressionsprofile von Genen zur Verfügung, die sich 
auf die depot-spezifische regulatorische Funktion des Fettgewebes bei laktierenden 
Milchkühen beziehen. Der hemmende Effekt von CLA auf die Milchfettsynthese könnte 
zumindest teilweise durch die Down-Regulation von PPARγ2 in der Milchdrüse erklärt 
werden. Darüber hinaus unterstützen die hier zusammengefassten Ergebnisse die These, 
dass eine Behandlung mit CLA die IS bei Milchkühen verringert. Die Bedeutung dieses 
CLA-induzierten Effektes in Hinblick auf die Tiergesundheit kann derzeit aufgrund 
fehlender Referenzwerte für die IS bei hochleistenden Milchkühen jedoch noch nicht 
endgültig bewertet werden. Die durch den RQUICKI berechnete reduzierte IS benötigt 
zudem eine Verifizierung durch eine direkte Messung, wie z.B. einen 
hyperinsulinämischen euglycämischen Clamp. Neben der umfassenden longitudinalen 
Charakterisierung der mRNA-Expression von Genen, die in Zusammenhang mit IS und 
Entzündungsreaktionen stehen, weist diese Arbeit sowohl auf lokale als auch auf 
systemische Effekte einer CLA-Behandlung in Bezug auf die IS hin. Des Weiteren deuten 
die Ergebnisse eher auf lokale als auf systemische anti-inflammatorische Effekte. Zur 
Bestätigung sollten diese Ergebnisse auf die Proteinebene erweitert werden. 
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